ofloxacin has been researched along with ciprofloxacin in 1242 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 192 (15.46) | 18.7374 |
| 1990's | 394 (31.72) | 18.2507 |
| 2000's | 443 (35.67) | 29.6817 |
| 2010's | 169 (13.61) | 24.3611 |
| 2020's | 44 (3.54) | 2.80 |
| Authors | Studies |
|---|---|
| Kazuno, K; Kise, M; Kitano, M; Matsuda, M; Matsuoka, M; Ozaki, M; Segawa, J; Shirahase, I; Tomii, Y | 1 |
| Cohen, MA; Domagala, JM; Mailloux, GB; Roland, GE; Suto, MJ | 1 |
| Chiba, K; Egawa, H; Fujita, M; Kataoka, M; Matsumoto, J; Minamida, A; Miyamoto, T; Nishimura, Y; Okada, H; Shibamori, K | 1 |
| Culbertson, TP; Gambino, L; Sanchez, JP; Sesnie, JA | 1 |
| Dorff, PH; Perni, RB; Rake, JB; Wentland, MP | 1 |
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
| Domagala, JM; Hagen, SE; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Trehan, AK | 1 |
| Araki, K; Hirayama, F; Ikeda, Y; Iwao, E; Kuroda, T; Moriguchi, A; Uemori, S; Yakushiji, T; Yokoyama, Y | 1 |
| Kawakami, K; Okuno, T; Sakamoto, F; Tsukamoto, G; Uno, T | 1 |
| Artico, M; Demontis, F; La Colla, P; Lostia, S; Mai, A; Massa, S; Musiu, C; Sbardella, G | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Blyn, LB; Jefferson, EA; Miyaji, A; Osgood, SA; Risen, LM; Swayze, EE | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Arpin, C; Ba, BB; Caignard, DH; Forfar-Bares, I; Grellet, J; Guillon, J; Jarry, C; Moreau, S; Quentin, C; Vidaillac, C | 1 |
| Balasubramanian, V; Bharath, S; Gaonkar, S; Jayaram, R; Jayashree, R; Kaur, P; Mahesh, BN; Nandi, V; Shandil, RK; Suresh, BL | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Katakami, M; Miyake, Y; Murakami, K; Ono, T; Susilowati, H; Viducic, D | 1 |
| Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Cattoir, V; Mazel, D; Nordmann, P; Poirel, L; Soussy, CJ | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 2 |
| Arsène, S; Leclercq, R | 1 |
| Acosta, CJ; Agtini, M; Albert, MJ; Anh, DD; Arjyal, A; Basnyat, B; Bhattacharya, SK; Bhutta, ZA; Campbell, JI; Canh, DG; Chau, TT; Chinh, NT; Clemens, JD; Diep, TS; Dolecek, C; Dong, B; Dougan, G; Dutta, S; Farrar, J; Galindo, CM; Hien, TT; Honghui, Y; La, TT; Naheed, A; Newton, PN; Nga, TT; Ochiai, RL; Page, AL; Parry, CM; Phetsouvanh, R; Phuong, LT; Rang, NN; Schultsz, C; Tuan, PQ; Van Be Bay, P; Van Minh Hoang, N; Van Vinh Chau, N; Vinh, H; von Seidlein, L; Wain, J | 1 |
| Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| German, N; Kaatz, GW; Kerns, RJ; Wei, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Espinal, P; Nordmann, P; Poirel, L; Silva-Sanchez, J | 1 |
| Hansen, S; Lewis, K; Vulić, M | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Fujimoto, S; Ike, Y; Okuzumi, K; Tanimoto, K; Tomita, H | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Aarestrup, FM; Cavaco, LM; Hasman, H; Xia, S | 1 |
| Baliani, A; Barrett, MP; Chollet, C; Gilbert, IH; Wong, PE | 1 |
| Gikas, A; Psaroulaki, A; Spyridaki, I; Tselentis, Y; Vranakis, I | 1 |
| Goy, G; Greub, G | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Dionisi, AM; Lucarelli, C; Luzzi, I; Owczarek, S; Villa, L | 1 |
| Chhasatia, MR; Gandhi, DS; Patel, MN | 1 |
| Caddick, JM; Gunell, M; Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Lilly, AJ; Piddock, LJ; Siitonen, A; Webber, MA | 1 |
| Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
| Larruskain, J; Montes, M; Orden, B; Perez-Trallero, E; Tamayo, E | 1 |
| Martínez, JL; Sánchez, MB | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Blango, MG; Mulvey, MA | 1 |
| Avdeef, A; Tam, KY | 1 |
| Ahn, JH; Bae, IK; Lee, JE; Lee, JJ; Lee, SH; Park, I; Park, KS; Sun, HI; Woo, GJ | 1 |
| Mima, T; Schweizer, HP | 1 |
| Goswami, M; Jawali, N | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Sen, S; Sinha, N | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Anderson, BE; Burda, WN; Cormier, R; Edlinger, J; Harrington, L; Kapolka, R; Kodigepalli, KM; Roma, G; Shaw, LN; Thomas, J; Turos, E | 1 |
| Anquetin, G; Aubry, A; Capton, E; Gomez, C; Jarlier, V; Lamouri, A; Pantel, A; Ponien, P; Serradji, N | 1 |
| Imai, YN; Oiki, S; Ryu, S | 1 |
| Kalinin, AA; Kulik, NV; Mamedov, VA; Voloshina, AD; Zobov, VV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, L; Fan, L; He, ZQ; Jiang, L; Lei, HS; Liu, CP; Liu, J; Peng, XM; Xu, XR; Yang, DC; Zhou, CH; Zhou, FW; Zou, YY | 1 |
| Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J | 1 |
| Beullens, S; Cammue, BP; Chaltin, P; Corbau, R; De Brucker, K; Fauvart, M; Fröhlich, M; Gerits, E; Knapen, WJ; Krona, A; Liebens, V; Lippell, A; Lövenklev, M; Marchand, A; Michiels, J; O'Neill, AJ; Robijns, S; Steenackers, HP; Swings, T; Thevissen, K; Veber, M; Verstraeten, N | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
| Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M | 1 |
| Cheng, XW; Fan, YL; Feng, LS; Wu, JB; Zhang, FZ | 1 |
| Chen, S; He, S; Liu, X; Qiu, G; Shi, J; Tang, W; Wu, X; Xu, K; Zhang, J | 1 |
| Zhang, B | 1 |
| Bera, S; Mondal, D | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
| Lyubina, AP; Mironov, VF; Pashirova, TN; Sapunova, AS; Shaihutdinova, ZM; Tatarinov, DA; Terekhova, NV; Voloshina, AD; Zakharova, LY | 1 |
| Bhagwat, S; Bhawsar, S; Deshpande, P; Joshi, S; Patel, M; Yeole, R | 1 |
| Chyrek-Borowska, S; Michalska, I; Siergiejko, Z; Szymański, W | 1 |
| Cobbs, CG; Smith, KR | 1 |
| Debbia, EA; Pesce, A; Schito, GC | 1 |
| García, I; Pascual, A; Perea, EJ | 1 |
| Arai, S; Gohara, Y; Kawashima, T; Kuwano, K; Matsu-Ura, I | 1 |
| Hammerschlag, MR; Hyman, CL; Roblin, PM | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Citron, DM; Goldstein, EJ | 2 |
| Jones, RN | 2 |
| Kiyota, H; Mitani, H | 1 |
| Erwin, ME; Jones, RN | 1 |
| Aoyama, H; Fukuda, H; Hirai, K; Hosaka, M; Tomizawa, H; Yasue, T | 1 |
| Mitsuhashi, S; Wakebe, H | 1 |
| Bornigia, S; De Sio, G; Morbiducci, V; Piersimoni, C; Scalise, G | 1 |
| Jabarit-Aldighieri, N; Raoult, D; Torres, H | 1 |
| Bartlett, RC; Mazens-Sullivan, MF; McCarter, YS | 1 |
| Barbé, J; Clerch, B; Llagostera, M | 1 |
| Chidiac, C; Mouton, Y; Senneville, E | 1 |
| Bakalova, LA; Bednova, VN; Bugrov, AV; Kisina, VI; Navolotskaia, TI; Vakhnina, TE | 1 |
| Poole, MD | 1 |
| Betti, S; D'Antonio, D; Dell'Isola, M; Di Gianfilippo, R; Fioritoni, G; Iacone, A; Olioso, P; Piergallini, A; Pizzigallo, E; Torlontano, G | 1 |
| Liu, YN; Sun, XD; Wang, R; Zhao, HZ | 1 |
| Barry, AL | 1 |
| Lang, R; Rubinstein, E; Shasha, B | 1 |
| Akalin, HE; Gür, D; Kocagöz, T | 1 |
| Sander, J | 1 |
| Sanders, CC | 1 |
| Gentry, LO | 1 |
| Cherubin, CE; Eng, RH; Smith, SM; Tan, EN | 1 |
| Kudo, M; Ohkubo, T; Sugawara, K | 1 |
| Nicolau, D; Nightingale, CH; Quintiliani, R | 1 |
| Davey, PG; Halliwell, RF; Lambert, JJ | 1 |
| Forstall, GJ; Knapp, CC; Washington, JA | 1 |
| Bethune, L; King, A; Phillips, I | 1 |
| Chin, NX; Neu, HC | 3 |
| Hardy, DJ | 2 |
| Fuchs, PC | 1 |
| Chodosh, S | 1 |
| Barry, AL; Fuchs, PC | 4 |
| Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Vallée, E | 1 |
| Conejo, MC; García, I; Pascual, A; Perea, EJ | 1 |
| Kimura, K; Kise, M; Kitano, M; Matsuda, M; Nishino, T; Otsuki, M; Ozaki, M; Segawa, J; Shibata, K; Tomii, Y | 1 |
| Lewin, CS; Morrissey, I; Smith, JT | 1 |
| Batmanov, VP | 1 |
| Enginar, N; Eroğlu, L | 1 |
| Skala, LZ | 1 |
| Alpan, RS; Cingi, MI; Erol, K; Gürer, F; Ozdemir, M; Ulak, G; Usluer, G | 1 |
| Gocke, E | 1 |
| Räisäinen, S; Schildt, R; Syrjälä, H | 1 |
| Byl, B; Jacobs, F; Thys, JP | 1 |
| Baer, JC; Bauer, SA; Glaros, DS; Nirankari, VS | 1 |
| Brook, I; Elliott, TB | 1 |
| Goh, KS; Rastogi, N | 1 |
| Mnatsakanian, VE; Padeĭskaia, EN | 1 |
| McQueen, CA; Queener, SM; Schlüter, G; Way, BM; Williams, GM | 1 |
| White, LO | 1 |
| Børsum, T; Dannevig, L; Melby, K; Størvold, G | 1 |
| Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E | 1 |
| Faro, S; Hammill, HA; Maccato, M; Martens, MG; Riddle, G | 1 |
| Chu, DT; Clement, JJ; Hardy, DJ; Shipkowitz, NL; Swanson, RN | 1 |
| Esteve, M; Gargallo-Viola, D; Guinea, J; Llovera, S; Roca, X | 1 |
| Chin, NX; Gu, JW; Neu, HC; Yu, KW; Zhang, YX | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Sato, K; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
| Janknegt, R | 1 |
| Nishino, T; Otsuki, M; Tanaka, M; Une, T | 1 |
| Furusawa, M; Iino, T; Marumoto, Y; Nozaki-Renard, J; Ohta, G; Sato, Y | 1 |
| al-Shammary, FJ; Bishop, SJ; Shibl, AM; Shoeb, HA; Tawfik, AF | 1 |
| Cullmann, W; Dechène, M; Leying, H | 1 |
| Heifets, LB; Lindholm-Levy, PJ | 2 |
| Blom-Potar, MC; Rastogi, N | 1 |
| Chin, NX; Neu, H | 1 |
| Allen, RA; Amyes, SG; Lewin, CS | 1 |
| Boeckk, M; Borner, K; Deppermann, N; Höffken, G; Koeppe, P; Lode, H | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Felmingham, D; Gemmell, CG | 1 |
| Allen, SD; Barry, AL; Fuchs, PC; Gerlach, EH; Pfaller, MA | 1 |
| Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S | 1 |
| Bailly, S; Fay, M; Gougerot-Pocidalo, MA | 1 |
| Gemeinhardt, A; Janssen, U; Klotz, U; Unseld, E; Ziegler, G | 1 |
| Fujimoto, T; Mitsuhashi, S | 1 |
| Barnett, G; Carbó, M; de la Torre, R; Segura, J | 1 |
| Fu, KP; Hilliard, J; Isaacson, D; McGuire, JL; Rosenthale, ME; Tobia, AJ | 1 |
| Brook, I; Elliott, TB; Ledney, GD | 1 |
| Mulert, R; Shah, PM | 1 |
| Guenounou, M; Miguères, ML; Ronco, E | 1 |
| Lingaas, E; Teigen, K | 1 |
| Midtvedt, T | 1 |
| Alestig, K | 1 |
| Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
| Van Caekenberghe, D | 1 |
| Gaillot, J; Montay, G | 1 |
| Biron, F; Boibieux, A; Peyramond, D; Tigaud, S | 1 |
| Dameron, G; Dournon, E; Pocidalo, JJ; Rajagopalan-Levasseur, P; Vilde, JL | 1 |
| Chaudhry, AZ; Knapp, CC; Sierra-Madero, J; Washington, JA | 1 |
| Arning, M; Aul, C; Heyll, A; Scharf, RE; Scheider, W; Wolf, HH | 1 |
| Bedsole, G; Brown, BA; Graham, DR; Sanders, CV; Smith, J; Steele, LC; Sumter, G; Wallace, RJ | 1 |
| Matsumoto, F; Morita, M; Takahashi, T | 1 |
| Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Berger, SA; Gorea, A; Homonnai, Z; Paz, G; Yavetz, H | 1 |
| Faegri, A; Melby, K | 1 |
| Houben, AW; Philips, JH; Stobberingh, EE | 1 |
| Daschner, F; Kropec, A | 1 |
| Croize, J; Gout, JP; Le Noc, P; Robert, J | 1 |
| Aubert, G; Denis, M; Dorche, G; Loboguerrero, M; Lucht, F; Puech, C | 1 |
| Bernard, E; Dellamonica, P; Drugeon, HB; Etesse, H; Garraffo, R | 1 |
| Akalin, HE; Akyön, Y; Diker, S; Gür, D; Hasçelik, G | 1 |
| Chen, CH; Heifets, LB; Lindholm-Levy, PJ; Shih, JF | 1 |
| Aravantinos, D; Gazis, J; Giamarellou, H; Kolokythas, E; Petrikkos, G; Sfikakis, P | 1 |
| Kotera, Y; Mitsuhashi, S | 1 |
| Horiuchi, S; Inagaki, Y; Nakaya, R; Une, T | 1 |
| Waldvogel, FA | 1 |
| Fong, IW | 1 |
| Dopp, C; Naumann, P | 1 |
| Nishino, T; Obana, Y | 2 |
| Lewin, CS; Smith, JT | 2 |
| Hooper, DC; Wolfson, JS | 3 |
| Martínez-Martínez, L; Pascual, A; Perea, EJ | 1 |
| Desiderio, JV; Fung-Tomc, J; Kessler, RE; Tsai, YH; Warr, G | 1 |
| Dailloux, M; Henry, C; Petitpain, N; Weber, M | 1 |
| Shalit, I; Zehavi-Willner, T | 1 |
| Dewachter, P; Dopff, C; Dureux, JB; Phelisse, F; Tronel, H; Voiriot, P; Weber, M | 1 |
| Kashimoto, S; Kojima, T; Kouno, K; Kurobe, N; Minami, A; Nakamura, S; Nakata, K; Ohue, T; Sakaguchi, Y; Yoshida, H | 1 |
| Dizon, M; Khan, MY; Kiel, FW | 1 |
| Hoffner, SE; Källenius, G; Kratz, M; Olsson-Liljequist, B; Svenson, SB | 1 |
| Kazmierczak, A; Nordmann, P; Pechinot, A | 1 |
| Shah, PM | 2 |
| Harder, S; Papenburg, A; Staib, AH; Stille, W | 1 |
| Dalhoff, A; Döring, G | 1 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W | 1 |
| Rehavi, M; Rubinstein, E; Segev, S | 1 |
| Neu, HC | 2 |
| Appleman, ME; Gaines, JK; Hadfield, TL; Winn, RE | 1 |
| Benonisen, E; Dibb, WL; Digranes, A | 1 |
| Chau, PY; Leung, YK; Lolekha, S; Ng, WS | 1 |
| Bergkvist, PI; Forsgren, A | 1 |
| Klesel, N; Limbert, M; Schrinner, E; Seibert, G; Winkler, I | 1 |
| Baur, C; Davies, BI; Maesen, FP; Teengs, JP | 2 |
| Bertele, RM; Harms, K; Kurz, CC; Marget, W | 1 |
| Brouwers, JR; Groeneveld, AJ | 1 |
| Edlund, C; Nord, CE | 2 |
| Bailey, J; Heppleston, C; Richmond, SJ | 1 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Smith, SM | 1 |
| Avesani, V; Delmee, M | 1 |
| Kemmerich, B; Pennington, JE; Small, GJ | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Zeiler, HJ | 1 |
| Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
| Baltch, AL; Bassey, CM; Smith, RP | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Aoyama, H; Hirai, K; Hosaka, M; Irikura, T; Niwata, Y; Oomori, Y; Suzue, S | 1 |
| Bremm, KD; Dahlhoff, A; Knöller, J; König, W; Schönfeld, W; Weber, B | 1 |
| Birnbaum, D; Krause, B; Lenk, V; Trautmann, M; Wagner, J | 1 |
| Verbist, L | 2 |
| Mizuno, S; Tsukamura, M | 1 |
| Grimm, H | 2 |
| Borner, K; Lode, H | 1 |
| Høiby, N | 1 |
| Grosse, F; Hussy, P; Maass, G; Schomburg, U; Tümmler, B | 1 |
| Hayakawa, I; Imamura, M; Osada, Y; Shibamura, S | 1 |
| Just, G; Shah, PM; Stille, W; Weigand, G | 1 |
| Beer, C; Harder, S; Mieke, S; Shah, P; Staib, AH; Stille, W | 1 |
| Brattström, C; Malmborg, AS; Tydén, G | 1 |
| Cohen, SP; Hooper, DC; Levy, SB; McMurry, LM; Souza, KS; Wolfson, JS | 1 |
| Osada, Y; Une, T | 1 |
| Cellini, L; Oliva, B; Renzini, G; Scazzocchio, F; Schippa, S; Selan, L | 1 |
| Davies, GF; Demoleas, SE | 1 |
| Crea, A; Naumann, P; Thomas, L | 1 |
| Ballard, RC; Fehler, G; Koornhof, HJ; Liebowitz, LD; Saunders, J | 1 |
| Digranes, A | 1 |
| Machka, K; Milatovic, D | 1 |
| Fass, RJ; Helsel, VL | 1 |
| Davies, S; Sparham, PD; Spencer, RC | 1 |
| Berlin, OG; Bruckner, DA; Young, LS | 1 |
| Kudoh, Y; Matsushita, S; Ohashi, M; Yamada, S | 1 |
| Saito, H; Sato, K; Tomioka, H; Watanabe, T | 1 |
| Habiyaremye, I; Vandepitte, J; Verbist, L | 1 |
| Braveny, I; Machka, K | 1 |
| Kubesch, P; Tümmler, B; Wehsling, M | 1 |
| Johnson, SM; Roberts, GD | 1 |
| Casal, M; González, J; Gutierrez, J; Ruiz, P | 1 |
| Pattyn, SR; Van Caekenberghe, DL; Verhoeven, JR | 1 |
| Bébéar, C; Fourche, J; Mormède, M; Texier-Maugein, J | 1 |
| Appelbaum, PC; Spangler, SK; Tamarree, T | 1 |
| Nakatomi, M; Neu, HC | 1 |
| Fay, M; Gougerot-Pocidalo, MA; Roche, Y | 1 |
| Chin, NX; Figueredo, VM; Neu, HC; Novelli, A | 1 |
| Krausse, R; Ullmann, U | 1 |
| Kohl, KH; Spohr, M; Traub, WH | 1 |
| Andrews, JM; Ashby, JP; Matthews, RS; Wise, R | 1 |
| Duval, J; Leclercq, R; Soussy, CJ | 1 |
| Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Bebear, C; de Barbeyrac, B; Quentin, C; Renaudin, H | 1 |
| Benonisen, E; Digranes, A; Salveson, A; Zahm, F | 1 |
| Cullmann, W; Dechène, M; Stieglitz, M | 1 |
| Hashimoto, Y; Itoh, N; Kawakami, S; Konno, M; Ohonari, S; Ubukata, K | 1 |
| Denamur, E; Laurans, G; Orfila, J; Suermondt, G | 1 |
| Andrews, JM; Ashby, JP; Wise, R | 1 |
| Kresken, M; Wiedemann, B | 1 |
| Ritzerfeld, W | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Nagayama, A; Nakao, T; Taen, H | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Forsgren, A | 1 |
| Butzler, JP; Coignau, H; De Mol, P; Ghysels, G; Goossens, H; Grados, O; Innocent, H; Levy, J | 1 |
| King, A; Phillips, I; Shannon, K | 1 |
| Bailey, J; Heppleston, C; Richmond, S | 1 |
| Dabernat, H; Delmas, C; Lareng, MB | 1 |
| Bergogne-Berezin, E; Joly-Guillou, ML | 1 |
| Blaufuss, H; Hartinger, A; Korting, HC; Neubert, U | 1 |
| Gulden, H; Kern, W; Kurrle, E; Vanek, E | 1 |
| Chin, NX; Neu, HC; Novelli, A | 1 |
| Kolnig, AM; Kromann-Andersen, B; Mitelman, F; Norrby, R; Sommer, P; Strömbeck, B; Wadstein, J | 1 |
| Kiely, JS; Schroeder, MC; Sesnie, JC | 1 |
| Lemmens, SE; van Saene, HK; van Saene, JJ | 1 |
| Kromann-Andersen, B; Larsen, V; Pers, C; Rasmussen, F; Sommer, P | 2 |
| Baskerville, A; Featherstone, AS; Fitzgeorge, RB | 1 |
| Borner, K; Höffken, G; Kirch, A; Koeppe, P; Lode, H; Olschewski, P; Sievers, B | 1 |
| Hirschl, AM; Rotter, M | 1 |
| Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L | 1 |
| Tunçkanat, F; Yuluğ, N | 1 |
| Cattier, B; Gavignet, M; Goudeau, A; Koubaa, N; Quentin, R | 1 |
| Beermann, D; Förster, D; Schacht, P; Wingender, W; Zeiler, HJ | 1 |
| Bergan, T; Dalhoff, A; Rohwedder, R | 1 |
| Chin, NX; Espinoza, AM; Neu, HC; Novelli, A | 1 |
| Ida, S; Ohno, I | 1 |
| Deforges, L; Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F | 1 |
| Walker, RC; Wright, AJ | 1 |
| Høiby, N; Jensen, T; Koch, C; Pedersen, SS | 1 |
| Bersani, C; Bertoletti, R; Fietta, A; Gialdroni Grassi, G; Santagada, T | 1 |
| Brattström, C; Malborg, AS; Tydén, G | 1 |
| Andrews, JM; Griggs, D; Lister, D; McNulty, CA; Wise, R | 2 |
| Mizuno, S; Toyama, H; Tsukamura, M | 1 |
| Rietbrock, N; Staib, AH | 1 |
| Chau, PY; Leung, YK; Ng, WW | 1 |
| Boogaerts, MA; Malbrain, S; Scheers, W; Verwilghen, RL | 1 |
| Dabbs, DJ; Limb, DI; Spencer, RC | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Arpi, M; Bentzon, MW; Gahrn-Hansen, B; Søgaard, P | 1 |
| Mazzei, T; Nicoletti, P; Periti, P | 1 |
| Barry, AL; Jones, RN | 1 |
| Wolff, M | 1 |
| Smith, CR | 1 |
| Kawane, H; Niki, Y; Soejima, R; Sumi, M; Umeki, S | 1 |
| Hvidberg, EF; Jensen, T; Pedersen, SS | 1 |
| Høiby, N; Jensen, T; Koch, C; Nielsen, CH; Pedersen, SS | 1 |
| Beer, C; Frech, K; Harder, S; Mieke, S; Shah, PM; Staib, AH; Stille, W | 1 |
| Benavente, MC; Casal, M; Gonzalez, AI; Rodriguez, F; Villalba, R | 1 |
| Baars, AM; van Herwaarden, CL; Vree, TB; Wijnands, WJ | 2 |
| Beer, C; Dietlein, G; Harder, S; Mieke, S; Shah, PM; Staib, AH; Stille, W | 1 |
| Akalin, E; Baykal, M | 1 |
| Etienne, D; Fay, M; Forest, N; Gougerot-Pocidalo, MA; Pocidalo, JJ; Roche, Y | 1 |
| Niculescu, E; Wagener, H | 1 |
| Davies, BI; Maesen, FP | 1 |
| Smith, JT | 4 |
| Cynamon, MH; Wilcox, GH | 1 |
| Eggleston, M; Park, SY | 1 |
| Meier-Ewert, H; Millott, G; Weil, G | 1 |
| Carlyn, CJ; Doyle, LJ; Knapp, CC; Ludwig, MD; Washington, JA | 1 |
| Hryniewicz, W; Trzciński, K; Tyski, S; Zareba, T | 1 |
| Kato, M; Takada, S; Takayama, S | 1 |
| Geweniger, KH; Isert, D; Iyer, P; Klesel, N; Koletzki, P; Limbert, M; Markus, A; Riess, G; Schramm, H | 1 |
| Bing Hoh, H; Diamond, JP; Easty, DL; Leeming, JP; White, L | 1 |
| Abel, SR; Brierton, DG; Mueller, BA | 1 |
| Alvarez, R; Arias, A; Felipe, A; Hernández, AM; Sierra, A | 1 |
| Essepian, JP; O'Brien, TP; Rajpal, R | 1 |
| Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Valerius, NH | 1 |
| Maiche, AG; Muhonen, T | 1 |
| Howard, BM; Pinney, RJ; Smith, JT | 2 |
| Kaatz, GW; Kang, SL; McGrath, BJ; Rybak, MJ; Seo, SM | 1 |
| Manzeniuk, IN; Stepanshin, IuG; Svetoch, EA; Volkovoĭ, KI | 1 |
| Jones, RN; Sutton, LD | 1 |
| Cormican, MG; Jones, RN | 1 |
| Amyes, SG; Baird, DR; Crook, DW; Gillespie, SH; Howard, AJ; Lawrie, SA; Oppenhiem, BA; Paull, A; Pedler, SJ; Tompkins, DS | 1 |
| Kaatz, GW; Larsson, AJ; Moody, JA; Rotschafer, JC; Walker, KJ; Zabinski, RA | 1 |
| Berning, SE; Iseman, MD; Madsen, L; Peloquin, CA | 1 |
| Beskid, G; Prosser, BL | 2 |
| Cormican, MG; Jones, RN; Marshall, SA | 1 |
| Sanders, CC; Thomson, KS | 2 |
| Abel, SR; Bowman, L; Brierton, DG; Mueller, BA | 1 |
| Doyle, LJ; Knapp, JS; Neal, SW; Parekh, MC; Rice, RJ; Washington, JA | 1 |
| Higa, H; Knapp, JS; Neal, SW; Ohye, R; Parekh, MC; Rice, RJ | 1 |
| Morissey, I; Smith, JT | 1 |
| Banba, H; Hiruma, M; Ishibashi, A; Kawada, A; Morimoto, K | 1 |
| Dellamonica, P; Fabre, R; Meyran, M; Moreau, N; Thabaut, A | 1 |
| Aoki, M; Goldstein, E; Kunii, O; Ono, Y | 1 |
| el-Kersh, TA; Ramadan, MA; Shibl, AM; Tawfik, AF | 1 |
| Kato, M; Takayama, S; Yoshida, M | 1 |
| Parte, AC; Smith, JT | 2 |
| Arman, D; Tural, D; Willke, A | 1 |
| Cherubin, CE; Stratton, CW | 1 |
| Jiang, SC; Miao, JZ; Wang, XF | 1 |
| Fujita, H; Matsuo, I | 1 |
| Akahane, K; Kato, M; Takayama, S | 1 |
| Noda, T; Ohkura, H; Saito, D; Sekiya, T; Shimosato, Y; Sugano, K; Tokue, Y | 1 |
| Beam, TR | 1 |
| Dominguez-Gil Hurlé, A; Martínez Cabarga, M; Sánchez Navarro, A | 1 |
| Advikolanu, K; Bruce, AW; Martin, RA; Reid, G; Sharma, S; Tieszer, C | 1 |
| Domarle, O; Hayem, G; Pocidalo, JJ; Thuong-Guyot, M | 1 |
| Cho, JK; Han, HJ; Kim, JH; Kim, K; Lee, DS; Park, WB | 1 |
| Hoban, DJ; Jones, RN | 1 |
| Bodey, GP; Dholakia, N; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
| Barretti, P; Bignardi, JH; Soares, VA | 1 |
| Haen, E; Kurz, H; Przybilla, B; Tiefenbacher, EM | 1 |
| Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM | 1 |
| Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Rodríguez-Benito, A | 1 |
| Bakst, CM; Loughlin, KA; Rybak, MJ | 1 |
| Frei, R; Hoban, DJ; Jones, RN; Marco, F; Pignatari, AC; Yamane, N | 1 |
| Morrissey, I; Smith, JT | 1 |
| Kaiser, AB; Kernodle, DS | 1 |
| Martínez-Martínez, L; Ortega, MC; Perea, EJ; Suárez, AI | 1 |
| Borobio, MV; Conejo, M; Perea, EJ; Ramirez, E; Suarez, AI | 1 |
| Cohen, MA; Dazer, ME; Domagala, JM; Huband, MD; Meservey, MA; Roland, GE; Yoder, SL | 1 |
| Fraimow, HS; French, P; Venuti, E | 1 |
| Mamet, R; Schoenfeld, N | 1 |
| Garcia-Rodriguez, JA; Gomez Garcia, AC | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Marshall, SA; Murray, PR; Washington, JA | 1 |
| Kivistö, KT; Lehto, P; Neuvonen, PJ | 1 |
| Ichikawa, N; Iwamoto, K; Naora, K | 1 |
| Echols, R; Heller, AH; O'Keeffe, B; Shah, A; Weinstein, MP | 1 |
| Iakovlev, VP | 1 |
| Griffiths, NM; Hirst, BH; Simmons, NL | 1 |
| Gospodarek, E | 1 |
| Aulicino, T; Donnenfeld, ED; Gombert, ME; Perry, HD; Schrier, A; Snyder, R | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Pfau, A; Sacks, TG | 2 |
| Mizuno, A; Nakashima, M; Uematsu, T | 1 |
| Kobayashi, I; Kumazawa, J; Matsumoto, T; Tanaka, M | 1 |
| Butzler, JP; Goldhar, J; Goossens, H; Levy, J; Schwartz, D | 1 |
| Croizé, J; Le Noc, D; Le Noc, P | 1 |
| Auckenthaler, R; Peyret, M; Rohner, P | 1 |
| Akashi, A; Arai, S; Furudera, T; Gohara, Y; Kuwano, K; Matsubara, S; Matumoto, M; Tseng, CC | 1 |
| Belliveau, P; Crowe, H; Gousee, G; Nightingale, CH; Quintiliani, R | 1 |
| Dalton, H; Echols, R; Ford, J; Gillum, JG; Harvey, K; Heller, AH; Israel, D; Polk, R; Towle, M; Turik, M | 1 |
| Neumann, T; Patton, M; Reichart, C; Zenilman, JM | 1 |
| Körner, RJ; MacGowan, AP; Reeves, DS | 1 |
| Benson, CA; Harrison, B; Levin, JM; Nelson, JA; Segreti, J; Strle, F | 1 |
| Ahlén, S; Malmborg, AS | 1 |
| Foleno, BD; Fu, KP; Lafredo, SC | 1 |
| Akashi, A; Arai, S; Gohara, Y; Kuwano, K; Nishimoto, M; Oizumi, K; Takeda, K; Yamaguchi, T; Yano, T | 1 |
| Mitsuhashi, S; Yoshida, T | 1 |
| Coll, R; Esteve, M; Garcia, J; Gargallo-Viola, D; Guinea, J; Pares, M; Robert, M; Roser, R; Tudela, E; Xicota, MA | 1 |
| Amsterdam, D; Beam, TR; Gorzynski, EA; Mandell, LA; Rotstein, C | 1 |
| Biswas, S; Sharma, AK; Tripathi, KD; Valecha, N | 1 |
| Aysev, AD | 1 |
| Fukuoka, Y; Ikeda, Y; Narita, H; Takahata, M; Todo, Y; Yamashiro, Y | 1 |
| Chakravorty, B; Gupta, B; Jain, N; Krishna, A; Rajvanshi, P; Sen, MK | 1 |
| Gabriel, L; Giamarellou, H; Kanellas, D; Kavouklis, E; Petrikkos, G | 1 |
| Nziramasanga, P; Shah, PM; Stille, W | 1 |
| Fekete, I; Kelentey, BA; Kelentey, BJ; Kozma, J | 1 |
| Coll, R; Mirelis, B; Miró, E; Navarro, F; Prats, G; Xicota, MA | 1 |
| Fenelon, LE; MacGowan, AP; Reeves, DS; Smyth, EG; Speirs, GE; Speller, DC; Wilcox, MH | 1 |
| Stein, GE | 1 |
| Berche, P; Gaillot, O | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
| Molinari, G; Schito, GC | 1 |
| Kahn, JB; Peterson, LR; Ristow, TA | 1 |
| Bar-On, S; Nasrallah, N; Rabau, M; Shalit, I | 1 |
| Gaziano, P; McCue, JD; Orders, D | 1 |
| Dixon, PS; Peretsman, SJ; Seay, TM | 1 |
| Hayden, MK; Matushek, MG; Trenholme, GM | 1 |
| Hale, JA; Knapp, JS; Neal, SW; Rice, RJ; Whittington, WL; Wintersheid, K | 1 |
| Klepser, ME; Nicolau, DP; Nightingale, CH; Patel, KB; Quintiliani, R | 1 |
| Asaoka, T; Imamori, K; Maebashi, K; Matsuda, H; Matsumoto, M; Tahara, Y | 1 |
| Ahmedy, A; Khardori, N; Toama, M; Yassien, M | 1 |
| Albay, A; Baysallar, M; Cinar, E; Doğanci, L; Gün, H; Haznedaroğlu, T | 1 |
| Bethell, DB; Chuong, LV; Day, NP; Duong, NM; Hien, TT; Len, NV; Phi, LT; Vinh, H; White, NJ | 1 |
| Iakovlev, SV; Iakovlev, VP; Izotova, GN | 1 |
| Aavitsland, P; Høiby, EA | 1 |
| Bignardi, G; Goldberg, L; Holmes, B; Johnson, AP; Riley, UB | 1 |
| Larsson, AJ; Madaras-Kelly, KJ; Rotschafer, JC | 1 |
| Mann, RD; Pearce, GL; Wilton, LV | 1 |
| Cheung, MM; Ho, NK; Kam, KM; Wong, PW | 1 |
| Amyes, SG; Brown, JC; Jesudason, MV; Shanahan, PM; Thomson, CJ | 1 |
| Callegan, MC; Engel, LS; Green, LC; Hill, JM; Jasheway, DW; O'Callaghan, RJ; Shimomura, Y | 1 |
| Hautekeete, ML; Holvoet, JK; Hubens, H; Kloppel, G; Kockx, MM; Naegels, S | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 5 |
| Chilima, BZ; Okazawa, Y; Tanno, K; Tosaka, M; Yamane, N | 1 |
| Hayakawa, I; Hohmura, M; Hoshino, K; Ishida, H; Kitamura, A; Nishino, T; Sato, K; Tanaka, M | 1 |
| Chambers, HF; Hackbarth, CJ; Kocagöz, T; Nikaido, H; Rosenberg, EY; Unsal, I | 1 |
| Hooper, DC; Ng, EY; Trucksis, M | 1 |
| Hovde, LB; Madaras-Kelly, KJ; Ostergaard, BE; Rotschafer, JC | 1 |
| Honmura, T; Komori, K; Matsuda, M; Nishimura, I; Nishino, T; Ozaki, M; Tomii, Y; Yamaguchi, R | 1 |
| Acar, JF; Goldstein, FW | 1 |
| Anastasiadis, A; Andreopoulos, AG; Dounis, E; Kanellakopoulou, K; Korakis, T; Tzivelekis, P | 1 |
| Behrens-Baumann, W | 1 |
| Banba, H; Banba, K; Hiruma, M; Ishibashi, A; Kawada, A; Marshall, J; Noguchi, H | 1 |
| Doern, GV; Jankins, M; Jones, RN; Torres, BB | 1 |
| Barrett, JF; Frosco, MB; Kulwich, BA; Licata, L; Melton, JL; Stewart, FP | 1 |
| Hecht, DW; Osmolski, JR | 1 |
| Nishino, T; Otsuki, M | 1 |
| Conejo, MC; García, I; Pascual, A; Perea, EJ; Salvador, J | 1 |
| Domingue, G; Johnson, AP; Speller, DC; Warner, M | 1 |
| Kunichan, AD; Mozhokina, GN; Shapatava, MN | 1 |
| Flynn, CM; Johnson, DM; Jones, RN | 1 |
| Itoh, T; Kai, A; Kudoh, Y; Ohta, K; Saito, K; Shingaki, M; Tadano, K; Takahashi, M; Yanagawa, Y | 1 |
| Ballesta, S; García, I; Pascual, A; Perea, EJ | 2 |
| Dai, J; Meatherall, R | 1 |
| Berning, SE; Peloquin, CA | 1 |
| Klecak, G; Urbach, F; Urwyler, H | 1 |
| Forbes, PD; Mäkinen, M; Stenbäck, F | 1 |
| Fabian, I; Gruss, T; Kletter, Y; Shalit, I; Weiss, K | 1 |
| Amaratunga, DJ; Barrett, JF; Frosco, MB; Yagel, SK | 1 |
| Choi, EC; Choi, KH; Hong, JS; Kim, SK; Lee, DK; Yoon, SJ | 1 |
| Barrett, JF; Frosco, M; Goldschmidt, RM; Licata, L; Smith, CE | 1 |
| Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 2 |
| Durmaz, B; Durmaz, R; Günal, S; Hepsen, IF; Marol, S; Oram, O | 1 |
| Cheng, C; Foo, KT; Li, MK; Png, JC; Rekhraj, IR; Tan, E | 1 |
| Bergogne-Bérézin, E | 1 |
| Chang, JC; Ho, SW; Hsieh, WC; Hsueh, PR; Luh, KT; Wu, JJ | 1 |
| Stewart, PS; Suci, PA; Vrany, JD | 1 |
| Akkan, AG; Gök, A; Mutlu, I; Ozüner, Z; Ozyazgan, S; Pekel, H; Senses, V; Yigit, U | 2 |
| Arakane, K; Hirobe, M; Mashiko, S; Nagano, T; Ryu, A; Umezawa, N | 1 |
| Beil, WJ; Georgopoulos, A; Graninger, W; Griesmacher, A; Hlousek, M; Robibaro, B; Schaumann, R; Vorbach, H; Weigel, G | 1 |
| Mattingly, SJ; Piña, SE | 1 |
| Morrissey, I | 1 |
| George, J; Morrissey, I | 1 |
| Dvorak, T; Ho, DH; LeBlanc, B; Rolston, KV; Streeter, H | 1 |
| Andriole, VT; Dembry, LM; Farrel, PA; Gerrity, LA; Orcutt, DR | 1 |
| Bhogal, H; Felmingham, D; Grüneberg, RN; Ingley, K; Leakey, A; Mathias, I; Ridgway, GL; Robbins, MJ | 1 |
| Gleichmann, E; Hunzelmann, N; Rönnau, AC; Ruzicka, T; Sachs, B; Schuppe, HC; von Schmiedeberg, S | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 2 |
| Deguchi, T; Kawada, Y; Kawamura, T; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Padeĭskaia, EN | 1 |
| Choi, EC; Kang, JA; Kim, BK; Kim, JH; Kim, JW; Kim, YG; Lee, JH | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Fujimura, H; Kohno, K; Niwa, M; Nozaki, M; Uematsu, T | 1 |
| Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC | 2 |
| Erlacher, L; Graninger, W; Graninger, WB; Köller, M; Menschik, M; Neumüller, J; Steiner, CW; Ullrich, R | 1 |
| Breithaupt, A; Breithaupt, H; Gehrke, R; Kraemer, HJ | 1 |
| Jones, RN; Pfaller, MA | 2 |
| Campbell, T; Gentry, LO; Gezon, J; Nichols, RL; Smith, JW; Sokol, P; Williams, RR | 1 |
| Bauernfeind, A | 1 |
| Förster, C; Günther, T; Lozo, E; Merker, HJ; Schwabe, R; Stahlmann, R; Vormann, J; Zippel, U | 1 |
| Beck, R; Drewelow, B; Fischer, U; Guthoff, R; Hehl, EM; von Keyserlingk, J | 1 |
| Belousov, IuB; Efremenkova, OV; Komarova, VP; Sokolov, AV; Tishchenkova, IF | 1 |
| Goldsmith, CE; Moore, JE; Murphy, PG | 1 |
| Arnold, B; Stout, JE; Yu, VL | 1 |
| Prabhu, S; Rewari, S | 1 |
| Choi, EC; Choi, KH; Kim, BK; Kim, JH; Kim, JW; Lee, JH | 1 |
| Evans, ME; Titlow, WB | 1 |
| Barrett, MS; Jones, RN | 1 |
| Colino, CI; García Turiño, A; Lanao, JM; Sanchez Navarro, A | 1 |
| McMillan, J; Schooley, S; Stein, GE | 1 |
| Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK | 1 |
| Armbruster, C; Georgopoulos, A; Graninger, W; Griesmacher, A; Hlousek, M; Reiter, M; Robibaro, B; Vorbach, H; Weigel, G | 1 |
| Gordon, YJ; Karenchak, LM; Kowalski, RP | 1 |
| Denstedt, JD; Reid, G; Riddell, JV; Tieszer, C; Wollin, TA | 1 |
| Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA | 1 |
| Arai, H; Furuhata, K; Hayakawa, H; Narita, H; Soumi, K; Watanabe, Y | 1 |
| Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
| Callery-D'Amico, S; Fowler, CL; Kim, SS; Klimberg, IN; Richard, GA | 1 |
| Baumann-Wilschke, I; Förster, C; Rücker, M; Shakibaei, M; Stahlmann, R; Vormann, J | 1 |
| Andrews, JM; Wise, R | 1 |
| Dorian, M; Grellet, J; Saux, MC | 1 |
| Colsky, AS; Kerdel, FA; Kirsner, RS | 1 |
| Engel, LS; Green, LC; Hill, JM; Moreau, JM; O'Callaghan, RJ | 1 |
| Shetty, M; Shivananda, PG | 1 |
| Gikas, A; Kofterithis, D; Psaroulaki, A; Spyridaki, I; Tselentis, Y | 1 |
| Knapp, JS | 1 |
| Beck, R; Drewelow, B; Guthoff, R; Hehl, EM; Kundt, G; Luthardt, K | 1 |
| Peters, G; Schumacher-Perdreau, F | 1 |
| Alperstein, P; France, K; Isenberg, HD | 2 |
| Ho, SW; Hsueh, PR; Jan, IS; Luh, KT; Teng, LJ | 1 |
| Noskin, GA; Peterson, LR; Postelnick, M; Pozdol, TL; Reisberg, B | 1 |
| Lee, S; Lee, Y | 1 |
| Chau, CH; Yew, WW | 2 |
| Dekitsch, C; Georgopoulos, A; Graninger, W; Kuen, B; Markopulos, E; Schein, R | 1 |
| Biavasco, F; Mingoia, M; Montanari, MP; Prenna, M; Ripa, S; Varaldo, PE | 1 |
| Anjo, S; Hara, A; Nakamura, M; Sakai, M | 1 |
| Aeschlimann, JR; Dresser, LD; Kaatz, GW; Rybak, MJ | 1 |
| Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR | 1 |
| Edwards, JR; Gaynes, RP; McGowan, JE; O'Hara, CM; Steward, CD; Stocker, SA; Swenson, JM; Tenover, FC | 1 |
| Beck, R; Drewelow, B; Fischer, U; Guthoff, R; van Keyserlingk, J | 1 |
| Bhaduri, AP; Chauhan, PM; Pandey, VC; Puri, SK; Shukla, A; Srivastava, S; Srivastava, SK | 1 |
| Amaratunga, D; Barrett, JF; Fernandez, J; Frosco, M; Licata, L | 1 |
| Lacy, MK; Lu, W; Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR; Xu, X | 1 |
| Peters, G; von Eiff, C | 1 |
| González Alonso, I; Rodríguez Cruz, MS; Sánchez-Navarro, A; Sayalero Marinero, ML | 1 |
| Andreu, M; Coll, S; Gana, J; Guarner, C; Miñana, J; Mirelis, B; Novella, MT; Ortiz, J; Prats, G; Sábat, M; Solá, R; Soriano, G; Vila, MC | 1 |
| Bosse, D; Kubin, R; Schacht, P | 1 |
| Bassaris, HP; Calangu, S; Kitzes, R; Kompan, L; Kosmidis, J; Raz, R; Salewski, E | 1 |
| Echols, RM; Heyd, A; Huck, W; McCarty, JM; Richard, G; Shan, M; Tosiello, RL; Tucker, RM | 1 |
| Dabernat, H | 1 |
| Holt, HA; MacGowan, AP; Wootton, M | 1 |
| Araki, H; Minami, S; Mitsuyama, J; Narita, H; Takahata, M; Todo, Y; Watanabe, Y; Yamashiro, Y; Yonezawa, M | 1 |
| Lister, PD; Sanders, CC | 2 |
| Casquero-Dorado, AC; Sanchez-Navarro, A; Weiss, M | 1 |
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Bébéar, C; Bébéar, CM; Leblanc, F; Renaudin, H; Schaeverbeke, T | 1 |
| Basci, NE; Batman, C; Bozkurt, A; Cekiç, O; Kayaalp, SO; Totan, Y; Yasar, U | 1 |
| Frémaux, A; Geslin, P; Sissia, G | 1 |
| Acar, JF; Goldstein, FW; Kitzis, MD; Miegi, M | 1 |
| Bryskier, A; Drugeon, HB; Juvin, ME | 1 |
| Goldstein, MH; Gordon, YJ; Kowalski, RP | 1 |
| Hashimoto, K; Minami, T; Owen, K; Takizawa, T; Yamashita, S | 1 |
| DeHaven, JI; Kamat, AM; Lamm, DL | 1 |
| Bui, KQ; Nicolau, DP; Nightingale, CH; Onyeji, CO; Owens, RC; Quintiliani, R | 1 |
| Maskell, JP; Sefton, AM; Williams, JD | 1 |
| Beck, R; Drewelow, B; Guthoff, R; Hehl, EM; Luthard, K | 1 |
| Gootz, TD; Haskell, SL; Kaczmarek, FS; Maurice, AE; Zaniewski, RP | 1 |
| Beyer, R; Cianciotto, NP; Noskin, GA; Pestova, E; Peterson, LR | 1 |
| Brisse, S; Fluit, AC; Köhrer, K; Martin, N; Milatovic, D; Scheuring, S; Schmitz, FJ; Verhoef, J | 1 |
| Baddour, LM; Smith, EA | 1 |
| Galas, M; Guelfand, L; Lopardo, H; Rossi, A; Tokumoto, M | 1 |
| Antolic, G; Grabnar, I; Kozjek, F; Mrhar, A; Suturkova, LJ | 1 |
| Aeschlimann, JR; Kaatz, GW; Rybak, MJ | 1 |
| Fourche, J; Leblanc, F; Maugein, J; Pellegrin, JL; Vacher, S | 1 |
| Bhavnani, SM; Haese, DD; Paladino, JA; Rifenburg, RP; Schentag, JJ | 1 |
| Bint, AJ; Legg, JM | 1 |
| Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
| Gomi, H; Hatanaka, K; Kawada, A; Matsuo, I | 1 |
| Greenberg, RN; Newman, MT; Pectol, RW; Shariaty, S | 1 |
| Abd-Allah, AR; Abdel-Aziz, AA; Aly, HA; Hamada, FM; Moustafa, AM | 1 |
| Akaki, T; Kajitani, H; Sato, K; Shishido, S; Tomioka, H | 1 |
| Hershberger, E; Rybak, MJ | 1 |
| Brooun, A; Lewis, K; Liu, S | 1 |
| Gilbert, D; Simmons, K; Zinner, SH | 1 |
| Amsterdam, D; Hardy, D; Mandell, LA; Rotstein, C | 1 |
| Neumeier, R; Tasman, AJ; Wallner, F | 1 |
| Basci, NE; Batman, C; Bozkurt, A; Cekiç, O; Kayaalp, SO; Totan, Y; Yasar, U; Zilelioglu, O | 1 |
| Anderson, VE; Gootz, TD; Kaczmarek, FS; Osheroff, N; Zaniewski, RP | 1 |
| Amicosante, G; Franceschini, N; Marchetti, F; Perilli, M; Segatore, B; Setacci, D | 1 |
| Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
| Chuang, AZ; Kiang, E; Mitra, S; Patel, GM; Ramesh, N; Yee, RW | 1 |
| Mayer, I; Nagy, E | 1 |
| Maru, C; Mori, K; Takasuna, K | 1 |
| Korfman, G; Naber, KG; Raizenberg, C; Raz, R; Rohana, Y; Unamba-Oparah, I; Yaniv, I | 1 |
| Edmond, M; Heinemann, B; Seifert, H; Wisplinghoff, H | 1 |
| Alonso, A; Alós, I; Campanario, E; Martíinez, JL; Sánchez, P | 1 |
| Alexandrakis, G; Alfonso, EC; Miller, D | 1 |
| Booth, MC; Callegan, MC; Gilmore, MS | 1 |
| Cai, R; Huang, Z; Liu, Z | 1 |
| Bebear, C; Bebear, CM; Charron, A; Gruson, D; Lefrancois, M; Renaudin, H | 1 |
| Deguchi, T; Fukuda, H; Ishihara, S; Kawada, Y; Yasuda, M; Yokoi, S | 1 |
| Funato, T; Hongo, T; Igari, J; Iinuma, Y; Ishigo, S; Ishii, K; Ishii, M; Itoh, C; Iwata, M; Kaimori, M; Kaku, M; Kamihira, S; Kanda, M; Kashitani, F; Katoh, J; Kawahara, S; Kawamura, C; Kudoh, M; Kuwabara, M; Matsudou, Y; Matsushima, T; Miyashita, N; Miyazaki, S; Miyazaki, Y; Murakami, N; Nakagawa, K; Nakasone, I; Negayama, K; Niki, Y; Nisawataira, T; Oguri, T; Okada, J; Ono, J; Saito, Y; Sato, N; Taira, M; Takada, T; Takii, M; Tamaki, I; Tashiro, H; Tazawa, Y; Toyoshima, S; Tsujio, Y; Uehara, N; Ueno, K; Watanabe, N; Yamaguchi, K; Yamanaka, K; Yasujima, M; Yoshida, T | 1 |
| Demasters, TA; Madaras-Kelly, KJ | 1 |
| Trissel, LA; Williams, KY; Xu, QA; Zhang, Y | 1 |
| Bajaksouzian, S; Jacobs, MR; Joloba, ML | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Kanayama, A; Kobayashi, I; Mochida, O; Naito, S; Saika, T; Tanaka, M; Tunoe, H | 1 |
| Dreses-Werringloer, U; Hudson, AP; Jürgens-Saathoff, B; Köhler, L; Padubrin, I; Zeidler, H | 1 |
| Katz, HR; Melia, M; Snyder-Perlmutter, LS | 1 |
| Hollauer, K; Kirchbauer, D; Naber, KG; Witte, W | 1 |
| Bravos, PD; Frenkel, B; Holtom, PD; Patzakis, MJ; Pavkovic, SA; Shepherd, LE | 1 |
| Doern, GV; Ernst, EJ; Klepser, ME; Petzold, CR; Rhomberg, P | 1 |
| Dworkin, RJ; Gilbert, DN; Grunkemeier, G; Kohlhepp, SJ; Leggett, JE; Lewis, G; Slama, KA; Slaughter, SE | 1 |
| Castell, JV; Morlière, P; Ouédraogo, G; Santus, R | 1 |
| Hedges, AJ; MacGowan, AP; Sunderland, J; Tobin, CM; White, LO | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| George, C; Lu, KL; McDonnell, PJ; Prajna, NV; Selvaraj, S; Srinivasan, M | 1 |
| Abell, S; Chapman, S; Nadin, L; Warren, R | 1 |
| Climent, A; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
| Beheshti, M; Denstedt, J; Habash, M; Reid, G; Riddell, J; Vachon, D | 1 |
| Danziger, LH; Gotfried, MH; Rodvold, KA | 1 |
| Sato, K; Tanaka, M; Wada, K | 1 |
| Graves, A; Henry, M; Hwang, DG; O'Brien, TP; Trousdale, MD; Van Buskirk, A | 1 |
| Eiferman, RA | 1 |
| Johnson, AP; Livermore, DM; Warner, M | 1 |
| Church, CA; Jinn, TH; John, EO; Jung, TT; Kim, DJ; Russell, PT | 1 |
| Alfonso, EC; Feuer, WJ; Lam, BL; McCulley, TJ; Miller, D; Song, A | 1 |
| Everett, D; Gillespie, SH; Morrissey, I | 1 |
| Kawahara, S; Nagare, H; Tada, A | 1 |
| Biedenbach, DJ; Jones, RN; Pfaller, MA | 1 |
| Appelbaum, PC; Davies, T; Edlund, C; El Amin, N; Oh, H | 1 |
| Belen, VA; Cardaño, RC; Derilo, JO; Grimaldo, ER; Quelapio, MI; Rivera, AB; Tupasi, TE | 1 |
| Ball, P | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Mombelli, B; Nicola, L; Valli, M | 1 |
| Chen, X; Hooper, B; Hooper, M; Hu, Z; Wu, S; Zhang, W; Zhao, Z | 1 |
| Jones, ME; Karlowsky, JA; Nealy, L; Sahm, DF; Thornsberry, C | 1 |
| Milkovich, G | 1 |
| Bonfiglio, G; Cafiso, V; Campanile, F; Messina, C; Santagati, M; Stefani, S | 1 |
| Cranidis, A; Kontoyiannis, DP; Maraki, S; Mavromanolakis, E; Samonis, G; Tselentis, Y | 1 |
| Bonner, DP; Fung-Tomc, J; Gradelski, E; Huczko, E; Minassian, B | 1 |
| Oreopoulos, D; Passadakis, P | 1 |
| Casquero-Dorado, AC; Colino, CI; Martínez, MS; Sánchez-Navarro, A | 1 |
| Boos, M; Fluit, AC; Hafner, D; Jagusch, H; Mayer, S; Schmitz, FJ; Verhoef, J | 1 |
| Wittpenn, JR | 1 |
| Cantor, LB; Donnenfeld, E; Finley, CD; Flarty, K; Gee, WL; Hoop, J; Katz, LJ; Lakhani, VK | 1 |
| Postnikov, SS | 1 |
| Abraham, E; Fish, DN; Malone, RS; Teitelbaum, I | 1 |
| Georgopoulos, A; Graninger, W; Grisold, A; Mueller-Uri, P; Presterl, E | 1 |
| Goldwater, SH; Lindgren, B; Milkovich, G; Morrison, AJ | 1 |
| Gordon, YJ; Husted, RC; Karenchak, LM; Kowalski, RP; Pandya, AN; Ritterband, DC; Romanowski, EG; Shah, MK | 1 |
| Bai, ZZ; Guan, DW; Zhang, QS | 1 |
| Kushner, JM; Peckman, HJ; Snyder, CR | 1 |
| Austin, MS; Dajcs, JJ; Marquart, ME; Moreau, JM; O'Callaghan, RJ; Stroman, DW; Thibodeaux, BA; Traidej, M | 1 |
| Halgren, JT; Pandit, RT; Sutphin, JE; Wagoner, MD | 1 |
| Ambler, J; Cardeñosa, O; Lemme, L; Lopez, H; Scarano, S; Smayevsky, J; Stepanik, D; Sucari, A; Vilches, V | 1 |
| Piddock, LJ; Ricci, V | 1 |
| Arias-Puente, A; Carrasco-Font, C; Fresnadillo-Martinez, MJ; García-Sáenz, MC | 1 |
| Beach, ML; Jones, RN; Pfaller, MA | 1 |
| Frothingham, R | 2 |
| Clark, DW; Layton, D; Pearce, GL; Shakir, SA; Wilton, LV | 1 |
| Bouchillon, SK; Butler, DL; Hoban, DJ; Johnson, JL; Miller, LA; Poupard, JA; Zhanel, GG | 1 |
| Coban, AY; Durupinar, B; Ekinci, B | 2 |
| Bahar, IH; Baskin, H; Doğan, Y; Yuluğ, N | 1 |
| Blondeau, JM | 1 |
| Jung, R; Messick, CR; Pendland, SL | 1 |
| Evans, ME | 1 |
| Loran, OB; Pushkar', DIu; Rasner, PI | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
| Drlica, K; Tillotson, G; Zhao, X | 1 |
| Barrett, JF; Frosco, M; Ho, H; Lawrence, LE; Mazzucco, CE; Ryan, BM; Warr, G | 1 |
| Karenchak, LM; Kowalski, RP; Mather, R; Romanowski, EG | 1 |
| Anderlik, P; Lengyel, J; Máthé, A; Rókusz, L; Rozgonyi, F; Szabó, D | 1 |
| Gillespie, T; Masterton, RG | 1 |
| Heddle, J; Maxwell, A | 1 |
| Dhaliwal, DK; Keverline, MR; Kowalski, RP | 1 |
| Stahlmann, R | 1 |
| Appelbaum, PC; Bozdogan, B; Clark, CL; Davies, TA; Dewasse, B; Jacobs, MR; Nagai, K | 1 |
| Domschke, W; Lügering, N; Richter, E; Rüsch-Gerdes, S; Wessling, J | 1 |
| Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL | 1 |
| Schaeffer, AJ | 1 |
| Bohle, A; Durek, C; Jocham, D; Jurczok, A; Werner, H | 1 |
| Catamo, G; D'Antonio, D; D'Ercole, S; Di Bonaventura, G; Piccolomini, R | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
| Bello, A; Kappel, EM; Shakibaei, M; Stahlmann, R | 1 |
| Burgess, DS; Nathisuwan, S | 1 |
| Lister, PD | 2 |
| Chan, JK; Ma, J | 1 |
| Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E | 1 |
| Erdem, I; Goktas, P; Kaya, B; Kaynar-Tascioglu, J | 1 |
| Frisbee-Hume, S; Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H | 1 |
| Bilgiç, A; Burhanoğlu, D; Cavuşoğlu, C; Ciçek-Saydam, C; Ozçam, H; Ozkalay, N; Ozkaya, D | 1 |
| Cheong, HJ; Choo, YS; Kang, MW; Kim, WJ; Kim, YS; Lee, KW; Park, YJ; Woo, JH; Yong, DE | 1 |
| Cambourieu, C; Nourry, H; Pouzaud, F; Rat, P; Warnet, JM | 1 |
| Castellano, G; Morillasa, JD; Pérez Carreras, M; Solís, JA; Tomás, ME | 1 |
| Cavallero, A; Gesu, GP; Marchetti, F; Piccoli, L | 1 |
| Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
| Bossi, P; Bricaire, F | 1 |
| Nazhimov, VP; Novichkova, GA; Postnikov, SS; Semykin, SIu | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Araake, M; Hara, T; Nishino, T; Watabe, H | 1 |
| Araake, M; Hara, T; Nishino, T; Shimizu, M; Tabata, M; Watabe, H | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yoshimori, K | 1 |
| Araake, M; Maebashi, K; Tani, M; Watabe, H | 1 |
| Bello, S; Torres, A | 1 |
| Basci, NE; Bozkurt, A; Duman, S; Yalvac, IS | 1 |
| Firsov, AA; Lubenko, IY; Portnoy, YA; Vostrov, SN; Zinner, SH | 1 |
| Esposito, S; Ianniello, F; Leone, S; Noviello, S | 2 |
| Abels, R; Chien, S; Goodman, DB; Hunt, TL; Natarajan, J; Noel, GJ | 1 |
| Kovalenko, AN; Lobzin, IuV | 1 |
| Cetin, CB; Cosar, G; Dinç, G; Ermertcan, S; Limoncu, MH | 1 |
| Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC | 1 |
| Dalhoff, A; Shalit, I | 1 |
| Aguilar, L; García-Calvo, G; García-Olmos, M; Giménez, MJ; Parra, A; Ponte, C; Soriano, F | 1 |
| Shakibaei, M; Stahlmann, R | 1 |
| Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY | 1 |
| Carpenter, TR; Kaufman, MB; McDonnell, PJ; Sarayba, MA; Sweet, PM; Taban, M; Tungsiripat, T | 1 |
| Doganay, M; Esel, D; Sumerkan, B | 1 |
| Aguilar, L; Garcia-Mendez, E; Jiménez De Anta, MT; Marco, F; Mensa, J; Ruiz, J; Sierra, JM; Vila, J | 1 |
| Kim, IS; Kim, MR; Lee, CJ; Lee, MH; Shim, JH | 1 |
| Chen, L; Jin, XY; Li, R; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Carter, O; Counts, C; Dodson, S; Lody, C; Madhusudhan, KT; Ojha, N | 1 |
| Coban, AY; Durupinar, B | 1 |
| Isaacson, G | 1 |
| Garrison, MW | 2 |
| Glupczynski, Y; Hanon, F; Marchandise, B; Schoevaerdts, D; Swine, C; Vander Borght, T; Vanpee, D | 1 |
| Fraschini, F; Mattina, R; Mouton, JW; Scaglione, F | 1 |
| Guo, XL; Huang, SP | 1 |
| Bundrick, W; Heron, SP; Kahn, JB; Ray, P; Schiff, WM; Tennenberg, AM; Wiesinger, BA; Wright, PA; Wu, SC; Zadeikis, N | 1 |
| Piddock, L; Ricci, V | 1 |
| Ono, C; Tanaka, M | 1 |
| Dhaliwal, DK; Gordon, YJ; Karenchak, LM; Kowalski, RP; Mah, FS; Ritterband, DC; Romanowski, EG | 1 |
| Almer, LS; Balli, DJ; Beyer, JM; Cai, Y; Flamm, RK; Hensey-Rudloff, D; Nilius, AM; Shen, LL | 1 |
| Cars, O; Löwdin, E; Odenholt, I | 1 |
| Ebisu, H; Fukuda, H; Kishii, R; Takei, M | 1 |
| Almaraz, F; Baquero, F; Cantón, R; Jones, RN; Loza, E; Martín, R; Morosini, MI; Pascual, A; Perea, E; Tubau, F | 1 |
| Hakim, MA; O'Brien, TP; Reviglio, VE; Song, JK | 1 |
| Bhavnani, SM; Callen, WA; Collins, DA; Forrest, A; Gilliland, KK; Paladino, JA; Schentag, JJ | 1 |
| Naber, KG; Sörgel, F | 1 |
| Leggett, J; Saravolatz, LD | 1 |
| Shah, P | 1 |
| Lobzin, IuV; Pozniak, AL; Volzhanin, VM | 1 |
| Benjamin, WH; Bishai, WR; Dorman, SE; Ginsburg, AS; Hooper, N; Sterling, TR; Woolwine, SC | 1 |
| Derevianko, II | 1 |
| Mallari, PL; McCarty, DJ; McKelvie, PA; Pollock, GA; Taylor, HR; White, JF | 1 |
| Colin, J; Geldsetzer, K; Ropo, A; Simonpoli, S | 1 |
| Baumann-Wilschke, I; Bello, A; Kastner, M; Rahm, U; Stahlmann, R | 1 |
| Anon, JB; Conroy, PJ; Dupre, SJ; Hogg, G; Kreisler, LS; Lanier, B; McLean, C; Potts, S; Reese, B; Roland, PS; Stroman, DW; Wall, GM | 1 |
| Barequet, IS; Denton, P; O'Brien, TP; Osterhout, GJ; Tuli, S | 1 |
| Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C | 1 |
| Hong, JW; Hu, CQ; Sheng, LS | 1 |
| Chiang, CH; Lu, DW; Tai, MC | 1 |
| Li, JL; Ma, XC; Tu, ZH; Xin, J; Zhang, T | 1 |
| Wu, XD; Yang, YH; Yao, K; Zhang, Z | 1 |
| Bucci, FA | 1 |
| Taustine, LR | 1 |
| Allen, Z; Andreini, HJ; Butler, WM; Curtis, RL; Donzella, JG; Lindert, DJ; Luna, IH; Merrick, GS | 1 |
| Colombo, A; De Vecchi, E; Drago, L; Gismondo, MR; Guerra, A; Medaglia, M; Nicola, L; Tocalli, L | 1 |
| Aracil, B; Campos, J; Cantón, R; Pérez-Vázquez, M; Román, F | 1 |
| Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC | 1 |
| Inui, K; Saito, H; Yamaguchi, H; Yano, I | 1 |
| Elliott, MA; Patel, R; Prabhu, RM | 1 |
| Amin, AS; Ragab, GH | 1 |
| Acharya, B; Arakawa, S; Gotoh, A; Hinata, N; Kamidono, S; Kawabata, M; Kinoshita, S; Kofuku, T; Okada, H; Shigemura, K; Shirakawa, T | 1 |
| Chow, C; Davis, E; Dunn, S; Hardten, D; Healy, DP; Holland, EJ; Lindstrom, RL; Nordlund, ML | 1 |
| Alfonso, EC; Miller, D | 1 |
| Iwashima, A; Kiguchi, T; Sato, K; Yamaguchi, M | 1 |
| Armitstead, JA; Empey, KL; Evans, ME; Martin, C; Ofotokum, I; Rapp, RP | 1 |
| Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA; Traidej, M | 1 |
| Akira, S; Ba-Thein, W; Dewi, BE; Hayashi, H | 1 |
| Artico, M; La Colla, P; Mai, A; Poni, G; Sbardella, G; Setzu, MG | 1 |
| Bao, L; Long, Y; Wu, YH; Xie, YX; Zeng, XW; Zhang, HD; Zhao, MC | 1 |
| Conroy, PJ; Dohar, JE; Dupre, SJ; Hekkenburg, R; Lane, EM; Lanier, BJ; Potts, SL; Roland, PS; Wall, GM | 1 |
| Duan, GC; Xi, YL; Zhu, JY | 1 |
| Christmann, D; Daniel, JP; Moulin, B | 1 |
| Schito, AM; Schito, GC | 1 |
| Naber, KG | 1 |
| Fukuda, Y; Hirakata, Y; Kadota, J; Kohno, S; Miyazaki, Y; Murata, I; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Caballero, AR; Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
| De Neeling, AJ; Geerlings, SE; Hoepelman, AI; Meiland, R | 1 |
| Graninger, W; Zeitlinger, M | 1 |
| Ambrosch, A; Dietlein, M; Kullmann, KH; Lehnert, H; Lobmann, R; Seewald, M; Zink, K | 1 |
| Michael Wall, G; Pontius, A; Roland, PS; Waycaster, CR | 1 |
| Arbogast, PG; Bansal, P; Hargrove, F; Hulgan, T; Kernodle, DS; Miller, RA; Rosenbloom, ST; Talbert, DA | 1 |
| Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A | 1 |
| El-Brashy, AM; El-Sayed Metwally, M; El-Sepai, FA | 1 |
| Drlica, K; Li, X; Mariano, N; Rahal, JJ; Urban, CM | 1 |
| Bonfiglio, G; Lanzafame, A; Mattina, R; Santini, L | 1 |
| Burgess, DS; Frei, CR; Moczygemba, LR | 1 |
| Crandall, AS; Fiscella, RG; Jensen, MK; Mooney, B; Moshirfar, M; Olson, RJ; Wallin, T | 1 |
| Beekmann, SE; Doern, GV; Heilmann, KP; Miller, NJ; Rice, CL; Richter, SS | 1 |
| Aguilar, L; Alkorta, M; Giménez, MJ; Pérez-Trallero, E; Vicente, D | 1 |
| Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V | 1 |
| Hatano, K | 1 |
| Köşem, M; Ozbek, H; Tuncay, I; Unal, O | 1 |
| Dong, C; Feng, YL | 1 |
| Lister, PD; Wolter, DJ | 1 |
| Kollef, MH; Shorr, AF; Susla, GB | 1 |
| Bose, M; Dam, T; Isa, M | 1 |
| Shmelev, EI | 1 |
| Blatun, LA; Iakovlev, VP; Svetukhin, AM; Ukhin, SA | 1 |
| Barcia-Macay, M; Mingeot-Leclercq, MP; Seral, C; Tulkens, PM; Van Bambeke, F | 1 |
| Arjratanakool, W; Asawapokee, N; Chaiprasert, A; Dhiraputra, C; Leechawengwong, M; Leelarasamee, A; Prammananan, T; Tingtoy, N | 1 |
| Daurès, JP; Fabbro-Peray, P; Kinowski, JM; Lavigne, JP; Mahamat, A; Sotto, A | 1 |
| Bauer, LA; Black, DJ; Garrison, J; Hooton, TM; Lill, JS; Raisys, VA | 1 |
| Gurkan, T; Oguz, E; Oguz, H; Ozbilge, H | 1 |
| Clarke, L; Elborn, JS; Goldsmith, CE; McCaughan, J; McKnight, AJ; Millar, BC; Moore, JE; Reid, A; Shaw, A | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Alferova, IV; Firsov, AA; Lubenko, IY; Portnoy, YA; Smirnova, MV; Zinner, SH | 1 |
| Kabra, SK; Kadhiravan, T; Kapil, A; Misra, A; Renuka, K; Wig, N | 1 |
| Michot, JM; Mingeot-Leclercq, MP; Seral, C; Tulkens, PM; Van Bambeke, F | 1 |
| Paramasivan, CN; Rahman, F; Sulochana, S | 1 |
| Fuller, JD; Low, DE | 1 |
| Kahn, JB; Schaeffer, AJ; Tennenberg, AM; Wu, SC | 1 |
| Abba, M; Donnelly, J; Hussain, B; Shervington, LA | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Tocalli, L | 1 |
| Espinosa-Mansilla, A; Gómez, DG; Peña, AM; Salinas, F | 1 |
| Squire, SB; Vizel, AA; Ziganshina, LE | 1 |
| Cabeza, JG; Hernandez, J; Llagostera, M; Mensa, J; Montero, T; Ruiz Chaler, M; Sierra, JM; Vila, J | 1 |
| Coll, P; Mirelis, B; Miró, E; Navarro, F; Rebollo, M; Rivera, A; Sánchez, F | 1 |
| Graff, JM; Kesler-Diaz, A; McDonnell, PJ; Osann, KE; Reiser, BJ; Sarayba, MA; Shamie, N; Sweet, PM; Taban, M | 1 |
| Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
| Ben-Zvi, Z; Holcberg, G; Katz, M; Polachek, H; Polachek, J; Sapir, G; Tsadkin-Tamir, M | 1 |
| Abelson, MB; Shapiro, A; Torkildsen, G; Wagner, RS | 1 |
| Jung, HC; Kim, JM; Kim, JS; Kim, N; Song, IS | 1 |
| Borrás-Blasco, J; Conesa-García, V; Gomez-Corrons, A; González-Delgado, M; Marín-Jiménez, F; Navarro-Ruiz, A | 1 |
| Kenton, I; McKinnon, PS; Mohr, JF; Okhuysen, PC; Peymann, PJ; Septimus, E | 1 |
| Hu, J; Wang, L; Wei, H; Yang, L; Zhong, H | 1 |
| Marchese, A; Roveta, S; Schito, AM; Schito, GC | 1 |
| Freisberg, L | 1 |
| Starr, MB | 1 |
| Katz, HR | 1 |
| Su, Y; Weng, S; Wu, J; Xu, Y; Yang, J; Yang, L; Yu, Z | 1 |
| Arjyal, A; Pandit, A | 1 |
| Hikida, M; Kariyama, R; Kato, Y; Kumon, H; Mikuniya, T; Monden, K | 1 |
| Cañada-Cañada, F; Espinosa-Mansilla, A; González Gómez, D; Muñoz de la Peña, A | 1 |
| Iannetta, M; Mineo, E; Neri, MG; Pessina, A | 1 |
| Brückner, O; Trautmann, M | 1 |
| Blondeau, JM; Hansen, GT | 1 |
| Aktas, E; Durmaz, R; Kalcioglu, MT; Ozturan, O | 1 |
| Abd El-Aty, AM; Kuroha, M; Nakamura, M; Regmi, NL; Shimoda, M | 1 |
| Dalhoff, A; Kinzig-Schippers, M; Naber, KG; Sörgel, F; Tischmeyer, U; Wagenlehner, C; Wagenlehner, FM | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Caballero, AR; Dajcs, JJ; Johnston, KH; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
| Blondeau, JM; Drlica, K; Hansen, GT; Zhao, X | 1 |
| Alvarez, AI; Merino, G; Molina, AJ; Prieto, JG; Pulido, MM; Schinkel, AH | 1 |
| Fukuda, H; Hayashi, K; Kadowaki, SE; Takei, M | 1 |
| Wooten, JM | 1 |
| Byrns, K; Goldner, B; Makaryus, AN; Makaryus, MN; Natarajan, U; Singer, C | 1 |
| Cox, CD; Meyerrose, GE; Peeters, MJ; Seifert, CF; Tsikouris, JP | 1 |
| Anguita-Alonso, P; Jacofsky, DJ; Osmon, DR; Patel, R; Piper, KE; Rouse, MS | 1 |
| Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Dhaliwal, DK; Gordon, YJ; Mah, FS; Romanowski, EG; Yates, KA | 1 |
| Lück, PC; Steinert, M | 1 |
| Chmielewska, A; Konieczna, L; Lamparczyk, H | 1 |
| Bae, CS; Bae, JG; Jeong, MJ; Kim, JC; Kim, SG; Kim, SH; Kim, YS; Lim, SC; Oh, DM | 1 |
| Hirota, K; Kayama, S; Miyake, Y; Murakami, K; Ono, T; Susilowati, H; Viducic, D | 1 |
| Adebayo, SA; Olapade-Olaopa, EO | 1 |
| Davis, NB; Kahn, J; Tennenberg, AM; Wu, SC | 1 |
| Appelbaum, PC; Bozdogan, B; Choi, DR; Credito, K; Dewasse, B; Kosowska-Shick, K; Lin, G; McGhee, P; Pankuch, GA; Ryu, JM | 1 |
| Caniça, M; Dias, R; Louro, D | 1 |
| Bosso, JA; Mauldin, PD | 1 |
| Carmeli, Y; Dodds, AE; Engemann, JJ; Kanafani, ZA; Kaye, KS; Weber, SG | 1 |
| Black, JA; Moland, ES; Thomson, KS; Wickman, PA | 1 |
| Bayar, B; Bozkurt, A; Dinçel, A; Duman, S; Kaya, E; Oflu, Y; Yağci, R; Yağci, S | 1 |
| Eiland, E; Hassoun, A | 1 |
| Aydemir, S; Cilli, F; Tunger, A | 1 |
| Bengoechea, JA; Campos, MA; Morey, P | 1 |
| Coll, P; Gurguí, M; Mateo, M; Mirelis, B; Miró, E; Navarro, F; Rebollo, M; Rivera, A | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
| Amarnath, SK; Joshi, S | 1 |
| Legout, L; Migaud, H; Mouton, Y; Rosele, B; Roussel-Delvalez, M; Savage, C; Senneville, E; Stern, R; Yazdanpanah, Y | 1 |
| Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M | 1 |
| Kinzig-Schippers, M; Naber, KG; Sörgel, F; Tischmeyer, U; Wagenlehner, C; Wagenlehner, FM | 1 |
| Black, JA; Hanson, ND; Smith Moland, E; Thomson, KS; Wickman, PA | 1 |
| Huang, CH; Zhang, H | 1 |
| Adam, HJ; Baudry, TJ; Hoban, CJ; Hoban, DJ; Laing, NM; Nichol, KA; Schurek, KN; Zhanel, GG | 1 |
| Kinzig-Schippers, M; Naber, KG; Sörgel, F; Wagenlehner, FM; Weidner, W | 1 |
| Borlenghi, E; Capucci, MA; Carosi, GP; Cattaneo, C; Franco, F; Grazioli, L; Pan, A; Quaresmini, G; Rossi, G | 1 |
| Drago, L; Esposito, S; Leone, S; Marchetti, F; Marvaso, A; Noviello, S | 1 |
| Lee, HB; Peart, TE; Svoboda, ML | 1 |
| Fiscella, RG; Jensen, MK | 1 |
| Rodríguez, JC; Royo, G; Ruiz, M; Sirvent, E | 1 |
| Harish, BN; Menezes, GA; Parija, SC; Sarangapani, K | 1 |
| Abd El-Aty, AM; Kubota, R; Regmi, NL; Shah, SS; Shimoda, M | 1 |
| D'Azevedo, PA; Francisco, W; Oliveira, AD | 1 |
| Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM | 1 |
| Amyes, SG; Dobay, O; Ghidán, A; Matuz, M; Nagy, K; Rozgonyi, F | 1 |
| Catero, M | 1 |
| Bassett, J; Byrne, WR; Fritz, D; Hartings, JM; Heine, HS; Ivins, BE; Miller, L; Norris, SL; Pitt, ML | 1 |
| Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J | 1 |
| Haggerty, CL; Ness, RB | 1 |
| Gualco, L; Marchese, A; Schito, AM; Schito, GC | 1 |
| Breithardt, G; Cakir, Y; Eckardt, L; Engelen, MA; Haverkamp, W; Hilker, E; Milberg, P; Mönnig, G; Osada, N; Ramtin, S; Stypmann, J | 1 |
| Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA | 1 |
| Blondeau, JM; Borsos, S; Hesje, CK | 1 |
| Clark, KP; Griffith, ME; Hawley, JS; Hospenthal, DR; Johnson, EN; Moon, JE; Murray, CK | 1 |
| Blondeau, JM; Hedlin, P | 1 |
| Ali, SH; Chandraker, A; DeCaprio, JA | 1 |
| Beier, RC; Ding, S; Feng, C; He, F; Jiang, H; Kai, Z; Li, J; Shen, J; Wan, Y; Wang, Z; Yang, X; Zhang, S; Zhu, Y | 1 |
| Alañón Molina, A; Durán Merás, I; Jiménez Girón, A; Muñoz de la Peña, A; Murillo, JA | 1 |
| Erkin, G; Isik, SR; Kalyoncu, AF; Karakaya, G | 1 |
| Choi, EC; Choi, JS; Joo, CK; Kim, SY; Lim, JA | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Omika, K; Sato, Y | 1 |
| Babayan, K; Fenichiu, O; Gaboulaud, V; Hovhannisyan, G; von Schoen-Angerer, T | 1 |
| Amicosante, G; Celenza, G; Larosa, M; Perilli, M; Segatore, B; Setacci, D | 1 |
| Oxley, KS; Ramadan, HH; Thomas, JG | 1 |
| Burgess, DS; Hall, RG | 1 |
| Brown, DL; Deziel, MR; Drusano, GL; Kulawy, RW; Liu, W; Louie, A | 1 |
| Brown, P; Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Klausner, HA; Peterson, J | 1 |
| Bruscas Izu, C; Mauri Llerda, JA; Medrano San Ildefonso, M | 1 |
| Christidou, A; Mourad, TA; Psaroulaki, A; Samoilis, G; Tabaa, D; Tselentis, Y; Turkmani, A | 1 |
| Buyten, J; Kaufman, G; Ryan, M | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Asari, M; Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Osaka, Y; Yasuda, S | 1 |
| Reyes, SA; Smith, LP; Younis, RT | 1 |
| Ito, K; Izumi, K; Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K | 1 |
| Baggett, P; Gaba, PD; Griffin, MR; Haley, C; Holt, E; Mitchel, E; Sterling, TR; Warkentin, J | 1 |
| Fisher, A; Kahn, JB; Kaul, S; Khashab, M; Peterson, J | 1 |
| Bezwada, P; Clark, LA; Schneider, S | 1 |
| Chang, ST; Chen, CC; Cheng, KC; Chuang, YC; Huang, HC; Shieh, CC; Yu, WL | 1 |
| Cantor, LB; Catoira, YP; Hoop, JS; Morgan, LS; Valluri, S; WuDunn, D; Yung, CW | 1 |
| Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Peterson, J | 1 |
| Squire, SB; Ziganshina, LE | 1 |
| Bhattacharya, M; Bhattacharya, SK; Clemens, JD; Dutta, S; Manna, B; Nair, S; Ochiai, RL; Sen, B; Sur, D; Wain, J | 1 |
| Nickel, JC; Xiang, J | 1 |
| Abdelmoula, L; Ben Hadj Yahia, C; Chaabouni, L; Manamani, L; Saidane, O; Tekaya, R; Zouari, R | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Carroll, DG; Carroll, DN | 1 |
| Chen, Y; Deng, L; Deng, Q; Ding, H; Lu, Q; Shen, X; Wang, A; Wang, L; Wang, Y; Yang, Y | 1 |
| Hung, PP; Lin, CF; Lin, YH; Liu, MF; Shi, ZY | 1 |
| Docobo-Pérez, F; García, I; Martínez-Martínez, L; Pachón, J; Pachón-Ibañez, ME; Pascual, A; Pichardo, C; Rodríguez-Martínez, JM | 1 |
| Chochlakis, D; Christidou, A; Psaroulaki, A; Tabaa, D; Tselentis, Y; Turkmani, A | 1 |
| Gopinath, K; Sankar, MM; Singh, S; Singla, R | 1 |
| Larsson, L; Mathiasson, L; Zorita, S | 1 |
| Chen, XF; Li, WY; Xuan, CS | 1 |
| Baines, SD; Freeman, J; O'Connor, R; Saxton, K; Wilcox, MH | 1 |
| Fiscella, RG; Jensen, MK; Mooney, B; Moshirfar, M | 1 |
| Asbell, PA; Epstein, SP; Sosa, AB | 1 |
| Bai, XQ; Deng, SJ; Li, L; Li, R; Liang, QF; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Abrahamian, FM; Krishnadasan, A; Moran, GJ; Stamm, WE; Talan, DA | 1 |
| Becnel Boyd, L; Morgan-Linnell, SK; Steffen, D; Zechiedrich, L | 1 |
| Becnel Boyd, L; Hamill, RJ; Horton, LB; Jimenez, JR; Maynard, MJ; Morgan-Linnell, SK; Steffen, D; Sucgang, R; Versalovic, J; Zechiedrich, L | 1 |
| Bürr, P; Haschke, M; Rätz Bravo, A; Stoll, R | 1 |
| Lajiness, MJ | 1 |
| Jia, YX; Liu, YM; Tian, W | 1 |
| Ge, DT; Ho, YY; Kong, SK; Law, PY | 1 |
| Qi, HM; Wei, MJ; Zhang, L; Zhao, CY | 1 |
| Abdi-Ali, A; Falsafi, T; Nikname, V; Rahmani-Badi, A | 1 |
| Choi, JS; Joo, CK; Kim, KA; Lim, JA; Park, SH | 1 |
| Meletiadis, J; Papaioannidou, P; Roilides, E; Sein, T; Stergiopoulou, T; Tsiouris, I; Walsh, TJ | 1 |
| Eve, O; Martinez, JY; Tran Van, D; Turc, J; Wey, PF | 1 |
| Holland, EJ; Lane, SS; Lindstrom, RL | 1 |
| McCulley, JP | 1 |
| Alam, MR; Garg, P; Gopinathan, U; Krishnaiah, S; Reddy, AK; Sharma, S | 1 |
| García-Rodríguez, JA; Lázaro, FG; Muñoz-Bellido, JL; Rodríguez-Tarazona, RE | 1 |
| Boussery, K; Colpaert, K; De Paepe, P; De Smet, J; De Sutter, P; Decruyenaere, J; Van Bocxlaer, J | 1 |
| Bhandari, SK; House, JD; Krause, DO; Nyachoti, CM; Setia, A | 1 |
| Pezzilli, R | 1 |
| López, JM; Noguera, O; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
| Naranjo-Tackman, R; Stangogiannis-Druya, C; Stangogiannis-Druya, E; Vanzzini, V; Villar-Kurí, J | 1 |
| Calenda, M; Franco, M; García, C; Passerini de Rossi, B; Vay, C | 1 |
| Basuino, L; Chambers, HF; Tattevin, P | 1 |
| Hussain, M; Jones, S | 1 |
| Kim, J; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
| Allen, GP; Hankins, CD | 1 |
| Carmona, IT; Diz Dios, P; Limeres Posse, J; Núñez Otero, V | 1 |
| Colak, O; Ergun, B; Saraçoğlu, A; Temel, HE | 1 |
| Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN | 1 |
| Lin, B | 1 |
| Chen, WL; Hu, FR; Tsai, TH | 1 |
| Bartoletti, R; Cai, T | 1 |
| Abuzeid, WM; Chiu, AG; Doghramji, L; Edelstein, PH; Guss, J | 1 |
| Burns, JL; Dudley, MN; Griffith, DC; King, P; Lomovskaya, O | 1 |
| Carda-Broch, S; Esteve-Romero, J; Rambla-Alegre, M | 1 |
| Monescillo Francia, A | 1 |
| Guo, W; Liu, N; Liu, Y | 1 |
| Eames, T; Grabein, B; Kroth, J; Wollenberg, A | 1 |
| Hager, JL; Hsu, S; Mir, MR | 1 |
| Chun, CL; Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Sun, KL | 1 |
| Anupama, M; Murthy, PB; Seiler, JP | 1 |
| Bell, B; D'Arienzo, PA; Dajcs, JJ; Jamison, T; Stroman, DW; Wagner, RS | 1 |
| Cliby, WA; Diehl, CL; El-Nashar, SA; Famuyide, AO; Stanhope, CR; Swanson, CL; Thompson, RL | 1 |
| Ferreira, JP; Gomes, FB; Riedstra, S | 1 |
| De Vecchi, E; Drago, L; Mattina, R; Nicola, L | 1 |
| Hiraoka, R; Nakazawa, K; Shinozaki, K; Suzuki, Y; Takeshita, K; Watabe, S; Yokoyama, Y | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Memmi, M; Messadi, AA; Thabet, L; Turki, A | 1 |
| Finley, R; Glass, SK; McEwen, SA; Pearl, DL | 1 |
| Conkle, JL; Cook, RL; Lattao, C; White, JR | 1 |
| Alves, G; Falcão, A; Fortuna, A; Lino, C; Pena, A; Sousa, J | 1 |
| Hsueh, PR; Lee, PI; Yang, JC | 1 |
| Andreu, I; Aranda, A; Ariza, A; Blanca-Lopez, N; Doña, I; Mayorga, C; Rosado, A; Torres, MJ | 1 |
| Gaborieau, V; Marchou, B; Weill, FX | 1 |
| Agtini, MD; Arjyal, A; Baker, S; Basnyat, B; Bhattacharya, SK; Bhutta, ZA; Campbell, JI; Canh, DG; Chinh, NT; Clemens, J; Dolecek, C; Dong, B; Dongol, S; Duy, PT; Farrar, JJ; Karkey, A; Naheed, A; Ochiai, L; Parry, CM; Thieu Nga, TV; Thuy, CT; Tinh Hien, T; Van Minh Hoang, N; Vinh, H; Wain, J | 1 |
| Chau, F; de Lastours, V; Fantin, B; Pasquet, B; Ruppé, E; Tubach, F | 1 |
| Ohtori, A; Tojo, K; Ueda, K | 1 |
| Cattoir, V; Kobal, A; Legrand, P | 1 |
| Alovero, FL; Manzo, RH; Romero, VL | 1 |
| Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
| Cheow, WS; Hadinoto, K | 1 |
| Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA | 1 |
| Gerding, DN; Johnson, S; Nagaro, K; Phillips, ST; Sambol, SP | 1 |
| Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
| Kaczmarek, M; Lis, S | 1 |
| Biedenbach, DJ; Farrell, DJ; Jones, RN; Liverman, LC | 1 |
| Ryzhko, IV; Trishina, AV; Verkina, LM | 1 |
| Anetseder, M; Capacchione, J; Hager, M; Metterlein, T; Muldoon, S; Roewer, N; Schuster, F; Tadda, L | 1 |
| Chamseddin, C; Jira, TH | 1 |
| Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK | 1 |
| Green, K; Low, DE; McGeer, A; Melano, R; Patel, SN; Pillai, DR; Tyrrell, GJ | 1 |
| Beytemur, O; Gulmez, T; Kaleagasioglu, F; Mutlu, Z; Olcay, E; Olgac, V | 1 |
| Endermann, R; Goh, F; Körber-Irrgang, B; Kresken, M; Labischinski, H; Leow, P; Stubbings, W; Yong, GC | 1 |
| Bartoletti, R; Boddi, V; Cai, T; Malossini, G; Mazzoli, S; Meacci, F; Mondaini, N | 1 |
| Cremades, R; Galiana, A; García-Pachón, E; López, P; Rodríguez, JC; Royo, G; Ruiz-García, M | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Chen, S; Hu, F; Hu, L; Li, T; Li, X; Shao, Y; Shen, J; Xiong, Z | 1 |
| Alecrim, Md; Almeida, NC; Ferreira, CM; Ferreira, WA; Gomes, Jde S; Naveca, FG; Silva, Mde F; Vasconcelos, Wde S | 1 |
| Sinkó, J | 1 |
| Herodes, K; Kipper, K; Leito, I; Nei, L | 1 |
| Izard, D; Mullié, C; Sonnet, P | 1 |
| Di Maggio, T; Mantengoli, E; Montagnani, F; Pallecchi, L; Pollini, S; Riccobono, E; Rossolini, GM | 1 |
| Bulitta, JB; Kinzig, M; Landersdorfer, CB; Naber, CK; Naber, KG; Sauber, C; Sörgel, F; Wagenlehner, FM | 1 |
| Azéma, J; Constant, P; Daffé, M; Guidetti, B; Kiss, R; Korolyov, A; Malet-Martino, M; Roques, C | 1 |
| Arlet, G; Emond, JP; Smati, M; Tankovic, J | 1 |
| Bansal, N; Chander, J; Kaistha, N | 1 |
| Enokida, H; Hayami, H; Kawahara, M; Nakagawa, M; Yamane, T | 1 |
| Gao, Q; Jiang, Z; Liu, Y; Pan, B; Wang, P; Wang, T; Xie, Z | 1 |
| Jia, CL; Lv, YK; Ma, Y; Sun, HW; Zhao, XB | 1 |
| Ergun, H; Köseoglu-Eser, O; Mamuk, S; Melli, M; Saribas, Z | 1 |
| Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
| Ebrahimpour, B; Moradi, M; Yamini, Y | 1 |
| Bello-Toledo, H; Domínguez-Yévenes, M; Elgorriaga-Islas, E; García-Cañete, P; González-Rocha, G; Guggiana-Nilo, P; Labarca-Labarca, J; Mella-Montecinos, S | 1 |
| Chavda, K; Drlica, K; Hussain, S; Kerns, RJ; Kreiswirth, BN; Kurepina, N; Malik, M; Shah, N; Zhao, X | 1 |
| Malithong, A; Phiboonbanakit, D; Santiwatanakul, S; Srisangchan, P; Srisurat, N; Susaengrat, W; Tantisiriwat, W; Thamlikitkul, V; Thunyaharn, S; Tiengrim, S | 1 |
| Cheng, J; Hu, LF; Li, JB; Yang, HF; Ye, Y | 1 |
| Liu, M; Xia, Q; Yang, Y | 1 |
| Baquero, F; Cantón, R; Fernández-Olmos, A; García-Castillo, M; Lamas, A; Maiz, L | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
| Ciullo, I; Flammini, S; Leonildi, A; Menichetti, F; Tagliaferri, E; Tascini, C | 1 |
| Guo, YL; Jin, FS; Liu, DM; Shen, ZJ; Sun, YH; Zhang, ZC | 1 |
| Albini, A; Fasani, E; Maraschi, F; Migliavacca, R; Nucleo, E; Pretali, L; Profumo, A; Speltini, A; Sturini, M | 1 |
| Fortier, LC; Meessen-Pinard, M; Sekulovic, O | 1 |
| Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
| Mehrani, M; Mortaz-Hejri, S; Sadeghipour, P; Yousefi-Nooraie, R | 1 |
| Avison, MB; Gould, VC; Okazaki, A | 1 |
| Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
| Iordanishvili, AK; Muzykin, MI; Okovityĭ, SV | 1 |
| Chen, X; Chen, Y; Fu, Y; Meng, F; Wang, H; Xu, H; Zhang, F; Zhang, W; Zhang, Y; Zhao, S | 1 |
| Hosono, M; Takayanagi, R; Yamada, Y; Yokoyama, H | 1 |
| Guo, H; Li, S; Liu, M; Lu, Y; Sun, L; Wang, B; Wang, J; Wei, Z | 1 |
| Davies, GR; Titarenko, AF; Ziganshina, LE | 1 |
| Huang, J; Jiang, Z; Jin, G; Lu, S; Wang, M; Ye, G | 1 |
| Balaji, K; Pandian, SK; Thenmozhi, R | 1 |
| Davies, TA; He, W; Lynch, AS; Queenan, AM | 1 |
| Bian, A; Blackman, A; Eden, S; Maruri, F; Mitchel, E; Shintani, AK; Sterling, TR; van der Heijden, YF; Warkentin, JV | 1 |
| Bochman, ML; Brodsky, JL; Schwacha, A; Seguin, S; Seibel, WL; Simon, N | 1 |
| Amorim, CL; Castro, PM; Maia, AS; Moreira, IS; Tiritan, ME | 1 |
| Amorim, CL; Castro, PM; Maia, AS; Mesquita, RB; Rangel, AO; Tiritan, ME; van Loosdrecht, MC | 1 |
| Alcaraz, MR; Araújo, MC; Goicoechea, HC; Gomes, Ade A | 1 |
| Amorim, CL; Barreiro, JC; Cass, QB; Castro, PM; Maia, AS; Ribeiro, AR; Tiritan, ME | 1 |
| Kodawara, T; Masada, M; Masuda, S; Matsubara, K; Nakamura, T; Yano, Y | 1 |
| Chen, X; Han, F; Hu, Y; Lü, Y; Qiu, J; Song, W; Zheng, P; Zhou, F; Zhou, X | 1 |
| Rodríguez-Díaz, JM; Sánchez-León, G | 1 |
| Djurdjevic, P; Ivanovic, N; Jakovljevic, I; Jelikic-Stankov, M; Joksovic, L | 1 |
| Dai, Z; Jin, R; Li, B; Liu, J; Tang, S | 1 |
| Igbinosa, IH | 1 |
| Brem, R; Karran, P; Macpherson, P; Peacock, M | 1 |
| Cui, YF; He, JT; Qiao, XC; Su, SH; Yang, L | 1 |
| Farhat, MR; Franke, MF; Jacobson, KR; Kaur, D; Mitnick, CD; Murray, M; Sloutsky, A | 1 |
| Bouyarmane, H; Coradin, T; El Hanbali, I; El Karbane, M; Laghzizil, A; Masse, S; Rami, A; Saoiabi, A; Saoiabi, S | 1 |
| Lee, CH; Lee, LN; Lee, MC; Wang, JT; Wang, JY; Yu, MC | 1 |
| Kang, H; Lin, L; Luo, Y; Tu, X; Wu, W; Xie, L; Yue, Z; Zhang, Y | 1 |
| Ahmadi, SH; Manbohi, A | 1 |
| Åhman, J; Kahlmeter, G; Matuschek, E; Petersen, A; Sjölund-Karlsson, M; Skov, R; Stegger, M; Torpdahl, M | 1 |
| Cass, QB; Denadai, M | 1 |
| Fernandes, M; Kumar, N; Medikonda, R; Vira, D | 1 |
| Chen, T; Liu, S; Shi, W; Tao, H; Wang, Y; Xu, Y | 1 |
| Chaminda, GT; Chiemchaisri, C; Chiemchaisri, W; Chulasak, R; Furumai, H; Honda, R; Masago, Y; Poonnotok, A; Sawaittayotin, V; Sienglum, C; Sunthonwatthanaphong, V; Tanong, K; Watanabe, T; Wongsila, K; Yamamoto, K | 1 |
| Chaiprasert, A; Disratthakit, A; Doi, N; Leechawengwongs, M; Prammananan, T; Thaipisuttikul, I; Tribuddharat, C | 1 |
| Hollert, H; Kueppers, S; Santiago-Schübel, B; Xiao, H; Zhu, L | 1 |
| Crowson, MG; Schulz, K; Tucci, DL | 1 |
| Dai, LL; Dai, XH; Li, N; Liu, HJ; Xue, YG; Yan, H | 1 |
| Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N | 1 |
| Luo, Q; Shi, C; Wang, X; Wu, J; Yu, N | 1 |
| Alcaraz, I; Caumes, E; Dupin, N; Janier, M; Maatouk, I; Timsit, FJ | 1 |
| Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O | 1 |
| Cheng, T; Guan, X; Liu, X; Wang, S; Zhang, H | 1 |
| Bonato, PS; Faria-E-Sousa, SJ; Jabor, VAP; Martinez, EZ; Silva, GCM | 1 |
| De Silva, BCJ; Heo, GJ; Hossain, S; Pathirana, HNKS; Wimalasena, SHMP | 1 |
| Gohil, RD; Syed, MI | 1 |
| Coradin, T; El Karbane, M; Gouza, A; Laghzizil, A; Laurent, G; Masse, S; Rami, A; Saoiabi, A; Saoiabi, S | 1 |
| Ding, H; Jin, H; Kong, Y; Qi, C; Ruan, Z; Xie, X; Zhang, J; Zou, Y | 1 |
| Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
| Antonelli, PJ; Dirain, CO; Redula, S | 1 |
| Antonelli, PJ; Dirain, CO; Kosko, B | 1 |
| Marchant, J | 1 |
| Carneiro, ZA; de Albuquerque, S; de Oliveira, LP; de Souza, MVN; Guerra, W; Lima, MF; Lopes, CD; Paixão, DA; Pavan, FR; Pivatto, M; Ribeiro, CM; Teixeira, LR | 1 |
| Cao, J; Cen, Y; Ding, Y; Hu, Y; Huang, J; Tang, H | 1 |
| Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
| Barceló, D; Blánquez, P; Hom-Diaz, A; Jaén-Gil, A; Llorca, M; Rodríguez-Mozaz, S; Vicent, T | 1 |
| Chu, F; Dahlgren, RA; Du, L; Gu, H; Li, Y; Ma, Y; Wang, H; Wang, X; Zheng, Y | 1 |
| Hai, RT; Li, J; Li, XH; Wang, XH; Zheng, Q | 1 |
| Ben Salem, C; Brahim, A; Fathallah, N; Ouni, B; Slim, R | 1 |
| Behan, P; Boehm, D; Bourke, P; Cullen, PJ; Gilmore, BF; Sarangapani, C; Ziuzina, D | 1 |
| Kurz, X; McGettigan, P; Morales, D; Pacurariu, A; Pinheiro, L; Slattery, J | 1 |
| Ahmed, S; Al-Shaer, MH; Alghamdi, WA; Alkabab, Y; Alsultan, A; An, G; Banu, S; Barbakadze, K; Cegielski, JP; Heysell, SK; Houpt, E; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA | 1 |
| Cui, P; Ding, YF; Liu, SC; Sun, SJ | 1 |
| Antonelli, PJ; Dirain, CO; Karnani, DN | 1 |
| Bandyopadhyay, B; Giri, N; Roy, B; Tousif Ahamed, SK | 1 |
| Nakagawa, Y; Sai, Y; Shimada, T; Suga, Y; Suzuki, T | 1 |
| Arun, S; Chakraborty, P; Ilango, K; Kumar, RM; Mukhopadhyay, M; Ruppa, J | 1 |
| Duque-Yemail, J; Grau-López, L; Palma-Alvarez, RF; Perea-Ortueta, M; Ramos-Quiroga, JA; Robles-Martínez, M; Ros-Cucurull, E | 1 |
| Golub, JS; Lin, J; Lustig, L; Valentini, C | 1 |
| Chang, Q; Gao, B; Yang, H | 1 |
| Cheng, D; E, Y; Lin, H; Liu, F; Liu, H; Liu, X | 1 |
| Bucsa, C; Farcas, A; Huruba, M; Leucuta, DC; Mogosan, C; Sipos, M | 1 |
| Chiffer, RC; Kirchner, GJ; McKinnon, BJ; Pasick, LJ; Yeakel, H | 1 |
| Dao, TS; Itayama, T; Iwami, N; Maseda, H; Nguyen, TD; Pham, TL; Ramaraj, R; Shimizu, K | 1 |
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
| Chi, W; Cui, G; Fang, X; Hao, P; Huang, F; Liu, Y; Shi, X; Tang, B; Wang, Q | 1 |
| Głowacki, R; Kośka, I; Kubalczyk, P; Purgat, K | 1 |
| Green, MD; Khanthavong, M; Mayxay, M; Newton, PN; Phonlavong, C; Sengaloundeth, S; Sichanh, C; Swamidoss, I; Tabernero, P; Vilayhong, C | 1 |
| Asareh Zadegan Dezfuli, A; Farajzadeh Sheikh, A; Keshavarzi, R; Khani, P; Saki, M; Seyed-Mohammadi, S; Shahin, M; Tabasi, M; Veisi, H | 1 |
| Hand, RA; Henderson, A; Sullivan, MV; Turner, NW | 1 |
| Kośka, I; Kubalczyk, P; Purgat, K | 1 |
| Essex, RW; Maddess, T; Pearce, JG | 1 |
| Du, H; Li, J; Li, Z; Yang, Y; Zhong, Z | 1 |
| Gao, M; Li, H; Li, W; Pan, X; Shan, L; Tian, H; Wang, J | 1 |
| Alarfaj, AA; Hirad, AH; Kosanam, S; Ponsudha, P; Prasada Rao, CMM; Selvam, N; Sundaram, SR; Surendhar, PA; Suriyakrishnaan, K; Vennila, T | 1 |
| Arun, S; Chakraborty, P; Gaonkar, O; Neppolian, B; Xin, L; Zhang, G | 1 |
| Gao, Y; Ji, Y; Lin, Y; Lin, Z; Lu, Y; Yang, Y; Zhang, L | 1 |
| Arques, A; Escudero-Oñate, C; Micó, P; Mora, M; Oller, I; Sciscenko, I | 1 |
| Chen, JP; Deng, S; Fu, X; He, J; Ni, F; Shen, F; Yang, G | 1 |
| Alavi, A; Bayatloo, MR; Nojavan, S; Salehpour, N | 1 |
| Brigmon, RL; Coutelot, FM; Friedman, A; Kugler, A; Polson, SW; Seaman, JC; Simpson, W | 1 |
| Chen, J; Cui, G; Gao, H; Hu, Y; Wang, C; Wang, P; Zhang, B; Zhang, J | 1 |
| Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
| Agrawal, D; Chatterjee, S; Gangwe, AB; Gomase, SN; Mishra, M; Parchand, SM | 1 |
| Han, J; Li, F; Li, L; Li, Z; Niu, Y; Wang, H; Xu, D; Xu, Y | 1 |
| Guo, L; Kuang, H; Lei, X; Liu, L; Xu, C; Xu, L | 1 |
| Amat, AM; Arques, A; Escudero-Oñate, C; Ferrando-Climent, L; García-Negueroles, P; Oller, I; Sciscenko, I | 1 |
| Antonelli, R; da Silva, MGC; Malpass, GRP; Vieira, MGA | 1 |
| Abou-Seri, SM; Elanany, MA; Gedawy, EM; Osman, EEA | 1 |
| Adams, KK; Clarke, LG; Shah, S | 1 |
| Han, Z; Li, Y; Lyu, C; Zhao, L; Zhou, M | 1 |
| Chakraborty, P; Karayi, M; Neppolian, B; Yazhini, C | 1 |
| Costa, HPS; da Silva, MGC; Duarte, EDV; Oliveira, MG; Spaolonzi, MP; Vieira, MGA | 1 |
| Cichomski, M; Kisielewska, A; Kośka, I; Kubalczyk, P | 1 |
| Acuña-Askar, K; Guzmán-Mar, JL; Larralde-Piña, IA; Murillo-Sierra, JC; Ruiz-Ruiz, EJ; Villanueva-Rodríguez, M | 1 |
| Al-Mohaimeed, AM; Al-Onazi, WA; Alabdulmonem, HA; Alarfaj, NA; El-Tohamy, MF | 1 |
76 review(s) available for ofloxacin and ciprofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoroquinolone derivatives and their anti-tubercular activities.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Quinolone antibiotics.
Topics: | 2019 |
[Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Enoxacin; Erythromycin; Humans; In Vitro Techniques; Legionnaires' Disease; Ofloxacin; Pefloxacin; Pneumonia, Mycoplasma | 1992 |
[Fluoroquinolones--a new and important group of antimicrobial agents].
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Humans; Ofloxacin | 1992 |
Review of preclinical studies with ofloxacin.
Topics: Animals; Bacteria; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Ofloxacin | 1992 |
Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Humans; Ofloxacin; Prodrugs; Skin Diseases, Infectious | 1992 |
Ofloxacin vs ciprofloxacin: a comparison.
Topics: Bacterial Infections; Ciprofloxacin; Humans; Metabolic Clearance Rate; Microbial Sensitivity Tests; Ofloxacin | 1992 |
Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Quinolones | 1991 |
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
CAPD peritonitis and fluoroquinolones: a review.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
Safety profile of quinolones.
Topics: Animals; Ciprofloxacin; Dogs; Drug Tolerance; Humans; Male; Norfloxacin; Ofloxacin; Rats | 1990 |
Pharmacokinetics of fluoroquinolones in hepatic failure.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Half-Life; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Ofloxacin; Pefloxacin | 1990 |
Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan.
Topics: Antitubercular Agents; Ciprofloxacin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifamycins; Taiwan; Tuberculosis, Pulmonary; United States | 1989 |
Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
Topics: Bacteria; Bacterial Infections; Ciprofloxacin; Drug Tolerance; Humans; Norfloxacin; Ofloxacin | 1989 |
Comparative pharmacokinetics of ofloxacin and ciprofloxacin.
Topics: Biological Availability; Ciprofloxacin; Humans; Ofloxacin | 1989 |
Action of quinolones on gene expression and bacterial membranes.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane; Ciprofloxacin; Gene Expression Regulation; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; SOS Response, Genetics; Topoisomerase II Inhibitors | 1987 |
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
Topics: Anti-Bacterial Agents; Bacteria; Blood Proteins; Ciprofloxacin; Enoxacin; Fluorine; Humans; Kidney; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Protein Binding; Quinolines; Urinary Tract Infections | 1985 |
Quinolones. Oral antibiotics of the future.
Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Foot Diseases; Humans; Microbial Sensitivity Tests; Ofloxacin | 1988 |
A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
Topics: Ciprofloxacin; Enoxacin; Humans; Intestines; Naphthyridines; Norfloxacin; Ofloxacin; Oropharynx; Oxazines; Pefloxacin; Quinolines | 1988 |
Pharmacokinetics of ciprofloxacin.
Topics: Anti-Infective Agents; Biological Availability; Ciprofloxacin; Humans; Norfloxacin; Ofloxacin; Oxazines; Tissue Distribution | 1988 |
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Humans; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Quinolines; Respiratory Tract Infections | 1987 |
Symposium on antimicrobial agents. The quinolones.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Humans; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
Quinolones.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
The mode of action of 4-quinolones and possible mechanisms of resistance.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1986 |
New antibiotics: areas of appropriate use.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1987 |
The role of 4-quinolones in the treatment of infections.
Topics: Bacterial Infections; Ciprofloxacin; Humans; Kinetics; Norfloxacin; Ofloxacin; Oxazines; Urinary Tract Infections | 1987 |
Review of the 4-quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Enoxacin; Humans; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
Fluoroquinolones in the treatment of cystic fibrosis.
Topics: Ciprofloxacin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Ofloxacin; Pseudomonas Infections | 1993 |
[Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Cocci; Hospital Units; In Vitro Techniques; Methicillin Resistance; Ofloxacin; Pefloxacin | 1994 |
Quinolone therapy in intensive care unit settings.
Topics: Administration, Oral; Aged; Ciprofloxacin; Clinical Protocols; Clinical Trials as Topic; Cross Infection; Drug Interactions; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Tissue Distribution | 1993 |
Oral treatment of gonorrhea and chlamydia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Chlamydia Infections; Ciprofloxacin; Doxycycline; Female; Gonorrhea; Guidelines as Topic; Humans; Male; Ofloxacin; Randomized Controlled Trials as Topic | 1994 |
In-vitro activities of quinolones against mycobacteria.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Mycobacterium leprae; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin | 1993 |
[Pharmacokinetics of fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin | 1993 |
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Drug Tolerance; Female; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Cocci; Humans; Male; Ofloxacin; Quinolones; Treatment Outcome | 1993 |
Fluoroquinolones reviewed.
Topics: Adult; Anti-Infective Agents; Child; Ciprofloxacin; Clinical Trials as Topic; Female; Humans; Norfloxacin; Ofloxacin; Urinary Tract Infections | 1993 |
[Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Pefloxacin; Quinolones; Renal Insufficiency | 1995 |
[Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts].
Topics: Anti-Infective Agents; Biological Availability; Ciprofloxacin; Humans; Ofloxacin; Tissue Distribution | 1997 |
[Value of ciprofloxacin in the therapy of tuberculosis and other mycobacterioses].
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections; Ofloxacin; Rifampin | 1997 |
[Injectable quinolones].
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; Injections, Intravenous; Levofloxacin; Ofloxacin | 2001 |
The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2001 |
Seizures associated with fluoroquinolones.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Levofloxacin; Magnesium; Ofloxacin; Seizures; Sodium | 2001 |
The role of fluoroquinolones in skin and skin structure infections.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus | 2002 |
Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Ofloxacin; Pneumonia, Pneumococcal; Staphylococcal Infections | 2001 |
The expanding role of fluoroquinolones.
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Quinolones; Urinary Tract Infections | 2002 |
[Anthrax in the era of biowarfare].
Topics: Adult; Amoxicillin; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Biological Warfare; Bioterrorism; Child; Ciprofloxacin; Doxycycline; Female; Humans; Infant, Newborn; Male; Ofloxacin; Penicillin G; Penicillins; Pregnancy; Prognosis; Risk Factors; Time Factors | 2003 |
Immunomodulatory effects of quinolones.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clinical Trials as Topic; Cytokines; Fluoroquinolones; Humans; Immune System; Models, Animal; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines | 2003 |
Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Body Fluids; Ciprofloxacin; Fluoroquinolones; Humans; Male; Ofloxacin; Osmolar Concentration; Prostate; Semen | 2003 |
[Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Kidney Failure, Chronic; Ofloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 2004 |
Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Italy; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Streptococcus pneumoniae | 2004 |
Levofloxacin in the treatment of urinary tract infections and prostatitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostatitis; Quinolones; Severity of Illness Index; Treatment Outcome; Urinary Tract Infections | 2004 |
Clinical applications of levofloxacin for severe infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Epithelium; Humans; Infections; Levofloxacin; Lung; Ofloxacin | 2004 |
Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic | 2005 |
[Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
Topics: Administration, Oral; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Injections, Intravenous; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Time Factors | 2004 |
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastrointestinal Diseases; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Skin Diseases; Skin Diseases, Bacterial; Soft Tissue Infections; Urea | 2004 |
A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Failure | 2005 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
[Pathogenesis, diagnosis and therapy of Legionella infections].
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Aza Compounds; Azithromycin; Ciprofloxacin; Diagnosis, Differential; DNA, Bacterial; Fluoroquinolones; Humans; Incidence; Legionella; Legionella pneumophila; Legionellosis; Legionnaires' Disease; Levofloxacin; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Serotyping; Virulence | 2006 |
Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment; Risk Factors; Treatment Outcome | 2006 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciprofloxacin; Decision Making; Drug Resistance; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Neoplasms; Neutropenia; Ofloxacin | 2006 |
Dysglycemia and fluoroquinolones: are you putting patients at risk?
Topics: Adolescent; Adult; Aza Compounds; Bacterial Infections; Blood Glucose; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Evidence-Based Medicine; Family Practice; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Incidence; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; United States; United States Food and Drug Administration | 2007 |
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2007 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Interactions between warfarin and three commonly prescribed fluoroquinolones.
Topics: Aza Compounds; Ciprofloxacin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Humans; International Normalized Ratio; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Warfarin | 2008 |
Efficacy of fluoroquinolones against pathogenic oral bacteria.
Topics: Aza Compounds; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Mouth Diseases; Moxifloxacin; Ofloxacin; Oral Medicine; Quinolines | 2009 |
[Treatment and prevention of infections in cancer patients with neutropenia].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Clinical Protocols; Drug Administration Schedule; Evidence-Based Medicine; Fever; Granulocyte Colony-Stimulating Factor; Humans; Mycoses; Neoplasms; Neutropenia; Ofloxacin; Patient Care Team; Risk Assessment | 2011 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Cystic Fibrosis; Disease Progression; Drug Administration Schedule; Humans; Injections, Intravenous; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Antibiotics for treating human brucellosis.
Topics: Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Rifampin; Streptomycin | 2012 |
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Topics: Antitubercular Agents; Ciprofloxacin; Drug Substitution; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Quinolone-induced psychosis: an updated review.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Delirium; Humans; Levofloxacin; Ofloxacin; Psychoses, Substance-Induced; Quinolones | 2020 |
The clinical treatment of bacterial keratitis: A review of drop instillation regimes.
Topics: Ciprofloxacin; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratitis; Ofloxacin | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
86 trial(s) available for ofloxacin and ciprofloxacin
| Article | Year |
|---|---|
[Effect of ofloxacin, ciprofloxacin and nalidixic acid on serum theophylline level in patients treated with methylxanthine preparations].
Topics: Administration, Oral; Adult; Aminophylline; Asthma; Biological Availability; Ciprofloxacin; Drug Therapy, Combination; Humans; Middle Aged; Nalidixic Acid; Ofloxacin; Theophylline; Time Factors | 1992 |
[Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
Topics: Chlamydia Infections; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gonorrhea; Humans; Ofloxacin; Proctitis; Sexually Transmitted Diseases; Trichomonas Infections; Ureaplasma Infections; Urethritis | 1992 |
Comparison of serum bactericidal activity of 4 fluoroquinolones in healthy volunteers.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Female; Fluoroquinolones; Gram-Positive Cocci; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Serum Bactericidal Test | 1992 |
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Cesarean Section; Ciprofloxacin; Endometritis; Endometrium; Female; Humans; Microbial Sensitivity Tests; Ofloxacin; Premedication; Prospective Studies; Puerperal Infection | 1991 |
Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ofloxacin; Pseudomonas aeruginosa | 1990 |
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
Topics: Bacterial Infections; Ciprofloxacin; Colistin; Humans; Neutropenia; Ofloxacin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Dermatitis; Enoxacin; Gram-Negative Bacteria; Humans; Ofloxacin; Osteomyelitis; Pefloxacin | 1989 |
4-quinolones inhibit biotransformation of caffeine.
Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline | 1988 |
[A cross-over study on the effectiveness of ofloxacin and ciprofloxacin administered orally].
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Humans; Male; Ofloxacin; Oxazines; Pseudomonas Infections; Quinolines; Respiratory Tract Infections | 1986 |
No cytogenetic effects of quinolone treatment in humans.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chromosome Aberrations; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Quinolines | 1988 |
Ofloxacin compared with ciprofloxacin in the treatment of complicated lower urinary tract infections.
Topics: Ciprofloxacin; Double-Blind Method; Humans; Ofloxacin; Prospective Studies; Random Allocation; Urinary Tract Infections | 1988 |
Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Ofloxacin; Oxazines; Peak Expiratory Flow Rate; Prospective Studies; Pseudomonas Infections; Random Allocation; Vital Capacity | 1987 |
Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis; Double-Blind Method; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Pseudomonas Infections; Random Allocation; Respiratory Function Tests | 1987 |
The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Prospective Studies; Pseudomonas Infections; Random Allocation | 1987 |
Interaction between quinolones and caffeine.
Topics: Adult; Anti-Infective Agents; Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Middle Aged; Naphthyridines; Ofloxacin; Oxazines; Quinolines | 1987 |
Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Ofloxacin; Oxazines; Prospective Studies; Random Allocation; Urinary Tract Infections; Urologic Diseases | 1986 |
Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Ofloxacin; Risk Factors; Time Factors | 1993 |
Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.
Topics: Administration, Oral; Adult; Biological Availability; Carbohydrates; Ciprofloxacin; Cross-Over Studies; Dietary Sucrose; Enteral Nutrition; Female; Food, Formulated; Humans; Intestinal Absorption; Male; Ofloxacin | 1994 |
[Clinical efficacy of ciprofloxacin and ofloxacin].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Dysentery, Bacillary; Female; Gonorrhea; Humans; Male; Middle Aged; Ofloxacin; Prospective Studies | 1994 |
Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin.
Topics: Adult; Animals; Calcium; Calcium Carbonate; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Drug Interactions; Half-Life; Humans; In Vitro Techniques; Intestinal Absorption; Kinetics; Ofloxacin; Rats | 1994 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Feces; Female; Fever; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neutropenia; Ofloxacin; Pefloxacin | 1994 |
The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin.
Topics: Absorption; Adult; Ciprofloxacin; Drug Interactions; Female; Ferrous Compounds; Humans; Male; Norfloxacin; Ofloxacin; Software | 1994 |
Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
Topics: Administration, Oral; Adult; Bacteria; Chromatography, High Pressure Liquid; Ciprofloxacin; Double-Blind Method; Humans; Injections, Intravenous; Male; Ofloxacin; Serum Bactericidal Test; Specimen Handling | 1994 |
Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aqueous Humor; Biological Assay; Biological Availability; Cataract Extraction; Ciprofloxacin; Female; Humans; Lenses, Intraocular; Male; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions | 1994 |
Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women.
Topics: Adult; Ciprofloxacin; Coitus; Female; Humans; Norfloxacin; Ofloxacin; Prospective Studies; Recurrence; Urinary Tract Infections | 1994 |
Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
Topics: Administration, Oral; Adult; Blood Bactericidal Activity; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterobacter cloacae; Escherichia coli; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae | 1993 |
Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Menopause; Middle Aged; Norfloxacin; Ofloxacin; Prospective Studies; Urinary Tract Infections | 1993 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
A randomised controlled trial of ofloxacin 200 mg 4 times daily or twice daily vs ciprofloxacin 500 mg twice daily in elderly nursing home patients with complicated UTI.
Topics: Aged; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Female; Humans; Male; Nursing Homes; Ofloxacin; Urinary Tract Infections | 1995 |
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
Topics: Adult; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross-Over Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Serum Bactericidal Test | 1995 |
Effects on growth of single short courses of fluoroquinolones.
Topics: Adolescent; Anti-Infective Agents; Body Height; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Female; Follow-Up Studies; Growth; Humans; Infant; Male; Ofloxacin; Prospective Studies; Typhoid Fever; Vietnam; Weight Gain | 1996 |
Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Biological Assay; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Tobramycin | 1997 |
Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Eye; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions; Spectrophotometry, Ultraviolet; Tears | 1997 |
Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aqueous Humor; Cataract Extraction; Ciprofloxacin; Eye Infections; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions | 1997 |
Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Infectious; Treatment Outcome | 1997 |
Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin.
Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Cross-Over Studies; Dose-Response Relationship, Drug; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Middle Aged; Ofloxacin; Staphylococcus | 1998 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1998 |
Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis | 1998 |
A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Ofloxacin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1999 |
Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration.
Topics: Administration, Topical; Adult; Aged; Anti-Infective Agents; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions | 1999 |
Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Contact Lenses, Hydrophilic; Drug Delivery Systems; Eye Infections; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Staphylococcus epidermidis; Tobramycin | 1999 |
Kinetics of 4-fluoroquinolones permeation into saliva.
Topics: Adult; Anti-Infective Agents; Biological Transport; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Monitoring; Humans; Male; Norfloxacin; Ofloxacin; Pefloxacin; Saliva | 1999 |
Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Osteomyelitis; Quinolones | 2000 |
Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Aqueous Humor; Cataract Extraction; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions | 1999 |
Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Ciprofloxacin; Corneal Topography; Drug Therapy, Combination; Epithelium, Corneal; Eye Infections, Bacterial; Female; Fluorophotometry; Humans; Lasers, Excimer; Male; Middle Aged; Myopia; Ofloxacin; Ophthalmic Solutions; Photorefractive Keratectomy; Wound Healing | 2000 |
Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Urinary Tract Infections; Urine | 2000 |
Effect of topical ciprofloxacin 0.3% and ofloxacin 0.3% on the reduction of bacterial flora on the human conjunctiva.
Topics: Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Humans; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis | 2000 |
Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
Topics: Adult; Anti-Infective Agents; Bacteria; Ciprofloxacin; Corneal Ulcer; Double-Blind Method; Drug Administration Schedule; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Safety; Time Factors; Treatment Outcome | 2001 |
Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation.
Topics: Administration, Oral; Adsorption; Anti-Infective Agents; Anti-Infective Agents, Urinary; Biofilms; Catheters, Indwelling; Chromatography, High Pressure Liquid; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Ofloxacin; Prosthesis-Related Infections; Staphylococcal Infections; Stents; Urinary Tract Infections | 2001 |
Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.
Topics: Adult; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cell Count; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Lung; Male; Middle Aged; Ofloxacin; Reference Values | 2001 |
Penetration of ofloxacin and ciprofloxacin into the aqueous humor of eyes with functioning filtering blebs: a randomized trial.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Therapy, Combination; Female; Filtering Surgery; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies | 2001 |
Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Aqueous Humor; Aza Compounds; Biological Availability; Cataract Extraction; Ciprofloxacin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tissue Distribution | 2001 |
[Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Pyelonephritis; Urinary Tract Infections | 2001 |
[On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
Topics: Adolescent; Age Factors; Anemia, Aplastic; Anti-Infective Agents; Body Height; Cartilage; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Infant; Joint Diseases; Knee Joint; Male; Ofloxacin; Pefloxacin; Prospective Studies; Treatment Outcome | 2002 |
Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous.
Topics: Administration, Topical; Aged; Anti-Infective Agents; Aqueous Humor; Bacteria; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Vitreous Body | 2003 |
Effects of three fluoroquinolones on QT interval in healthy adults after single doses.
Topics: Adult; Aged; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines | 2003 |
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa | 2003 |
Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2003 |
Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin.
Topics: Administration, Topical; Aged; Anti-Infective Agents; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Double-Blind Method; Female; Humans; Levofloxacin; Male; Ofloxacin; Ophthalmic Solutions | 2003 |
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.
Topics: Acute Disease; Administration, Topical; Anti-Infective Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Infant; Male; Middle Ear Ventilation; Ofloxacin; Otitis Media with Effusion; Prospective Studies; Suspensions | 2004 |
[Aqueous humor penetration of topically applied ofloxacin, ciprofloxacin and tobramycin].
Topics: Administration, Topical; Aged; Aqueous Humor; Ciprofloxacin; Endophthalmitis; Female; Humans; Male; Middle Aged; Ofloxacin; Tobramycin | 2003 |
An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
Topics: Absorption; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Therapy, Combination; Female; Gas Chromatography-Mass Spectrometry; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Single-Blind Method | 2004 |
Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Corneal Stroma; Double-Blind Method; Female; Humans; Keratoplasty, Penetrating; Levofloxacin; Male; Ofloxacin; Ophthalmic Solutions; Prospective Studies | 2004 |
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes.
Topics: Administration, Topical; Adolescent; Anti-Infective Agents; Anti-Inflammatory Agents; Cerebrospinal Fluid Otorrhea; Child; Ciprofloxacin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulation Tissue; Humans; Male; Middle Ear Ventilation; Ofloxacin; Otitis Media with Effusion; Prospective Studies; Solutions; Suspensions | 2004 |
Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Diabetic Foot; Female; Humans; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2004 |
Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.
Topics: Acecainide; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Female; Humans; Kidney; Levofloxacin; Male; Ofloxacin; Procainamide | 2005 |
Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2005 |
[Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy].
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Prostatic Diseases; Ultrasonography, Interventional; Urinary Tract Infections | 2001 |
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Female; Humans; Hydrogen-Ion Concentration; Levofloxacin; Male; Middle Aged; Ofloxacin | 2006 |
Effects of three fluoroquinolones on QT analysis after standard treatment courses.
Topics: Analysis of Variance; Aza Compounds; Ciprofloxacin; Cross-Over Studies; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Levofloxacin; Long QT Syndrome; Male; Moxifloxacin; Ofloxacin; Quinolines; Statistics, Nonparametric; Torsades de Pointes | 2006 |
Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Topics: Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Delayed-Action Preparations; Humans; Levofloxacin; Ofloxacin; Proteus mirabilis; Staphylococcus; Urine | 2006 |
Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Cross-Over Studies; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Ofloxacin | 2006 |
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Placebos; Pyuria; Single-Blind Method; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections | 2006 |
Lack of inhibitory effects of several fluoroquinolones on cytochrome P-450 3A activities at clinical dosage in dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Enrofloxacin; Fluoroquinolones; Injections, Intravenous; Male; Microsomes, Liver; Ofloxacin; Quinidine | 2007 |
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Penicillin V; Treatment Outcome; Viridans Streptococci | 2007 |
A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis | 2007 |
[Effectiveness of switch therapy for peritonitis].
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Health Care Costs; Humans; Injections, Intravenous; Meropenem; Middle Aged; Naphthyridines; Ofloxacin; Oxazines; Peritonitis; Thienamycins | 2007 |
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2007 |
Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial.
Topics: Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Ciprofloxacin; Drug Therapy, Combination; Eye Infections, Bacterial; Filtering Surgery; Humans; Levofloxacin; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Single-Blind Method; Surgical Wound Infection | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections | 2008 |
In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Basophil Degranulation Test; Ciprofloxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Immediate; Immunologic Tests; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Radioimmunoassay; Sensitivity and Specificity; Young Adult | 2011 |
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult | 2011 |
Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combination.
Topics: Adolescent; Adult; Body Fluids; Ciprofloxacin; Cross-Over Studies; Drug Combinations; Drug Interactions; Female; Humans; Levofloxacin; Male; Ofloxacin; Prostate; Semen; Seminal Vesicles; Tissue Distribution; Vagina; Young Adult | 2011 |
Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients.
Topics: Adult; Anti-Bacterial Agents; Asian People; Ciprofloxacin; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome | 2012 |
1081 other study(ies) available for ofloxacin and ciprofloxacin
| Article | Year |
|---|---|
Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acids.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Carboxylic Acids; Escherichia coli Infections; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Quinolones; Structure-Activity Relationship | 1992 |
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
Topics: Animals; Anti-Infective Agents; Cricetinae; Cricetulus; Fluoroquinolones; Microbial Sensitivity Tests; Structure-Activity Relationship | 1992 |
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Molecular Conformation; Phenylbutyrates; Pseudomonas Infections; Rats; Streptococcal Infections; Structure-Activity Relationship; Theophylline; X-Ray Diffraction | 1990 |
Quinolone antibacterial agents substituted at the 7-position with spiroamines. Synthesis and structure-activity relationships.
Topics: Bacteria; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Piperazines; Pyrrolidines; Quinolines; Spiro Compounds; Structure-Activity Relationship | 1990 |
Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative.
Topics: Animals; Bacteroides; Chemical Phenomena; Chemistry; Ciprofloxacin; Escherichia coli; Mice; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Topoisomerase II Inhibitors | 1988 |
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship | 1988 |
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Escherichia coli; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Morpholines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 1993 |
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Mice; Microbial Sensitivity Tests; Piperazines; Rats; Structure-Activity Relationship | 1993 |
Nitroquinolones with broad-spectrum antimycobacterial activity in vitro.
Topics: 4-Quinolones; Anti-Infective Agents; Cells, Cultured; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium smegmatis; Quinolones; Staphylococcus; Streptococcus; Structure-Activity Relationship | 1999 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Antibacterial activity of quinolone-macrocycle conjugates.
Topics: Anti-Bacterial Agents; Escherichia coli; Heterocyclic Compounds; Microbial Sensitivity Tests; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2003 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Indicators and Reagents; Kinetics; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Omeprazole; Staphylococcus aureus; Structure-Activity Relationship | 2007 |
Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoroquinolones; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Quinolines; Time Factors; Tuberculosis | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
rpoN gene of Pseudomonas aeruginosa alters its susceptibility to quinolones and carbapenems.
Topics: Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Promoter Regions, Genetic; Pseudomonas aeruginosa; Quinolones; RNA Polymerase Sigma 54; Transcription, Genetic; Virulence | 2007 |
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Computer Simulation; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleic Acid Amplification Techniques; Open Reading Frames; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Vibrio | 2007 |
Plasmid-mediated quinolone resistance determinant QnrB4 identified in France in an Enterobacter cloacae clinical isolate coexpressing a QnrS1 determinant.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacter cloacae; Escherichia coli; France; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Plasmids; Quinolones; Transformation, Genetic | 2007 |
Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Culture Media; DNA Gyrase; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
Topics: Anti-Bacterial Agents; Asia; Bangladesh; China; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Microbial; Fluoroquinolones; Humans; India; Indonesia; Laos; Microbial Sensitivity Tests; Mutation; Nepal; Pakistan; Salmonella typhi; Vietnam | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps.
Topics: Carrier Proteins; Fluoroquinolones; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli.
Topics: Base Sequence; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Quinolones | 2008 |
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Nucleotides; Ofloxacin | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
Topics: Base Sequence; beta-Lactam Resistance; Carbapenems; DNA Primers; DNA, Bacterial; Doripenem; Fluoroquinolones; Genes, Bacterial; Humans; In Vitro Techniques; Meropenem; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cattle; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Quinolones; Salmonella enterica | 2009 |
Targeted delivery of compounds to Trypanosoma brucei using the melamine motif.
Topics: Animals; Eflornithine; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Triazines; Trypanocidal Agents; Trypanosoma brucei brucei | 2009 |
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Coxiella burnetii; Humans; Microbial Sensitivity Tests; Minocycline; Q Fever; Tigecycline; Vero Cells | 2009 |
Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.
Topics: Acanthamoeba castellanii; Animals; Anti-Bacterial Agents; Chlamydiales; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quinolones | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Microbial Sensitivity Tests; Multigene Family; Plasmids; Quinolones; Salmonella typhimurium | 2009 |
Interaction of drug based binuclear mixed-ligand complexes with DNA.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Ciprofloxacin; Cobalt; DNA, Bacterial; Ligands; Magnetic Resonance Spectroscopy; Magnetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Oxidation-Reduction; Spectrophotometry, Infrared; Structure-Activity Relationship; Temperature; Viscosity | 2009 |
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Electroporation; Genotype; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella enterica | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Mutation; Prospective Studies; Spain; Streptococcal Infections; Streptococcus pyogenes | 2010 |
SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Plasmids; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Stenotrophomonas maltophilia | 2010 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Novel variants of the qnrB gene, qnrB22 and qnrB23, in Citrobacter werkmanii and Citrobacter freundii.
Topics: Animals; Bacterial Proteins; Chickens; Citrobacter; Citrobacter freundii; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Quinolones; Swine | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Expectorants; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Studies on the antimicrobial properties of N-acylated ciprofloxacins.
Topics: Acylation; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bartonella; Bartonella Infections; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2012 |
Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; DNA Cleavage; DNA Gyrase; Fluoroquinolones; Gatifloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium leprae; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2013 |
The synergic modeling for the binding of fluoroquinolone antibiotics to the hERG potassium channel.
Topics: Anti-Bacterial Agents; Binding Sites; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Models, Molecular; Potassium Channel Blockers; Structure-Activity Relationship | 2013 |
Antimicrobial activity of imidazo[1,5-a]quinoxaline derivatives with pyridinium moiety.
Topics: Animals; Anti-Infective Agents; Bacteria; Drug Design; Female; Fungi; Imidazoles; Male; Mice; Microbial Sensitivity Tests; Pyridinium Compounds | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Design, synthesis, and biological evaluation of dihydroartemisinin-fluoroquinolone conjugates as a novel type of potential antitubercular agents.
Topics: Antitubercular Agents; Artemisinins; Drug Design; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2014 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological Availability; Chronic Disease; DNA Gyrase; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Macrophages; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Piperidines; Protein Subunits; Rats; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis, Pulmonary | 2014 |
Identification and characterization of an anti-pseudomonal dichlorocarbazol derivative displaying anti-biofilm activity.
Topics: Anti-Bacterial Agents; Biofilms; Carbazoles; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2014 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones | 2017 |
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus cereus; Dose-Response Relationship, Drug; Free Radicals; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Design and synthesis of amphiphilic 2-hydroxybenzylphosphonium salts with antimicrobial and antitumor dual action.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Arthrodermataceae; Bacillus cereus; Candida albicans; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Organophosphorus Compounds; Staphylococcus aureus | 2020 |
WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperidines; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Structure-Activity Relationship | 2022 |
In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Time Factors | 1992 |
Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
Topics: Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Ciprofloxacin; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1992 |
[In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Macrolides; Mycoplasma pneumoniae; Norfloxacin; Ofloxacin; Quinolones; Tetracyclines | 1992 |
In vitro activities of five quinolones against Chlamydia pneumoniae.
Topics: Anti-Infective Agents; Chlamydophila pneumoniae; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1992 |
In vitro evaluation of E-4695, a new fluoro-naphthyridine.
Topics: Anti-Bacterial Agents; Azetidines; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones | 1992 |
[Influence of new quinolones on superoxide anion generation of polymorphonuclear leukocytes].
Topics: Ciprofloxacin; Enoxacin; Humans; In Vitro Techniques; Neutrophils; Norfloxacin; Ofloxacin; Superoxides | 1992 |
In vitro activity of CP-74667 compared with four other fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones | 1992 |
In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Evaluation, Preclinical; Fluoroquinolones; Gatifloxacin; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Piperazines; Quinolones; Tissue Distribution | 1992 |
Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Topoisomerases, Type II; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus | 1992 |
In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones | 1992 |
Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Coxiella burnetii; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Rickettsia; Rickettsia rickettsii; Viral Plaque Assay | 1992 |
The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1992 |
The role of the excision and error-prone repair systems in mutagenesis by fluorinated quinolones in Salmonella typhimurium.
Topics: Ciprofloxacin; DNA Repair; Dose-Response Relationship, Drug; Enoxacin; Genes, Bacterial; Genotype; Mutagenesis; Mutagenicity Tests; Mutagens; Ofloxacin; Salmonella typhimurium | 1992 |
Limiting the use of the quinolones--ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Humans; Ofloxacin; Otorhinolaryngologic Diseases | 1992 |
Occurrence of bacteremia in hematologic patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Bone Marrow Transplantation; Catheterization; Ciprofloxacin; Female; Female Urogenital Diseases; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Male Urogenital Diseases; Middle Aged; Neutropenia; Odds Ratio; Ofloxacin; Risk Factors; Staphylococcal Infections; Staphylococcus epidermidis | 1992 |
Prediction of ofloxacin susceptibility from in-vitro tests with ciprofloxacin.
Topics: Ciprofloxacin; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests | 1992 |
Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
Topics: Administration, Oral; Animals; Brucellosis; Ciprofloxacin; Doxycycline; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
[In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin | 1992 |
A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Conformation; Ofloxacin; Respiratory System; Respiratory Tract Infections; Sputum | 1992 |
Determination of ofloxacin in human serum by high-performance liquid chromatography with column switching.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Humans; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Spectrophotometry, Ultraviolet | 1992 |
The effects of quinolones and NSAIDs upon GABA-evoked currents recorded from rat dorsal root ganglion neurones.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; GABA-A Receptor Antagonists; Ganglia, Spinal; Ofloxacin; Phenylacetates; Phenylbutyrates; Rats | 1991 |
Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus | 1991 |
The in-vitro activity of temafloxacin compared with other antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Species Specificity | 1991 |
In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1991 |
Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections | 1991 |
In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterococcus; Fluoroquinolones; Gram-Positive Cocci; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus | 1991 |
In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Topics: Anti-Infective Agents; Campylobacter; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial | 1991 |
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Penicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus | 1991 |
Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Lung Diseases; Mice; Mice, Inbred Strains; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 1991 |
Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluorescence; Fluoroquinolones; Humans; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1991 |
Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests; Quinolones | 1991 |
In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dogs; Drug Evaluation, Preclinical; Enoxacin; Female; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Prodrugs; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Urinary Tract Infections | 1991 |
The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterococcus faecalis; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus | 1991 |
[Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders].
Topics: Animals; Ciprofloxacin; Cricetinae; Drug Resistance, Microbial; Glanders; Guinea Pigs; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pseudomonas | 1991 |
The effect of ofloxacin and ciprofloxacin on pentylenetetrazol-induced convulsions in mice.
Topics: Animals; Ciprofloxacin; Diazepam; Epilepsy, Tonic-Clonic; Male; Mice; Ofloxacin; Pentylenetetrazole | 1991 |
[Comparative study on growth kinetics of organisms causing purulent infections in the presence of ofloxacin and ciprofloxacin].
Topics: Ciprofloxacin; Kinetics; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1991 |
[The effects of ciprofloxacin and ofloxacin on the cellular and humoral immune response in mice].
Topics: Animals; Antibody Formation; Ciprofloxacin; Complement Fixation Tests; Hypersensitivity, Delayed; Immunity, Cellular; Mice; Ofloxacin | 1991 |
Mechanism of quinolone mutagenicity in bacteria.
Topics: Anti-Infective Agents; Blotting, Southern; Ciprofloxacin; DNA Topoisomerases, Type II; Enrofloxacin; Escherichia coli; Fleroxacin; Fluoroquinolones; Genes, Bacterial; Mutation; Novobiocin; Ofloxacin; Oxolinic Acid; Quinolones; Salmonella | 1991 |
In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Francisella tularensis; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Tularemia | 1991 |
Streptococcus sanguis survival in K-Sol. Comparison of gentamicin and the fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Chondroitin Sulfates; Ciprofloxacin; Colony Count, Microbial; Gentamicins; HEPES; Norfloxacin; Ofloxacin; Streptococcus sanguis | 1991 |
Quinolone therapy in the prevention of mortality after irradiation.
Topics: Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Cobalt Radioisotopes; Female; Gamma Rays; Mice; Ofloxacin; Pefloxacin; Radiation Injuries, Experimental | 1991 |
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin | 1991 |
[Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Enoxacin; Meningoencephalitis; Mice; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 1991 |
Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; DNA; DNA Repair; Liver; Norfloxacin; Ofloxacin; Pefloxacin; Phosphorus Radioisotopes; Rats | 1991 |
Tissue concentration of quinolone antibiotics.
Topics: Bronchi; Ciprofloxacin; Humans; Ofloxacin | 1991 |
Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Topics: Amoxicillin; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia trachomatis; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Erythromycin; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Urethra | 1990 |
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae | 1991 |
Activity of temafloxacin against respiratory pathogens.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gerbillinae; Gram-Positive Bacteria; Guinea Pigs; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections | 1991 |
In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Fluoroquinolones; Magnesium; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones | 1991 |
In vitro activity of sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin | 1991 |
[Antibacterial activity of ciprofloxacin against fresh clinical isolates from superficial suppurative foci].
Topics: Amoxicillin; Bacteria; Cefaclor; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Suppuration | 1991 |
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Staphylococcus; Staphylococcus aureus | 1991 |
In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin.
Topics: Animals; Bacteria; Bacterial Infections; Ciprofloxacin; Culture Media; Hydrogen-Ion Concentration; Isomerism; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin | 1990 |
Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Cell Survival; Ciprofloxacin; Enoxacin; HIV-1; Humans; Lymphocytes; Norfloxacin; Ofloxacin | 1990 |
Influence of new quinolones on normal immune capabilities.
Topics: Animals; Anti-Infective Agents; Antibody Formation; Ciprofloxacin; Hypersensitivity, Delayed; Immunity, Cellular; Injections, Intramuscular; Male; Mice; Norfloxacin; Ofloxacin; Pefloxacin; Phagocytosis | 1990 |
Role of the outer membrane for quinolone resistance in enterobacteria.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Lipopolysaccharides; Nalidixic Acid; Ofloxacin; Serratia marcescens; Species Specificity | 1990 |
MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Ofloxacin; Quinolones | 1990 |
Intracellular bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis H37Rv multiplying in the J-774 macrophage cell line.
Topics: Animals; Cell Line; Ciprofloxacin; Histocytochemistry; Macrophages; Microscopy, Electron; Mycobacterium tuberculosis; Ofloxacin; Phagocytosis | 1990 |
Comparative in vitro activity of the new fluoroquinolone BMY-40062.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1990 |
Antibacterial activity of fluoroquinolones in combination with zidovudine.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Quinolones; Salmonella; Staphylococcus; Zidovudine | 1990 |
Quinolone pharmacokinetics and metabolism.
Topics: Administration, Oral; Anti-Infective Agents; Biological Availability; Biotransformation; Ciprofloxacin; Enoxacin; Fleroxacin; Half-Life; Humans; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin | 1990 |
New techniques for assessing pathogenicity of quinolone-resistant bacteria.
Topics: Bacteriological Techniques; Ciprofloxacin; Humans; Neutrophils; Ofloxacin; Opsonin Proteins; Phagocytosis; Pseudomonas aeruginosa; Staphylococcus aureus | 1990 |
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa | 1990 |
[Effect of quinolones on TNF-alpha production by human monocytes].
Topics: Ciprofloxacin; Cyclic AMP; Dose-Response Relationship, Drug; Endotoxins; Humans; Leukocytes, Mononuclear; Ofloxacin; Pefloxacin; Tumor Necrosis Factor-alpha | 1990 |
Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.
Topics: Adult; Animals; Brain Chemistry; Ciprofloxacin; Double-Blind Method; Electroencephalography; Female; Flunitrazepam; Humans; In Vitro Techniques; Male; Middle Aged; Norfloxacin; Ofloxacin; Quinolones; Radioligand Assay; Random Allocation; Rats; Rats, Inbred Strains; Receptors, GABA-A; Synaptic Membranes | 1990 |
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
Topics: Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Topoisomerase II Inhibitors | 1990 |
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
Topics: Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Models, Biological; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones | 1990 |
In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice.
Topics: Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Liver; Mice; Microbial Sensitivity Tests; Ofloxacin; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1990 |
Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin.
Topics: Animals; Ciprofloxacin; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Ofloxacin; Pefloxacin; Radiation Injuries, Experimental | 1990 |
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; In Vitro Techniques; Klebsiella pneumoniae; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype | 1990 |
In vitro activity of 9 antimicrobial agents against 177 strains of Haemophilus influenzae isolated from hospitalized patients.
Topics: Aztreonam; beta-Lactamases; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Norway; Ofloxacin; Time Factors | 1990 |
The influence of quinolones on the faecal flora.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Feces; Humans; Intestines; Norfloxacin; Ofloxacin; Pefloxacin | 1990 |
The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
Topics: Administration, Oral; Ciprofloxacin; Half-Life; Humans; Intestinal Absorption; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Time Factors | 1990 |
Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
Topics: Anti-Infective Agents; Ciprofloxacin; Fusidic Acid; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Species Specificity | 1990 |
[Treatment of salmonellosis and shigellosis with the new quinolones].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciprofloxacin; Dysentery, Bacillary; Female; Humans; Male; Middle Aged; Ofloxacin; Pefloxacin; Salmonella; Salmonella Infections; Shigella | 1990 |
Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1.
Topics: Cell Division; Ciprofloxacin; Humans; Intracellular Fluid; Legionella; Macrophages; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Serotyping; Time Factors | 1990 |
Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Cell Adhesion; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Plastics; Staphylococcus aureus; Staphylococcus epidermidis | 1990 |
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
Topics: Adult; Aged; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium; Mycobacterium Infections; Ofloxacin; Skin Diseases, Infectious | 1990 |
[Therapeutic drug monitoring of fluoroquinolone].
Topics: Anti-Infective Agents; Bile; Biological Assay; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones; Sputum | 1990 |
[Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype; Staphylococcus aureus | 1990 |
Concentration of ofloxacin and ciprofloxacin in human semen following a single oral dose.
Topics: Administration, Oral; Adult; Ciprofloxacin; Humans; Male; Ofloxacin; Prospective Studies; Semen; Time Factors | 1990 |
The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
Topics: Ampicillin; Ampicillin Resistance; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Penicillin Resistance | 1989 |
In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Topics: Anti-Infective Agents; Bacteria; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas; Staphylococcus; Streptococcus | 1989 |
In vitro activity of cefpodoxime, a new oral cephalosporin.
Topics: beta-Lactamases; Cefaclor; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas | 1989 |
In vitro activity of S-ofloxacin.
Topics: Bacteria; Calcium; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Positive Bacteria; Magnesium; Ofloxacin; Pseudomonas aeruginosa; Steroid Isomerases | 1989 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
[In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Ofloxacin; Pseudomonas aeruginosa | 1989 |
[Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Serratia marcescens | 1989 |
Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
Topics: Administration, Oral; Adult; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Escherichia coli; Female; Humans; Male; Ofloxacin; Osteomyelitis; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 1989 |
[In vitro susceptibility of Campylobacter jejuni and Campylobacter coli to quinolone antibiotics].
Topics: Anti-Infective Agents; Campylobacter; Campylobacter jejuni; Ciprofloxacin; Feces; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin | 1989 |
Pharmacokinetics of three newer quinolones in pregnant and lactating women.
Topics: Adult; Ciprofloxacin; Female; Humans; Lactation; Maternal-Fetal Exchange; Milk, Human; Ofloxacin; Pefloxacin; Pregnancy; Pregnancy Trimester, Third | 1989 |
In vitro and in vivo antibacterial activities of KB-5246, a new tetracyclic quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Phenalenes; Quinolones | 1989 |
In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Diarrhea; Humans; Microbial Sensitivity Tests; Ofloxacin; Stereoisomerism; Travel | 1989 |
Clinical role of the quinolones today and in the future.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Protocols; Forecasting; Humans; Ofloxacin; Respiratory Tract Infections; Sexually Transmitted Diseases; Urinary Tract Infections | 1989 |
[Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
Topics: Adult; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Ofloxacin | 1989 |
In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Norfloxacin; Ofloxacin; Pipemidic Acid; Time Factors; Urinary Tract Infections; Uterus | 1989 |
Interactions of the 4-quinolones with other antibacterials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin | 1989 |
Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci.
Topics: Ciprofloxacin; Humans; In Vitro Techniques; Neutrophils; Ofloxacin; Opsonin Proteins; Phagocytosis; Staphylococcus | 1989 |
In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Macrophages; Mice; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1989 |
[In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mycobacterium; Norfloxacin; Ofloxacin; Pefloxacin | 1989 |
Enhancement of interleukin-2 production in human lymphocytes by two new quinolone derivatives.
Topics: Biological Assay; Chromatography, Gel; Ciprofloxacin; DNA; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin M; Interleukin-2; Leukocytes; Lymphocytes; Ofloxacin; Phytohemagglutinins; Protein Biosynthesis; Tumor Cells, Cultured | 1989 |
[In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
Topics: Animals; Ciprofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1989 |
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Lung Diseases; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Skin Diseases, Infectious; Urinary Tract Infections | 1989 |
Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.
Topics: Anti-Infective Agents; Brucella; Brucellosis; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin | 1989 |
In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Norfloxacin; Ofloxacin | 1989 |
Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes.
Topics: Alanine Transaminase; Animals; Anti-Infective Agents; Aspartate Aminotransferases; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Ciprofloxacin; L-Lactate Dehydrogenase; Liver; Male; Ofloxacin; Pefloxacin; Rats; Rats, Inbred Strains | 1989 |
The role of quinolones in staphylococcal infection.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin; Staphylococcal Infections | 1989 |
[Gyrase inhibitors modify metabolising processes in the liver].
Topics: Caffeine; Ciprofloxacin; DNA Topoisomerases, Type II; Enoxacin; Humans; Liver; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Topoisomerase II Inhibitors | 1987 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
Topics: Animals; Ciprofloxacin; Diclofenac; Drug Synergism; GABA Antagonists; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Ofloxacin; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Theophylline | 1988 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Osteomyelitis; Oxazines; Pefloxacin; Quinolines; Respiratory Tract Infections; Sexually Transmitted Diseases; Surgical Wound Infection; Urinary Tract Infections | 1987 |
Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Whooping Cough | 1987 |
In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Topics: 4-Quinolones; Acinetobacter; Anti-Infective Agents; Anti-Infective Agents, Urinary; Cinoxacin; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Quinolones; Trimethoprim | 1985 |
In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Hong Kong; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Thailand | 1986 |
Effect of ciprofloxacin on phagocytosis.
Topics: Chemotaxis, Leukocyte; Ciprofloxacin; Humans; Luminescent Measurements; Neutrophils; Norfloxacin; Ofloxacin; Oxazines; Phagocytosis; Providencia; Quinolines; Staphylococcus aureus | 1985 |
Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Oxazines; Pneumonia; Quinolines | 1986 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Neisseria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pneumococcal Infections; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 1986 |
Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Spectrophotometry, Ultraviolet | 1986 |
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Ciprofloxacin; Clostridium; Enoxacin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The action of quinolone carboxylic acids on Chlamydia trachomatis in vitro.
Topics: Animals; Carboxylic Acids; Cells, Cultured; Chlamydia trachomatis; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperazines; Quinolines; Staphylococcus aureus | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Guinea Pigs; Kinetics; Naphthyridines; Ofloxacin; Oxazines; Pneumonia; Pseudomonas Infections; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
Topics: Ciprofloxacin; Escherichia coli; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Urine | 1985 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines | 1986 |
In vitro evaluation of A-56619 and A-56620, two new quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Piperazines; Quinolines | 1986 |
In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Male; Mice; Mice, Inbred ICR; Norfloxacin; Ofloxacin; Oxazines; Pneumonia; Quinolines; Urinary Tract Infections | 1986 |
Determination of ciprofloxacine, norfloxacine, and ofloxacine by high performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1986 |
Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.
Topics: Adult; Amoxicillin; Chloramphenicol; Ciprofloxacin; Drug Combinations; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxazines; Quinolines; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Comparative in vitro activity of the new quinolone CI-934.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Haemophilus influenzae; Ofloxacin; Oxazines; Quinolines; Streptococcus | 1986 |
[Differentiation between mycobacterial species by the susceptibility test to ciprofloxacin--comparison of antimycobacterial spectra between ofloxacin and ciprofloxacin].
Topics: Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Mycobacterium; Ofloxacin; Oxazines; Quinolines | 1986 |
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors | 1985 |
[Biotransformation of selected gyrase inhibitors].
Topics: Anti-Infective Agents; Biotransformation; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.
Topics: Cell Division; Cell Line; Ciprofloxacin; DNA Polymerase II; DNA Topoisomerases, Type I; DNA, Bacterial; Electrophoresis, Agar Gel; Humans; Lymphocytes; Novobiocin; Ofloxacin; Oxazines; Quinolines; Spheroplasts; Thymus Gland | 1986 |
Inhibition of DNA gyrase by optically active ofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Electrophoresis, Agar Gel; Escherichia coli; Micrococcus; Norfloxacin; Ofloxacin; Oxazines; Topoisomerase II Inhibitors | 1987 |
[Resistance against new gyrase inhibitors--1985/86].
Topics: Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Topoisomerase II Inhibitors | 1987 |
Gyrase-inhibitors impair caffeine elimination in man.
Topics: Adult; Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Kinetics; Male; Naphthyridines; Ofloxacin; Oxazines; Topoisomerase II Inhibitors | 1987 |
Penetration of ciprofloxacin and ofloxacin into human allograft pancreatic juice.
Topics: Adult; Ciprofloxacin; Diabetes Mellitus, Type 1; Half-Life; Humans; Middle Aged; Ofloxacin; Pancreas Transplantation; Pancreatic Juice | 1988 |
Bactericidal mechanisms of ofloxacin.
Topics: Chloramphenicol; Ciprofloxacin; Drug Interactions; Escherichia coli; Ofloxacin; Staphylococcus | 1988 |
Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
Topics: Anti-Infective Agents; Biological Transport, Active; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Enoxacin; Escherichia coli; Kinetics; Norfloxacin; Ofloxacin; Spheroplasts | 1988 |
Penetrability of ofloxacin into cultured epithelial cells and macrophages.
Topics: Animals; Cell Membrane Permeability; Cells, Cultured; Ciprofloxacin; Epithelium; HeLa Cells; Macrophages; Male; Norfloxacin; Ofloxacin; Salmonella typhimurium; Shigella | 1988 |
Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; R Factors | 1988 |
[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
Topics: Acinetobacter; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Immunodiffusion; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas | 1986 |
[In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Ofloxacin; Oxazines | 1986 |
In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Female; Fluoroquinolones; Gardnerella vaginalis; Genitalia; Haemophilus; Haemophilus ducreyi; Humans; Male; Microbial Sensitivity Tests; Mycoplasma; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Oxazines; Ureaplasma | 1986 |
In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Oxazines; Pseudomonas | 1987 |
Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enterobacteriaceae; Humans; Male; Ofloxacin; Oxazines; Pseudomonas aeruginosa | 1987 |
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Naphthyridines; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
[In vitro antibacterial activity of new derivatives of pyridonecarboxylic acid, norfloxacin, ofloxacin, enoxacin and ciprofloxacin, against Vibrio cholerae O-1].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Vibrio cholerae | 1987 |
[In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Mice; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines | 1987 |
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1987 |
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enterobacteriaceae; Enterococcus faecalis; Fleroxacin; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Staphylococcus | 1987 |
Membrane permeability of Pseudomonas aeruginosa to 4-quinolones.
Topics: Anti-Bacterial Agents; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Polymyxin B; Pseudomonas aeruginosa; Quinolines | 1987 |
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines | 1987 |
In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Ofloxacin; Oxazines | 1987 |
In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazines; Rifampin | 1987 |
In vitro activity of five new quinolones against cultivable mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Ofloxacin; Oxazines | 1988 |
[Clinical study on development of resistance of respiratory bacterial pathogens to ofloxacin and ciprofloxacin].
Topics: Adult; Bacteria; Child; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Respiratory Tract Infections | 1987 |
Enhancement of interleukin 2 production by quinolone-treated human mononuclear leukocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; In Vitro Techniques; Interleukin-2; Kinetics; Leukocytes, Mononuclear; Lymphocyte Activation; Mitomycin; Mitomycins; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Receptors, Immunologic; Receptors, Interleukin-2 | 1988 |
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Topics: Anti-Bacterial Agents; Cefotaxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Hydrogen-Ion Concentration; Imipenem; Magnesium; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Quinolones; Thienamycins | 1988 |
Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Fleroxacin; Humans; Leucomycins; Mycoplasma; Ofloxacin; Oxazines; Ureaplasma | 1988 |
In vitro activity of three fluoroquinolones against enterococci and Pseudomonas aeruginosa: modified categorization system for discrepant broth dilution and agar disk diffusion test results.
Topics: Ciprofloxacin; Drug Evaluation, Preclinical; Immunodiffusion; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Streptococcus | 1988 |
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Blood Proteins; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Ofloxacin; Oxazines; Protein Binding; Pseudomonas aeruginosa; Quinolines; Quinolones; Staphylococcus; Streptococcus; Trimethoprim | 1988 |
[In vitro antibacterial activity of piperacillin/quinolone combinations].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Synergism; Escherichia coli; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens | 1988 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin | 1988 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Mycoplasmataceae; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Quinolones; Ureaplasma | 1988 |
Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Topics: Ciprofloxacin; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Ofloxacin; Oxazines | 1987 |
In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Culture Media; Fleroxacin; Hydrogen-Ion Concentration; Ofloxacin | 1988 |
[Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Humans; Mutation; Ofloxacin; Serratia marcescens; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Trends of fluoroquinolone-resistant strains isolated from clinical materials].
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Humans; Norfloxacin; Ofloxacin | 1988 |
[In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Pefloxacin; Respiratory Tract Infections | 1988 |
In vitro activity of PD 127,391, an enhanced-spectrum quinolone.
Topics: Anti-Infective Agents; Bacteria; Cefuroxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Ofloxacin | 1988 |
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1988 |
Comparative studies of fleroxacin and ofloxacin in experimental pyelonephritis.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli; Fleroxacin; Half-Life; Klebsiella; Ofloxacin; Pseudomonas aeruginosa; Pyelonephritis; Rats; Rats, Inbred Strains | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Topics: Anti-Infective Agents; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Fleroxacin; Fluoroquinolones; Minocycline; Norfloxacin; Ofloxacin; Quinolones | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus | 1985 |
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
Topics: Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Leucomycins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
Topics: Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Oxazines; Quinolines; Staphylococcus; Streptococcus | 1985 |
Antichlamydial activity of quinolone carboxylic acids.
Topics: Chlamydia trachomatis; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria meningitidis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Streptococcus pneumoniae | 1985 |
[Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Topics: Acinetobacter; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1985 |
[In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Topics: Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Sexually Transmitted Diseases | 1988 |
In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Microbial; Humans; Imipenem; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1988 |
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Magnesium; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones | 1988 |
New "ofloxacin" type antibacterial agents. Incorporation of the spiro cyclopropyl group at N-1.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Mice; Microbial Sensitivity Tests; Ofloxacin | 1988 |
Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers.
Topics: Adult; Ciprofloxacin; Enterobacteriaceae; Feces; Female; Humans; Intestines; Male; Ofloxacin | 1988 |
The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes.
Topics: Animals; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Erythromycin; Guinea Pigs; Legionella; Legionnaires' Disease; Ofloxacin; Phagocytes; Pulmonary Alveoli | 1988 |
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
Topics: Adult; Ciprofloxacin; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Ofloxacin | 1988 |
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Bites and Stings; Bites, Human; Cats; Cefuroxime; Cephalosporins; Ciprofloxacin; Clavulanic Acids; Dogs; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Wound Infection | 1988 |
Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Experimental; Female; Fluoroquinolones; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin; Pyelonephritis; Quinolones; Respiratory Tract Infections; Urinary Tract Infections | 1988 |
[The antibacterial effect of ciprofloxacin, ofloxacin and norfloxacin in vitro].
Topics: Bacteria; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin | 1988 |
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections | 1988 |
[The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Ofloxacin; Pefloxacin; Pseudomonas; Urinary Tract Infections | 1988 |
In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Female; Genital Diseases, Female; Genital Diseases, Male; Haemophilus; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1988 |
Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
Topics: Administration, Oral; Ciprofloxacin; Escherichia coli; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines | 1988 |
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
Topics: Anti-Bacterial Agents; Bacteria; Ceftazidime; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Imipenem; Naphthyridines; Ofloxacin; Oxazines; Thienamycins | 1988 |
[In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen | 1987 |
Fluoroquinolone derivatives: effects on neutrophil functional tests.
Topics: Anti-Infective Agents; Candida albicans; Chemotaxis, Leukocyte; Ciprofloxacin; Humans; In Vitro Techniques; Neutrophils; Norfloxacin; Ofloxacin; Pefloxacin; Phagocytosis; Staphylococcus aureus | 1987 |
Penetration of ciprofloxacin and ofloxacin into pancreatic juice.
Topics: Administration, Oral; Ciprofloxacin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidney Transplantation; Ofloxacin; Pancreas Transplantation; Pancreatic Juice | 1987 |
The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Half-Life; Humans; Kinetics; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Tissue Distribution | 1986 |
Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Ciprofloxacin; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
[Comparison of in vitro growth-inhibitory activities of ofloxacin, ciprofloxacin and norfloxacin against various species of mycobacteria (comparison of organ concentrations and blood concentrations in mice)].
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Male; Mice; Mycobacterium; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines | 1986 |
[Gyrase inhibitors: unwanted central nervous system effects].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Brain Chemistry; Brain Diseases; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Solubility | 1987 |
The comparative pharmacokinetics of five quinolones.
Topics: Administration, Oral; Adult; Ciprofloxacin; Enoxacin; Half-Life; Humans; Infusions, Intravenous; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Ofloxacin; Oxazines | 1986 |
Effects of quinolones on granulocyte function in vitro.
Topics: Anti-Infective Agents; Cell Survival; Ciprofloxacin; Hexosephosphates; Humans; Neutrophils; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Phagocytosis | 1986 |
In-vitro selection of bacteria resistant to the 4-quinolone agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Staphylococcus; Streptococcus | 1987 |
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Regression Analysis | 1987 |
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Therapeutic contribution of the new quinolones].
Topics: Anti-Infective Agents; Bacterial Infections; Biotransformation; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Therapy, Combination; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
The adverse effects of fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
New synthetic quinolone antibacterial agents and serum concentration of theophylline.
Topics: Adult; Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Theophylline | 1987 |
Decrease of caffeine elimination in man during co-administration of 4-quinolones.
Topics: Adult; Anti-Infective Agents; Caffeine; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Enoxacin; Half-Life; Humans; Male; Naphthyridines; Ofloxacin; Oxazines; Quinolines | 1987 |
In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines | 1987 |
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middle Aged; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
[Fluoroquinolones].
Topics: Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
Comparative effects of quinolones on human mononuclear leucocyte functions.
Topics: Cell Survival; Ciprofloxacin; Humans; Indomethacin; Interleukin-1; Lymphocyte Activation; Lymphocytes; Mercaptoethanol; Monocytes; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of ciprofloxacin, norfloxacin, and ofloxacin against multi-resistant Enterobacteriaceae.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin | 1987 |
Clinical efficacy of the new quinolones in lower respiratory infections.
Topics: Aged; Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pefloxacin; Respiratory Tract Infections; Sputum | 1987 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
Mutational resistance to 4-quinolone antibacterial agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli; Humans; Mutation; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Species Specificity | 1984 |
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1984 |
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Quinolones; Spiro Compounds | 1995 |
Comparison of simple methods of methicillin-resistance detection and evaluation of some properties of methicillin-resistant Staphylococcus aureus strains.
Topics: Ciprofloxacin; Cross Infection; Evaluation Studies as Topic; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 1993 |
Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles.
Topics: Administration, Oral; Animals; Bleomycin; Camptothecin; Cartilage, Articular; Chondroitin Lyases; Ciprofloxacin; Collagenases; Cycloheximide; Ethylmaleimide; Etoposide; Fluorescent Dyes; Hydroxyurea; Injections, Intra-Articular; Iodoacetates; Iodoacetic Acid; Irinotecan; Levofloxacin; Male; Ofloxacin; Papain; Rats; Rats, Sprague-Dawley; Rhodamines; Topoisomerase I Inhibitors | 1994 |
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.
Topics: Abscess; Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Female; Granuloma; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Pyelonephritis; Rats; Rats, Wistar; Sepsis; Stereoisomerism; Streptococcus pneumoniae | 1995 |
Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions | 1995 |
Fluoroquinolone bioavailability in patients receiving nutritional supplements.
Topics: Biological Availability; Carbohydrates; Ciprofloxacin; Dietary Sucrose; Food-Drug Interactions; Food, Formulated; Humans; Intestinal Absorption; Ofloxacin | 1995 |
Fluoroquinolones for the eye.
Topics: Chloramphenicol; Ciprofloxacin; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Ofloxacin | 1994 |
Determination of the susceptibility in vitro of 54 isolates of Mycobacterium fortuitum against three fluoroquinolones using two methods.
Topics: Anti-Infective Agents; Ciprofloxacin; Microbial Sensitivity Tests; Mycobacterium; Norfloxacin; Ofloxacin | 1995 |
Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo.
Topics: Administration, Topical; Animals; Calcinosis; Chemical Precipitation; Ciprofloxacin; Cornea; Corneal Diseases; Epithelium; Humans; Hydrogen-Ion Concentration; Male; Microscopy, Confocal; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions; Rabbits; Random Allocation; Tears; Wound Healing | 1995 |
Function of the SOS process in repair of DNA damage induced by modern 4-quinolones.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; DNA Damage; DNA Repair; DNA, Bacterial; Escherichia coli; Mutation; Nalidixic Acid; Norfloxacin; Ofloxacin; RNA, Bacterial; SOS Response, Genetics | 1993 |
Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Stereoisomerism | 1994 |
[In vitro development of fluoroquinolone resistance in the glanders pathogen].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Mutation; Ofloxacin; Pseudomonas; Virulence | 1994 |
Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates.
Topics: Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Reproducibility of Results | 1995 |
Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacin.
Topics: Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1995 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin | 1994 |
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.
Topics: Anaerobiosis; Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcus aureus | 1995 |
Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Ofloxacin; Retrospective Studies; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1995 |
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
Topics: Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fleroxacin; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Spiro Compounds | 1995 |
Dissociated resistance among fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Quinolones | 1994 |
Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.
Topics: beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Ohio | 1994 |
Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Penicillin Resistance; Penicillinase | 1994 |
Activity of 4-quinolones against Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Gram-Negative Bacteria; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 1994 |
Fixed drug eruption induced by ciprofloxacin followed by ofloxacin.
Topics: Adult; Ciprofloxacin; Drug Eruptions; Humans; Male; Ofloxacin | 1994 |
Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Extracellular Space; Fluoroquinolones; Humans; Luminescent Measurements; Neutrophils; Ofloxacin; Quinolones; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Zymosan | 1994 |
In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Fluoroquinolones; Norfloxacin; Ofloxacin; Proteus; Providencia; Quinolones; Surface Properties; Urea; Urease | 1995 |
Effect of levofloxacin and ciprofloxacin injection on permeability of the tail vein in mice and skin microvasculature in rats.
Topics: Animals; Anti-Infective Agents; Capillary Permeability; Ciprofloxacin; Diphenhydramine; Hydrogen-Ion Concentration; Injections, Intravenous; Levofloxacin; Male; Mast Cells; Mice; Mice, Inbred BALB C; Microcirculation; Ofloxacin; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Skin; Tail; Veins | 1994 |
Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
Topics: Ciprofloxacin; Culture Media; Escherichia coli; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Stereoisomerism; Temperature | 1994 |
In vitro activity of eight antibiotics against Salmonella and Shigella species.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Listeria monocytogenes; Listeriosis; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
Topics: Absorption; Anti-Infective Agents; Azides; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Lipid Peroxidation; Norfloxacin; Ofloxacin; Oxygen; Photochemistry; Photosensitivity Disorders; Quinolones; Sodium Azide; Squalene; Ultraviolet Rays | 1994 |
Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice.
Topics: Acetamides; Alcohol Oxidoreductases; Animals; Ciprofloxacin; Excitatory Amino Acid Antagonists; Injections, Intravenous; Injections, Spinal; Levofloxacin; Male; Mice; Mice, Inbred Strains; Neurotransmitter Agents; Ofloxacin; Receptors, GABA; Seizures | 1993 |
Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing.
Topics: Base Sequence; Ciprofloxacin; DNA, Bacterial; DNA, Single-Stranded; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleic Acid Conformation; Ofloxacin; Oligonucleotides; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Staphylococcus aureus | 1994 |
Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Body Temperature; Ciprofloxacin; Levofloxacin; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Temperature | 1994 |
Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Chromatography, High Pressure Liquid; Ciprofloxacin; Equipment Contamination; Humans; Microscopy, Electron, Scanning; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry, Ultraviolet; Urinary Catheterization | 1994 |
Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production.
Topics: Animals; Anti-Infective Agents; Cartilage; Cell Survival; Cells, Cultured; Ciprofloxacin; Flow Cytometry; Free Radicals; Macrophages, Alveolar; Nalidixic Acid; Ofloxacin; Pefloxacin; Rabbits | 1994 |
Dissociation and complexation of fluoroquinolone analogues.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Ferric Compounds; Models, Theoretical; Norfloxacin; Ofloxacin; Spectrophotometry | 1994 |
North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.
Topics: Bacteria; Bacterial Infections; Canada; Ciprofloxacin; Enterobacteriaceae; Female; Genitalia; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus; Streptococcus; Topoisomerase II Inhibitors; United States; Urinary Tract Infections | 1994 |
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Ofloxacin; Stereoisomerism | 1994 |
Successful treatment of peritonitis in IPD with oral fluoroquinolone.
Topics: Administration, Oral; Ciprofloxacin; Humans; Ofloxacin; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome | 1994 |
Photodegradation of some quinolones used as antimicrobial therapeutics.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Light; Mass Spectrometry; Ofloxacin; Photochemistry; Spectrophotometry, Ultraviolet; Ultraviolet Rays | 1994 |
In-vitro slime production by Staphylococcus epidermidis in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcus epidermidis | 1994 |
Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.
Topics: Asia; Ciprofloxacin; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; North America; Ofloxacin; South America | 1994 |
The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin.
Topics: Ciprofloxacin; Escherichia coli; Ofloxacin; Oxidation-Reduction; Oxygen; Staphylococcus aureus; Time Factors | 1994 |
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.
Topics: Animals; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Guinea Pigs; Male; Ofloxacin; Staphylococcal Infections; Vancomycin; Wound Infection | 1994 |
Comparative in vitro activities of new quinolones against coryneform bacteria.
Topics: Anti-Infective Agents; Ciprofloxacin; Corynebacterium; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1994 |
Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
Topics: Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1994 |
In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Topoisomerase II Inhibitors | 1993 |
In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Enterococcus faecium; Novobiocin; Ofloxacin | 1993 |
Interference of ofloxacin with determination of urinary porphyrins.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; False Positive Reactions; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Porphyrins; Spectrometry, Fluorescence | 1994 |
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Cefixime; Cefotaxime; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Injections, Intravenous; Male; Nalidixic Acid; Norfloxacin; Ofloxacin; Rats; Rats, Wistar | 1994 |
Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Topics: Aminocoumarins; Anti-Infective Agents; Ciprofloxacin; Coumarins; DNA Topoisomerases, Type II; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Rifampin | 1994 |
Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Ohio | 1994 |
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
Topics: Biological Transport; Carbon Radioisotopes; Cells, Cultured; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Humans; Intestinal Mucosa; Norfloxacin; Ofloxacin; Pefloxacin; Quinolizines | 1994 |
[Susceptibility to antibiotics and biochemical activity of strains of Acinetobacter sp. isolated from various sources].
Topics: Acinetobacter; Animals; Ciprofloxacin; Drug Resistance, Microbial; Environmental Microbiology; Humans; Imipenem; Netilmicin; Ofloxacin; Patients' Rooms; Soil Microbiology; Species Specificity; Water Microbiology | 1993 |
Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Xanthomonas | 1994 |
From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Ohio | 1994 |
Simultaneous determination of ofloxacin, norfloxacin and ciprofloxacin in human hair by high-performance liquid chromatography and fluorescence detection.
Topics: Adult; Chromatography, High Pressure Liquid; Ciprofloxacin; Hair; Humans; Middle Aged; Norfloxacin; Ofloxacin; Reproducibility of Results; Spectrometry, Fluorescence; Spectrum Analysis | 1994 |
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
Topics: Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Serotyping; Urethritis | 1994 |
Plasmid profiles and antimicrobial susceptibility of Campylobacter jejuni isolated from Israeli children with diarrhea.
Topics: Amoxicillin; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Erythromycin; Furazolidone; Humans; Israel; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
[Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Fluoroquinolones; Helicobacter pylori; Humans; In Vitro Techniques; Ofloxacin; Pefloxacin; Quinolones; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1993 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Cricetinae; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Lung; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1993 |
Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Penicillin Resistance; Piperazines; Quinolones; Tetracycline Resistance | 1993 |
Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.
Topics: Administration, Oral; Adult; Aged; Ciprofloxacin; Community-Acquired Infections; Female; Humans; Male; Ofloxacin; Respiratory Tract Infections | 1994 |
In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Borrelia burgdorferi Group; Cephalosporins; Ciprofloxacin; Humans; Macrolides; Microbial Sensitivity Tests; Ofloxacin | 1993 |
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections | 1993 |
Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones; Streptococcus pneumoniae | 1993 |
A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters.
Topics: Animals; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Cricetinae; Female; Fluoroquinolones; Half-Life; Humans; Lung; Mesocricetus; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1993 |
Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Dioxolanes; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Topoisomerase II Inhibitors | 1993 |
In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.
Topics: Animals; Anti-Infective Agents; Bacteria; Ciprofloxacin; Culture Media; Fleroxacin; Fluoroquinolones; Horses; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Topics: Animals; Chloroquine; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Plasmodium falciparum | 1993 |
[In vitro activity of ofloxacin and ciprofloxacin against Mycobacterium tuberculosis strains].
Topics: Ciprofloxacin; Culture Media; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin | 1993 |
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Lung Diseases; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Urinary Tract Infections | 1993 |
Chloramphenicol resistant enteric fever.
Topics: Adolescent; Adult; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Pregnancy; Salmonella typhi; Typhoid Fever | 1993 |
Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Pefloxacin; Premedication | 1993 |
Control of intracellular growth of Mycobacterium fortuitum by human monocytes in vitro.
Topics: Ciprofloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Monocytes; Mycobacterium; Ofloxacin; Phagocytosis | 1993 |
[Excretion of fluoroquinolones into saliva].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Mice; Ofloxacin; Pefloxacin; Rabbits; Saliva | 1995 |
In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1995 |
An audit of ciprofloxacin use in a district general hospital.
Topics: Anti-Infective Agents; Bacterial Infections; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Utilization Review; Hospitals, General; Humans; Ofloxacin; Postoperative Complications; United Kingdom | 1995 |
Fluoroquinolone resistance patterns after formulary addition of ofloxacin. A clinical isolate study.
Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Formularies, Hospital as Topic; Humans; Ofloxacin | 1995 |
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
Topics: Adult; Anti-Infective Agents; Bacteria; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Otitis Media; Quinolones; Sinusitis | 1995 |
In vitro antimicrobial activity of CP-99,219, a new 7-azabicyclonaphthyridone.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1995 |
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1995 |
In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia.
Topics: Anti-Infective Agents; Cefoperazone; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Therapy, Combination; Kinetics; Microbial Sensitivity Tests; Ofloxacin; Time Factors; Xanthomonas | 1995 |
In vitro effect of ciprofloxacin and ofloxacin on murine and human colon carcinoma cell lines.
Topics: Animals; Anti-Infective Agents; Cell Count; Cell Division; Ciprofloxacin; HT29 Cells; Humans; Mice; Ofloxacin; Thymidine; Tumor Cells, Cultured | 1995 |
Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Carcinoma, Transitional Cell; Cell Division; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ofloxacin; Time Factors; Urinary Bladder Neoplasms | 1996 |
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Vancomycin | 1995 |
Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Diffusion; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Quinolones | 1995 |
In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
Topics: Anti-Infective Agents; Azepines; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Norfloxacin; Ofloxacin; Quinolones | 1995 |
Modulation of biofilms of Pseudomonas aeruginosa by quinolones.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Catheterization; Ciprofloxacin; Glycoproteins; Norfloxacin; Ofloxacin; Pefloxacin; Polysaccharides; Pseudomonas aeruginosa | 1995 |
Short-term quinolones for successful eradication of multiply resistant Vibrio cholerae in adult patients.
Topics: Adult; Anti-Infective Agents; Cholera; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Feces; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Treatment Outcome; Vibrio cholerae | 1995 |
[Treatment of uncomplicated gonorrhea in adults. New guidelines from the working group against gonorrhea].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Gonorrhea; Humans; Male; Norway; Ofloxacin | 1996 |
Quinolone resistance in Oligella urethralis-associated chronic ambulatory peritoneal dialysis peritonitis.
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Humans; Male; Moraxella; Neisseriaceae Infections; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1996 |
A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa.
Topics: Analysis of Variance; Anti-Infective Agents; Ciprofloxacin; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 1996 |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome | 1996 |
Detection of quinolone-resistant Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Fleroxacin; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Quinolones; Reference Standards | 1996 |
Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.
Topics: Amino Acid Sequence; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Ofloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella typhi | 1996 |
Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
Topics: Animals; Anti-Infective Agents; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Norfloxacin; Ofloxacin; Ophthalmic Solutions; Rabbits; Tears | 1996 |
Cholestatic hepatitis related to quinolones: a report of two cases.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin | 1995 |
Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests; Prevalence; Quality Control | 1996 |
[Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Culture Media; Fluoroquinolones; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Quinolones | 1996 |
Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; Culture Media; Culture Media, Serum-Free; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Kinetics; Levofloxacin; Metals; Microbial Sensitivity Tests; Microscopy, Electron; Ofloxacin; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Urine | 1996 |
Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
Topics: Anti-Infective Agents; Antitubercular Agents; Base Sequence; Cell Wall; Cephaloridine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Permeability; Quinolones | 1996 |
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
Topics: Anti-Infective Agents; Chromosome Mapping; Chromosomes, Bacterial; Ciprofloxacin; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Ofloxacin; Polymorphism, Restriction Fragment Length; Staphylococcus aureus; Transformation, Bacterial | 1996 |
Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.
Topics: Anti-Infective Agents; Ciprofloxacin; Kinetics; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Pseudomonas aeruginosa; Regression Analysis | 1996 |
Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes.
Topics: Amino Acids; Anti-Infective Agents; Antimetabolites; Ciprofloxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Neutrophils; Nucleic Acids; Ofloxacin; Phagocytosis; Piperazines; Pseudomonas aeruginosa; Quinolones | 1996 |
Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Europe; Humans; Longitudinal Studies; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 1996 |
In vitro release of new quinolones from biodegradable systems: a comparative study.
Topics: Anti-Infective Agents; Biodegradation, Environmental; Ciprofloxacin; Culture Media; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; In Vitro Techniques; Lactic Acid; Molecular Weight; Ofloxacin; Polyesters; Polymers; Time Factors | 1996 |
Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.
Topics: Absorption; Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Blood-Aqueous Barrier; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Disease Models, Animal; Dose-Response Relationship, Drug; Gentamicins; Infusions, Intravenous; Keratitis; Male; Ofloxacin; Ophthalmic Solutions; Rabbits | 1996 |
Fixed drug eruption induced by ofloxacin.
Topics: Anti-Infective Agents; Blister; Ciprofloxacin; Drug Eruptions; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged; Ofloxacin | 1996 |
Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System.
Topics: Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity | 1996 |
In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Female; Kidney; Levofloxacin; Methicillin Resistance; Mice; Ofloxacin; Pyelonephritis; Staphylococcal Infections | 1996 |
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1996 |
The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
Topics: Anti-Infective Agents; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Ofloxacin; Serratia marcescens | 1996 |
Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophils.
Topics: Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Cisplatin; Doxorubicin; Fluoroquinolones; Humans; Levofloxacin; Neutrophils; Ofloxacin; Paclitaxel; Quinolones; Staphylococcus aureus | 1996 |
In-vitro activity of levofloxacin (l-ofloxacin), ofloxacin and ciprofloxacin against clinical isolates of Streptococcus pneumoniae obtained in England and Wales.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; England; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Wales | 1996 |
[Effect of drugs of the fluoroquinolone series on morphokinetic parameters of the cellular elements of lung tissue].
Topics: Animals; Anti-Infective Agents; Cell Division; Ciprofloxacin; Culture Techniques; Dogs; Fluoroquinolones; Guinea Pigs; Lung; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Ofloxacin; Quinolones | 1996 |
In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
[Evolution of susceptibilities of Campylobacter jejuni isolated from diarrhoeal cases to fluoroquinolones in Tokyo].
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Humans; Norfloxacin; Ofloxacin; Tokyo | 1996 |
Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells.
Topics: Anti-Infective Agents; Cell Survival; Cells, Cultured; Ciprofloxacin; Epithelium; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Macrophages, Peritoneal; Naphthyridines; Neutrophils; Ofloxacin; Staphylococcus aureus; Temperature | 1997 |
False-positive EMIT II opiates from ofloxacin.
Topics: Anti-Infective Agents; Antibodies; Ciprofloxacin; Cross Reactions; Enzyme Multiplied Immunoassay Technique; False Positive Reactions; Humans; Morphine; Nalidixic Acid; Norfloxacin; Ofloxacin | 1997 |
Advice on treatment of drug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Ciprofloxacin; Cycloserine; Drug Monitoring; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethionamide; Humans; Ofloxacin; Tuberculosis, Multidrug-Resistant | 1997 |
Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fleroxacin; Fluoroquinolones; Mice; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Quinolones; Skin Neoplasms; Ultraviolet Rays | 1997 |
Quinolone antibacterials: a new class of photochemical carcinogens.
Topics: Animals; Anti-Infective Agents; Carcinoma, Squamous Cell; Ciprofloxacin; Dermatitis, Phototoxic; Fleroxacin; Fluoroquinolones; Methoxsalen; Mice; Mice, Hairless; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Papilloma; Quinolones; Skin Neoplasms | 1997 |
Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Quinolones | 1997 |
Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones.
Topics: Animals; Anti-Infective Agents; Bone Marrow; Cells, Cultured; Ciprofloxacin; Cobalt Radioisotopes; Colony-Forming Units Assay; Culture Media, Conditioned; Fleroxacin; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Hemoglobins; Interleukin-3; Leukocyte Count; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Norfloxacin; Ofloxacin; Quinolones; Whole-Body Irradiation | 1997 |
In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Female; Levofloxacin; Mice; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 1996 |
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1997 |
Is Escherichia coli ATCC 25922 useful for monitoring broth microdilution tests of fluoroquinolones?
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Reproducibility of Results | 1997 |
Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Ciprofloxacin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Streptococcus pneumoniae | 1997 |
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.
Topics: Acinetobacter; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Combinations; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1997 |
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Cats; Ciprofloxacin; Dogs; Fluoroquinolones; Haplorhini; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Swine; Wound Infection | 1997 |
A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion.
Topics: Administration, Oral; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Therapy, Combination; Humans; Infant, Newborn; Male; Ofloxacin; Prospective Studies; Prostatic Hyperplasia | 1997 |
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Diffusion; Flavobacterium; Humans; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Piperacillin | 1997 |
Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics.
Topics: Anti-Infective Agents; Biofilms; Biological Transport; Ciprofloxacin; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Spectroscopy, Fourier Transform Infrared | 1997 |
Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1997 |
Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dermatitis, Phototoxic; DNA; DNA Damage; Enoxacin; Fluoroquinolones; Free Radical Scavengers; Hematoporphyrins; Molecular Structure; Ofloxacin; Oxygen; Photosensitizing Agents; Quinolones; Reactive Oxygen Species; Spectroscopy, Near-Infrared; Superoxides | 1997 |
Endothelial cell compatibility of fluoroquinolone solutions for intravenous use.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Triphosphate; Anti-Infective Agents; Cell Survival; Cells, Cultured; Ciprofloxacin; Endothelium, Vascular; Epoprostenol; Firefly Luciferin; Fleroxacin; Humans; Injections, Intravenous; Luciferases; Ofloxacin; Radioimmunoassay; Thromboxane A2; Umbilical Veins | 1997 |
The role of fluoroquinolones in the promotion of alginate synthesis and antibiotic resistance in Pseudomonas aeruginosa.
Topics: Alginates; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Glucuronic Acid; Hexuronic Acids; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa | 1997 |
Bactericidal index: a new way to assess quinolone bactericidal activity in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterococcus faecalis; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1997 |
The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Fluoroquinolones; Levofloxacin; Ofloxacin; Quinolones; Streptococcus pneumoniae | 1997 |
In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Neoplasms; Norfloxacin; Ofloxacin; Quinolones | 1997 |
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Topics: Ampicillin; Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Sulbactam; Vancomycin | 1997 |
In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
Topics: Anti-Infective Agents; Chlamydia; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mycoplasma; Naphthyridines; Ofloxacin; Ureaplasma | 1997 |
Cutaneous adverse reaction to ciprofloxacin: demonstration of specific lymphocyte proliferation and cross-reactivity to ofloxacin in vitro.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Lymphocyte Activation; Middle Aged; Ofloxacin; Patch Tests | 1997 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxacillin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Asparagine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serine; Urinary Tract Infections | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae | 1997 |
In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Culture Media; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1997 |
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Respiratory Tract Infections | 1997 |
Role of nitric oxide in the convulsive seizures induced by fluoroquinolones coadministered with 4-biphenyl acetic acid.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Convulsants; Cyclic AMP; Dizocilpine Maleate; Enoxacin; Enzyme Inhibitors; Male; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ofloxacin; Phenylacetates; Seizures | 1997 |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch | 1997 |
Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro.
Topics: Adult; Anti-Infective Agents; Cartilage; Chondrocytes; Ciprofloxacin; Culture Techniques; Humans; Male; Necrosis; Ofloxacin | 1997 |
Simultaneous quantification of cefotaxime, desacetylcefotaxime, ofloxacine and ciprofloxacine in ocular aqueous humor and in plasma by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Cefotaxime; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Lens, Crystalline; Ofloxacin | 1997 |
In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Legionella; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1997 |
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae | 1997 |
Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus | 1997 |
Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
Topics: Age Factors; Animals; Anti-Infective Agents; Calcium; Cartilage; Ciprofloxacin; Contraindications; Female; Fleroxacin; Joint Diseases; Knee Joint; Magnesium; Magnesium Deficiency; Male; Ofloxacin; Rats; Rats, Wistar | 1997 |
Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humours of patients by different topical application modes.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Prospective Studies | 1997 |
[Treatment of lower respiratory tract infections in the elderly].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Ciprofloxacin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillins | 1997 |
Pneumococcal resistance in the UK.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Northern Ireland; Ofloxacin; Oxacillin; Penicillin Resistance; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Retrospective Studies; Streptococcus pneumoniae; Tetracycline | 1997 |
Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Erythromycin; HL-60 Cells; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results | 1998 |
Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Time Factors | 1997 |
A comparative study of anxiogenic effects of fluoroquinolones in rats.
Topics: Animals; Anti-Infective Agents; Anxiety; Ciprofloxacin; Female; Injections, Intraperitoneal; Male; Ofloxacin; Pefloxacin; Rats | 1998 |
In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1998 |
Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus | 1998 |
Timed kill kinetic studies of levofloxacin, ofloxacin, and ciprofloxacin against Moraxella catarrhalis.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Levofloxacin; Moraxella catarrhalis; Neisseriaceae; Ofloxacin; Piperazines; Time Factors | 1998 |
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bites and Stings; Bites, Human; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Species Specificity; Wound Infection | 1998 |
A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Erythrocytes; Male; Ofloxacin; Rabbits | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
Endothelial purine content. An alternative model for testing antibiotic solutions for intravenous use.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Cell Survival; Cells, Cultured; Ciprofloxacin; Drug Evaluation, Preclinical; Endothelium, Vascular; Epoprostenol; Fleroxacin; Humans; Ofloxacin; Solutions; Thromboxane A2; Umbilical Veins | 1998 |
Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
Topics: Anti-Infective Agents; Biological Availability; Ciprofloxacin; Colony Count, Microbial; Cornea; Gram-Positive Bacteria; Humans; Keratitis; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies | 1998 |
Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans.
Topics: Administration, Oral; Adsorption; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Physiological Phenomena; Biofilms; Chromatography, High Pressure Liquid; Ciprofloxacin; Electron Probe Microanalysis; Humans; Microscopy, Electron, Scanning; Ofloxacin; Stents; Trimethoprim; Ureter | 1998 |
Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. I. Effects of doses and infusion rate on blood pressure, heart rate and plasma histamine concentration.
Topics: Animals; Anti-Infective Agents; Blood Pressure; Ciprofloxacin; Dogs; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Heart Rate; Histamine; Histamine Antagonists; Histamine Release; Infusions, Intravenous; Male; Ofloxacin | 1998 |
In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Vancomycin | 1998 |
Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; Extremities; Fleroxacin; Fluoroquinolones; Magnesium Deficiency; Mice; Microscopy, Electron; Ofloxacin; Pefloxacin; Quinolones | 1998 |
A comparison of the activity of ciprofloxacin and levofloxacin with other agents against respiratory tract pathogens.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Uptake of fluoroquinolones in human monocytes isolated from peripheral blood.
Topics: Anti-Infective Agents; Cell Adhesion; Cell Separation; Ciprofloxacin; Flow Cytometry; Fluoroquinolones; Humans; Monocytes; Ofloxacin; Quinolones | 1998 |
Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Dermatitis; Drug Resistance, Microbial; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Hospitalization; Humans; Leg Ulcer; Ofloxacin; Oxacillin; Pemphigoid, Bullous; Penicillin Resistance; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections; Psoriasis; Retrospective Studies; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Delivery Systems; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Polystyrenes; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1998 |
In vitro susceptibility of multiple drug resistant Salmonella typhimurium to newer fluroquinolone derivatives.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea, Infantile; Drug Resistance, Multiple; Humans; In Vitro Techniques; Infant; Norfloxacin; Ofloxacin; Salmonella Infections; Salmonella typhimurium | 1995 |
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Quinolones | 1998 |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
Topics: Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Coxiella burnetii; Doxycycline; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin | 1998 |
Neisseria gonorrhoeae resistant to ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Neisseria gonorrhoeae; Ofloxacin | 1998 |
[Corneal penetration of various aminoglycosides and quinolones].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Aqueous Humor; Cataract Extraction; Ciprofloxacin; Contact Lenses; Cornea; Dose-Response Relationship, Drug; Drug Delivery Systems; Gentamicins; Humans; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Tobramycin | 1998 |
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Clindamycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Corynebacterium; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1998 |
Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
Topics: Anti-Infective Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Ciprofloxacin; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Thienamycins | 1998 |
Management of fluoroquinolone resistance in Pseudomonas aeruginosa--outcome of monitored use in a referral hospital.
Topics: Anti-Infective Agents; Ciprofloxacin; Disease Management; Drug Monitoring; Drug Resistance, Microbial; Evaluation Studies as Topic; Hospitals, Teaching; Humans; Ofloxacin; Pseudomonas Infections; Referral and Consultation; Treatment Outcome | 1998 |
Ofloxacin resistance mechanism in PA150 and PA300-clinical isolates of Pseudomonas aeruginosa in Korea.
Topics: Base Sequence; Ciprofloxacin; DNA; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Humans; Korea; Ofloxacin; Pseudomonas aeruginosa | 1998 |
Fluoroquinolones and tuberculosis.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.
Topics: Anti-Infective Agents; Aza Compounds; Cells, Cultured; Ciprofloxacin; Epithelial Cells; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Neutrophils; Ofloxacin; Quinolines; Staphylococcus aureus | 1999 |
Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae.
Topics: Amino Acid Substitution; Anti-Infective Agents; Ciprofloxacin; Codon; Deoxyribonucleases, Type II Site-Specific; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Polymorphism, Restriction Fragment Length | 1999 |
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1998 |
Comparison of the complexation of fluoroquinolone antimicrobials with metal ions by nuclear magnetic resonance spectroscopy.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Magnetic Resonance Spectroscopy; Metals; Ofloxacin; Quinolones; Solutions; Temperature | 1999 |
Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
Topics: Anti-Infective Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; Drug Synergism; Humans; Levofloxacin; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1999 |
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; United States | 1999 |
Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aqueous Humor; Bacteria; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions; Prospective Studies | 1999 |
Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone.
Topics: Amides; Animals; Anti-Infective Agents; Ciprofloxacin; Cytochrome-B(5) Reductase; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Methemoglobin; Methemoglobinemia; Norfloxacin; Ofloxacin; Quinolones; Structure-Activity Relationship | 1999 |
Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Staphylococcal Skin Infections | 1999 |
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Penicillins; Pneumococcal Infections | 1999 |
In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Micrococcus; Neutropenia; Ofloxacin | 1998 |
In vitro study of the interaction between quinolones and polyvalent cations.
Topics: Absorption; Aluminum; Anti-Infective Agents; Cations; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Interactions; Iron; Kinetics; Ofloxacin | 1999 |
In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
Topics: Anti-Infective Agents; beta-Lactams; Burkholderia cepacia; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Xanthomonas | 1999 |
Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Ofloxacin; Time Factors; Treatment Outcome | 1999 |
The system of objective judgement analysis method: less objectivity than pretended?
Topics: Ciprofloxacin; Dosage Forms; Drug Administration Routes; Drug Utilization; Ofloxacin; Pefloxacin; Statistics as Topic | 1995 |
Cost-minimisation analysis of sequential treatment with ofloxacin or ciprofloxacin in hospitalised patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Health Care Costs; Hospitalization; Humans; Ofloxacin; Retrospective Studies | 1997 |
The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1999 |
The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 1999 |
In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Indoles; Injections, Subcutaneous; Isoindoles; Male; Mice; Naphthyridines; Ofloxacin; Quinolones | 1999 |
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Streptococcus pneumoniae | 1999 |
Distribution and binding kinetics of ciprofloxacin and ofloxacin in the hindlimb of the rat.
Topics: Animals; Anti-Infective Agents; Binding Sites; Ciprofloxacin; Female; Hindlimb; Mathematical Computing; Models, Chemical; Ofloxacin; Perfusion; Rats; Rats, Wistar; Tissue Distribution | 1999 |
Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Dose-Response Relationship, Drug; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.
Topics: Anti-Infective Agents; Ciprofloxacin; Doxycycline; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma; Ofloxacin; Piperazines; Ureaplasma urealyticum | 1999 |
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 1999 |
In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Pefloxacin | 1999 |
Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1999 |
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Pennsylvania; Retrospective Studies | 1999 |
The comparative arthropathy of fluoroquinolones in dogs.
Topics: Animals; Anti-Infective Agents; Body Weight; Ciprofloxacin; Dogs; Eating; Fluoroquinolones; Joint Diseases; Male; Ofloxacin; Piperazines; Synovial Fluid | 1999 |
Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer.
Topics: Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Transitional Cell; Ciprofloxacin; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Humans; Ofloxacin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1999 |
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia.
Topics: Acute Kidney Injury; Administration, Cutaneous; Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Humans; Lethal Dose 50; Levofloxacin; Mice; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Survival Analysis; Time Factors; Uranyl Nitrate | 1999 |
Selection of resistant variants of respiratory pathogens by quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Nalidixic Acid; Ofloxacin; Pneumonia, Bacterial; Streptococcus pneumoniae | 1999 |
Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Topics: Adrenergic Uptake Inhibitors; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Drug Interactions; Drug Resistance, Microbial; Enzyme Inhibitors; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Reserpine; Staphylococcus aureus; Topoisomerase II Inhibitors | 1999 |
Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Phenotype; Streptococcus pneumoniae; Transformation, Bacterial | 1999 |
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterat
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Enterobacter cloacae; Fluoroquinolones; Gatifloxacin; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines | 1999 |
Multidrug resistance among Streptococcus pneumoniae isolated at a university hospital in eastern Tennessee.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Hospitals, University; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillins; Prospective Studies; Streptococcus pneumoniae; Tennessee | 1999 |
[In vitro activity of trovafloxacin, of other fluoroquinolones and of related antimicrobials against clinical isolates. Grupo colaborativo WHONET-Argentina].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Naphthyridines; Ofloxacin | 1999 |
The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Enzyme Inhibitors; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Multidrug Resistance-Associated Proteins; Norfloxacin; Ofloxacin; Omeprazole; Species Specificity; Staphylococcal Infections; Staphylococcus aureus | 1999 |
Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Mycobacterium; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Ofloxacin; Piperazines; Tuberculosis | 1999 |
Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibility.
Topics: Anti-Infective Agents; Benchmarking; Ciprofloxacin; Drug Costs; Humans; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 1999 |
Will pneumococci put quinolones in their place?
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Ofloxacin; Streptococcus pneumoniae | 1999 |
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rats; Streptococcal Infections; Streptococcus; Streptococcus sanguis; Treatment Outcome | 1999 |
In vitro phototoxicity of new quinolones: production of active oxygen species and photosensitized lipid peroxidation.
Topics: Anti-Infective Agents; Ciprofloxacin; Dermatitis, Phototoxic; DNA Damage; Fleroxacin; Fluoroquinolones; Humans; Lipid Peroxidation; Norfloxacin; Ofloxacin; Quinolones; Reactive Oxygen Species; Squalene; Time Factors; Ultraviolet Rays | 1999 |
National guideline for the management of gonorrhoea in adults. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Contact Tracing; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Ofloxacin; Penicillins; Urethritis | 1999 |
National guideline for the management of prostatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adrenergic alpha-Antagonists; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Inflammatory Agents, Non-Steroidal; Cephalosporins; Chronic Disease; Ciprofloxacin; Humans; Male; Ofloxacin; Prostatitis; Urinary Tract Infections | 1999 |
National guideline for the management of epididymo-orchitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Epididymitis; Humans; Male; Neisseria gonorrhoeae; Ofloxacin; Orchitis; Sexually Transmitted Diseases | 1999 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; Genital Diseases, Male; Humans; Male; Ofloxacin; Pelvic Inflammatory Disease; Peritonitis; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases | 1999 |
Adverse testicular effects of some quinolone members in rats.
Topics: Acid Phosphatase; Animals; Anti-Infective Agents; Ciprofloxacin; Fertility; L-Lactate Dehydrogenase; Male; Ofloxacin; Organ Size; Pefloxacin; Prostate; Rats; Sperm Count; Sperm Motility; Testicular Diseases; Testis | 2000 |
Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Topics: 4-Quinolones; Aminopyridines; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Rifamycins | 2000 |
Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.
Topics: Anti-Infective Agents; Blood Coagulation; Ciprofloxacin; Fibrin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Biofilms; Carrier Proteins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Tetracycline Resistance | 2000 |
Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an In vitro dynamic model.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Humans; Levofloxacin; Ofloxacin; Streptococcus pneumoniae | 2000 |
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines | 2000 |
[Antibiotic impregnation of cartilage implants: diffusion kinetics of fluoroquinolones].
Topics: Anti-Infective Agents; Biological Availability; Cartilage; Ciprofloxacin; Diffusion; Freeze Drying; Humans; Ofloxacin; Surgical Wound Infection | 2000 |
Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
Topics: Anti-Infective Agents; Catalysis; Ciprofloxacin; DNA; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Levofloxacin; Naphthyridines; Ofloxacin; Staphylococcus aureus; Topoisomerase II Inhibitors | 2000 |
Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2000 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
Topics: 4-Quinolones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Automation; Ceftazidime; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Netilmicin; Ofloxacin; Pefloxacin; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections | 2000 |
Characterization of histamine release induced by fluoroquinolone antibacterial agents in-vivo and in-vitro.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dogs; Female; Histamine Release; Levofloxacin; Male; Mast Cells; Ofloxacin; Rats; Rats, Sprague-Dawley; Species Specificity | 2000 |
Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Germany; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines | 2000 |
[Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Blotting, Western; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Membrane Potentials; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Stenotrophomonas maltophilia; Uncoupling Agents | 2000 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; Florida; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Tobramycin | 2000 |
In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Eye Infections, Bacterial; Humans; In Vitro Techniques; Ofloxacin | 2000 |
Study on three-dimensional fluorescent spectral characteristics of fluoroquinolones in varying media.
Topics: Acids; Anti-Infective Agents; Ciprofloxacin; Dioctyl Sulfosuccinic Acid; Micelles; Norfloxacin; Ofloxacin; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence; Water | 2000 |
In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycoplasma hominis; Naphthyridines; Ofloxacin; Ureaplasma urealyticum | 2000 |
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Topics: Anti-Infective Agents; Aspartic Acid; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Selection, Genetic; Serine | 2000 |
[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Respiratory Tract Infections; Urinary Tract Infections | 2000 |
In vitro characterization of fluoroquinolone concentration/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Levofloxacin; Logistic Models; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Streptococcus pneumoniae | 2000 |
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Drug Stability; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones | 2000 |
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Gonorrhea; Humans; Levofloxacin; Naphthyridines; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin | 2000 |
Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.
Topics: Anti-Infective Agents; Antigens, Bacterial; Cells, Cultured; Chlamydia trachomatis; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Ofloxacin | 2000 |
In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Klebsiella; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Urinary Tract Infections | 2000 |
Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro.
Topics: Animals; Anti-Infective Agents; Bromodeoxyuridine; Calcification, Physiologic; Cell Count; Cell Division; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Extracellular Matrix; Fluoroquinolones; Levofloxacin; Mice; Naphthyridines; Ofloxacin; Osteoblasts | 2000 |
Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Streptococcus pneumoniae; Time Factors | 2001 |
Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Phenotype; Pseudomonas aeruginosa; Regression Analysis; Reproducibility of Results; Staphylococcus aureus | 2001 |
Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones.
Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Cytoplasm; Fibroblasts; Fluoroquinolones; Humans; Mitochondria; Norfloxacin; Ofloxacin; Photosensitizing Agents; Quinolones; Skin | 2000 |
Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography.
Topics: Anti-Infective Agents; Aza Compounds; Biological Assay; Chromatography, High Pressure Liquid; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacter cloacae; Escherichia coli; Fluoroquinolones; Klebsiella; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Photochemistry; Quinolines | 2001 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Seasonal variation in fluoroquinolone prescribing.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; England; Humans; Norfloxacin; Ofloxacin; Seasons; Urinary Tract Infections | 1999 |
In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Spain | 2001 |
In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Conjunctivitis, Bacterial; Drug Evaluation; Drug Resistance, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2001 |
In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Eye Infections, Bacterial; Microbial Sensitivity Tests; Ofloxacin | 2001 |
Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Piperazines; Quinolines; Streptococcus pneumoniae | 2001 |
Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells.
Topics: Administration, Topical; Animals; Cell Survival; Cells, Cultured; Chinchilla; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Hair Cells, Auditory, Outer; Hydrocortisone; Neomycin; Ofloxacin; Polymyxin B | 2001 |
Pseudomonas aeruginosa in vitro corneal isolate sensitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative study.
Topics: Anti-Infective Agents; Ciprofloxacin; Cornea; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa | 2001 |
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Quinolines | 2001 |
[Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Mycobacterium; Mycobacterium fortuitum; Mycobacterium kansasii; Mycobacterium tuberculosis; Ofloxacin | 2001 |
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).
Topics: Anti-Infective Agents; Ciprofloxacin; Databases, Factual; Enterobacteriaceae; Fluoroquinolones; Gatifloxacin; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests; Pseudomonas aeruginosa | 2001 |
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States.
Topics: Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Europe; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Indoles; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; United States | 2001 |
gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
Topics: Amino Acid Substitution; Anti-Infective Agents; Aza Compounds; Bacteroides fragilis; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Quinolines | 2001 |
Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Hospitals; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Philippines; Retrospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Safety of the new fluoroquinolones compared with ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines | 2000 |
Activity of levofloxacin and ciprofloxacin against urinary pathogens.
Topics: Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Urinary Tract Infections | 2001 |
Fluorescence characteristic study of the ternary complex of fluoroquinolone antibiotics and cobalt (II) with ATP.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Ciprofloxacin; Cobalt; Fluorescence; Molecular Structure; Norfloxacin; Ofloxacin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2001 |
Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; North America; Ofloxacin; Pneumococcal Infections; Population Surveillance; Streptococcus pneumoniae | 2001 |
Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience.
Topics: Administration, Oral; Aged; Anti-Infective Agents; APACHE; Ciprofloxacin; Community-Acquired Infections; Cost-Benefit Analysis; Drug Utilization; Female; Hospitalization; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Virginia | 2001 |
In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Staphylococcus | 2001 |
The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans.
Topics: Adult; Aged; Anti-Infective Agents; Candida albicans; Ciprofloxacin; Digestive System; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Urinary Tract Infections | 2001 |
Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Ofloxacin; Staphylococcus aureus; Streptococcus pneumoniae | 2001 |
Influence of dose on the distribution kinetics of ciprofloxacin and ofloxacin in the isolated hindlimb of the rat.
Topics: Algorithms; Animals; Anti-Infective Agents; Ciprofloxacin; Female; Hindlimb; In Vitro Techniques; Ofloxacin; Pharmaceutical Preparations; Protein Binding; Rats; Rats, Wistar | 2000 |
Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Streptococcus pneumoniae | 2001 |
Effect of ciprofloxacin and ofloxacin on bacterial flora.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Humans; Ofloxacin; Ophthalmic Solutions | 2001 |
[Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
Topics: Adolescent; Anti-Infective Agents; Arthritis; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Female; Humans; Infant; Knee Joint; Male; Ofloxacin; Pefloxacin; Respiratory Tract Infections | 2001 |
Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patients.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Renal Insufficiency; Renal Replacement Therapy | 2001 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Ofloxacin; Oxazolidinones; Polymerase Chain Reaction; Quinolines; Sensitivity and Specificity; Staphylococcus aureus; Teicoplanin; Vancomycin | 2001 |
Comparison of therapeutic interchange with standard educational tools for influencing fluoroquinolone prescribing.
Topics: Anti-Infective Agents; Chi-Square Distribution; Ciprofloxacin; Cost Control; Cost Savings; Drug Costs; Drug Utilization; Female; Hospital Bed Capacity; Humans; Levofloxacin; Male; Ofloxacin; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Statistics, Nonparametric; Therapeutic Equivalency; Treatment Outcome; Virginia | 2001 |
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Eye Infections, Bacterial; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Time Factors | 2001 |
[Degradation of liquid preparations of four fluoroquinolones by factorial experiment. ].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Light; Norfloxacin; Ofloxacin; Quinolones | 1997 |
Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye Infections, Bacterial; Keratitis; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2001 |
Triple anterior stromal ring infiltrate associated with presumed HSV keratitis.
Topics: Acyclovir; Anti-Infective Agents; Antiviral Agents; Ciprofloxacin; Corneal Stroma; Drug Therapy, Combination; Glucocorticoids; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Male; Middle Aged; Ofloxacin; Prednisolone | 2001 |
Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Community-Acquired Infections; Fluoroquinolones; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Quinolines | 2001 |
Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Gatifloxacin; Humans; Lactams; Latin America; Levofloxacin; Microbial Sensitivity Tests; North America; Ofloxacin; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections; Regional Medical Programs; Urinary Tract Infections | 2001 |
Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Electrocardiography; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies; Torsades de Pointes | 2001 |
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
Topics: Adult; Aged; Anti-Infective Agents; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Cohort Studies; Databases, Factual; Drug Monitoring; England; Enoxacin; Family Practice; Female; Humans; Liver Diseases; Male; Middle Aged; Norfloxacin; Ofloxacin; Product Surveillance, Postmarketing; Retrospective Studies; Surveys and Questionnaires; Time Factors | 2001 |
Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Europe; Fluoroquinolones; Gemifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 2001 |
In vitro effects of ampicillin, ciprofloxacin and ofloxacin on Salmonella typhi within human monocyte-derived macrophages.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Ofloxacin; Penicillins; Salmonella typhi | 2001 |
Effect of subminimal inhibitory concentrations of three fluoroquinolones on adherence of uropathogenic strains of Escherichia coli.
Topics: Anti-Infective Agents; Bacterial Adhesion; Cell Line; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Hemagglutination; Humans; Inhibitory Concentration 50; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Urinary Tract Infections | 2002 |
In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Synergism; Humans; Lactams; Levofloxacin; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Penicillins; Piperacillin; Pseudomonas aeruginosa | 2002 |
Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Piperazines; Streptococcus pneumoniae | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Penicillins; Quinolines; Streptococcal Infections; Streptococcus | 2001 |
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Indoles; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Sensitivity and Specificity; Staphylococcus aureus | 2002 |
Utility of fluoroquinolones in multidrug-resistant tuberculosis (MDR-TB)--a balanced view?
Topics: Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Philippines; Risk Assessment; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2002 |
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2002 |
In vitro and in vivo activities of ciprofloxacin and levofloxacin against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Topics: Animals; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin | 2002 |
Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Selection, Genetic; Time Factors | 2002 |
Quinolone-binding pocket of DNA gyrase: role of GyrB.
Topics: Adenosine Triphosphatases; Anti-Infective Agents; Binding Sites; Ciprofloxacin; DNA; DNA Gyrase; DNA, Superhelical; Drug Resistance, Microbial; Models, Molecular; Mutation; Ofloxacin; Protein Conformation | 2002 |
In vitro comparison of ciprofloxacin, ofloxacin, and povidone-iodine for surgical prophylaxis.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Bacteria; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Ophthalmologic Surgical Procedures; Povidone-Iodine; Time Factors | 2002 |
Clinical toxicological aspects of fluoroquinolones.
Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Diseases; Ciprofloxacin; Connective Tissue Diseases; Diarrhea; Dizziness; Gastrointestinal Diseases; Headache; Humans; Nausea; Norfloxacin; Ofloxacin; Vomiting | 2002 |
Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Biological Transport; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Indoles; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Streptococcus pneumoniae | 2002 |
Mycobacterium avium subsp. paratuberculosis infection in a patient with HIV, Germany.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Fatal Outcome; Germany; HIV Infections; Humans; Male; Mycobacterium avium subsp. paratuberculosis; Ofloxacin; Polymerase Chain Reaction; Tuberculosis | 2002 |
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States | 2002 |
Optimal treatment of systemic bacillus Calmette-Guérin infection: investigations in an animal model.
Topics: Animals; Cell Survival; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Ofloxacin; Prednisolone; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Virulence | 2002 |
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Staphylococcus aureus; Stenotrophomonas maltophilia | 2002 |
Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 2002 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage Diseases; Cartilage, Articular; Ciprofloxacin; Fluoroquinolones; Indoles; Knee Joint; Ofloxacin; Quinolones; Rats; Rats, Wistar | 2002 |
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sensitivity and Specificity; Tazobactam | 2002 |
Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae.
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Streptococcus pneumoniae | 2002 |
Granulomatous osteomyelitis caused by bacteria other than mycobacteria: a report of two cases.
Topics: Adult; Ampicillin; Anti-Infective Agents; Ciprofloxacin; Female; Granuloma; Humans; Male; Middle Aged; Ofloxacin; Osteomyelitis; Penicillins; Salmonella; Salmonella Infections; Serratia Infections; Serratia marcescens; Treatment Outcome | 2002 |
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2002 |
The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2002 |
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Indoles; Levofloxacin; Male; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Sensitivity and Specificity | 2002 |
Moxifloxacin: new preparation. A me-too with more cardiac risks.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Approval; Fluoroquinolones; France; Humans; Levofloxacin; Long QT Syndrome; Ofloxacin; Pneumonia | 2002 |
[Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin | 2002 |
In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Haemophilus influenzae; Korea; Levofloxacin; Microbial Sensitivity Tests; Moraxella; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2002 |
[Tenotoxic potential of fluoroquinolones in the choice of surgical antibiotic prophylaxis in ophthalmology].
Topics: Achilles Tendon; Aged; Animals; Antibiotic Prophylaxis; Cells, Cultured; Ciprofloxacin; Data Interpretation, Statistical; Fluoroquinolones; Free Radicals; Humans; Levofloxacin; Middle Aged; Ofloxacin; Ophthalmologic Surgical Procedures; Pefloxacin; Rabbits; Rupture; Tendons; Time Factors | 2002 |
[Rupture of the Achilles' tendon secondary to levofloxacin].
Topics: Achilles Tendon; Adult; Ceftriaxone; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans; Intestinal Perforation; Levofloxacin; Male; Methylprednisolone; Metronidazole; Ofloxacin; Rupture; Tendinopathy | 2003 |
Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2003 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
Fluoroquinolones in ambulatory ENT and respiratory tract infections: rarely appropriate.
Topics: Ambulatory Care; Ciprofloxacin; Contraindications; Fluoroquinolones; Humans; Ofloxacin; Otitis; Respiratory Tract Infections | 2003 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
[In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
Topics: Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dosage Forms; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fleroxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Prodrugs; Quinolones | 2002 |
[In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Levofloxacin; Ofloxacin; Piperazines; Prodrugs; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Time Factors | 2002 |
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Ciprofloxacin; Dosage Forms; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Macrolides; Ofloxacin; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Urinary Tract Infections | 2002 |
[Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; Ciprofloxacin; Dioxolanes; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Fluoroquinolones; Gatifloxacin; Levofloxacin; Ofloxacin; Piperazines; Prodrugs; Pseudomonas aeruginosa; Quinolones; Topoisomerase II Inhibitors | 2002 |
[Pneumococcus and quinolone resistance].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Multivariate Analysis; Mutation; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumonia, Pneumococcal; Quinolines; Recurrence; Risk Factors; Streptococcus pneumoniae | 2003 |
Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters.
Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Time Factors | 2002 |
[Comparative in vitro bacteriostatic and bactericidal activity of levofloxacin and ciprofloxacin against urinary tract pathogens determined by MIC, MBC, Time-Kill curves and bactericidal index analysis].
Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Negative Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Urinary Tract Infections | 2002 |
[Combined infection of abdominal typhoid and hepatitis A and E].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Diagnosis, Differential; Endemic Diseases; Hepatitis A Virus, Human; Hepatitis E virus; Hepatitis, Viral, Human; Humans; Male; Ofloxacin; Salicylates; Tajikistan; Typhoid Fever | 2003 |
Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains.
Topics: Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Phenotype; Serial Passage; Staphylococcus aureus | 2003 |
Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Guinea Pigs; Levofloxacin; Lung; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Survival Analysis | 2003 |
Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature rats.
Topics: Achilles Tendon; Administration, Oral; Animals; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluoroquinolones; Male; Microscopy, Electron; Ofloxacin; Rats; Rats, Wistar | 2003 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2003 |
Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Keratomileusis, Laser In Situ; Levofloxacin; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps | 2003 |
Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin G; Penicillins; Turkey | 2003 |
In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Genes, Bacterial; Gonorrhea; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Nalidixic Acid; Naphthyridines; Neisseria gonorrhoeae; Ofloxacin; Quinolines | 2003 |
Simultaneous measurement of fluoroquinolones in eggs by a combination of supercritical fluid extraction and high pressure liquid chromatography.
Topics: Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Ciprofloxacin; Eggs; Enrofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Ofloxacin; Quinolones; Solvents | 2003 |
[In vitro fluoroquinolone resistance in ocular bacterial isolates].
Topics: Actinomyces; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Eye; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Norfloxacin; Ofloxacin | 2003 |
Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2003 |
The effect of nitric oxide combined with fluoroquinolones against Salmonella enterica serovar Typhimurium in vitro.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella typhimurium; Transcription Factors; Triazenes | 2003 |
Treatment of otitis externa.
Topics: Amoxicillin; Candida; Child, Preschool; Ciprofloxacin; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Ofloxacin; Otitis Externa; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Humans; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Prolonged survival of an elderly woman with Salmonella dublin aortitis and conservative treatment.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Aortic Aneurysm, Thoracic; Aortitis; Ciprofloxacin; Female; Follow-Up Studies; Humans; Ofloxacin; Quality of Life; Radiography, Abdominal; Radiography, Thoracic; Salmonella Infections; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Levofloxacin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Protein Binding; Streptococcus pneumoniae; Survival Analysis | 2003 |
[Study on two kinds of antibiotics by the fluorescence thin-layer chromatograph].
Topics: Anti-Infective Agents; Chromatography, Thin Layer; Ciprofloxacin; Ofloxacin; Spectrometry, Fluorescence | 2002 |
Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.
Topics: Aza Compounds; Bacteroides fragilis; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2003 |
Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
Topics: Binding Sites; Chloroquine; Ciprofloxacin; Drug Interactions; Enoxacin; Fluoroquinolones; Levodopa; Levofloxacin; Melanins; Monophenol Monooxygenase; Norfloxacin; Ofloxacin; Quinolones; Timolol | 2003 |
Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2003 |
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Blood Proteins; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Protein Binding; Quinolones; Rats | 2003 |
Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Escherichia coli; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae | 2003 |
The effect of pharmacokinetic/pharmacodynamic (PK/PD) parameters of gatifloxacin on its bactericidal activity and resistance selectivity against clinical isolates of Streptococcus pneumoniae.
Topics: Administration, Oral; Area Under Curve; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Theoretical; Ofloxacin; Streptococcus pneumoniae | 2003 |
[Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)].
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus; Streptococcus pneumoniae | 2003 |
Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Blotting, Western; Ciprofloxacin; Cornea; Debridement; Female; Immunoenzyme Techniques; Levofloxacin; Matrix Metalloproteinases; Ofloxacin; Ophthalmic Solutions; Rats; Rats, Inbred Lew | 2003 |
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals.
Topics: Anti-Bacterial Agents; Benchmarking; Ciprofloxacin; Drug Costs; Drug Resistance, Bacterial; Economics, Hospital; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; United States | 2003 |
Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.
Topics: Aza Compounds; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2003 |
[Do tendon lesions occur during quinolone administration?].
Topics: Achilles Tendon; Adult; Age Factors; Anti-Infective Agents; Bronchitis; Ciprofloxacin; Enzyme Inhibitors; Fluoroquinolones; Humans; Incidence; Male; Norfloxacin; Ofloxacin; Risk Factors; Rupture; Time Factors | 2003 |
[New achievements in the diagnosis and treatment of disseminated urogenital chlamydiosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Ciprofloxacin; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Josamycin; Male; Ofloxacin; Radionuclide Imaging; Time Factors; Treatment Outcome | 2003 |
The rapid development of fluoroquinolone resistance in M. tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prostatitis; Tuberculosis | 2003 |
[Cefepime (maxipime) in the treatment of severe urinary tract infection].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Sensitivity and Specificity; Treatment Outcome; Urinary Tract Infections | 2003 |
In vivo effects of fluoroquinolones on rabbit corneas.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Apoptosis; Ciprofloxacin; Collagen; Cornea; Corneal Injuries; DNA; Drug Therapy, Combination; Epithelial Cells; Female; Fibroblasts; Ofloxacin; Ophthalmic Solutions; Rabbits; Wound Healing | 2003 |
Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Cartilage, Articular; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Male; Ofloxacin; Rats; Rats, Wistar; Specific Pathogen-Free Organisms | 2004 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Ophthalmic Solutions; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Streptococcal Infections | 2004 |
Factors influencing fluoroquinolone resistance.
Topics: Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Streptococcus pneumoniae | 2003 |
[Analysis of the response factors of different quinolones detected by evaporative light-scattering detector].
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Light; Linear Models; Ofloxacin; Quinolones | 2003 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
Compare two methods of measuring DNA damage induced by photogenotoxicity of fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Comet Assay; Cricetinae; Cricetulus; DNA; DNA Damage; Fibroblasts; Fluoroquinolones; Levofloxacin; Ofloxacin; Quinolones; Ultraviolet Rays | 2004 |
Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Aqueous Humor; Bacteria; Biological Availability; Ciprofloxacin; Humans; Ofloxacin; Vitreous Body | 2004 |
Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Disease Susceptibility; Epididymitis; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Ofloxacin; Prostate; Ultrasonography, Interventional | 2004 |
[Resistance of Pseudomonas aeruginosa to ciprofloxacin and levofloxacin: 1998-2002].
Topics: Body Fluids; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2003 |
Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
Topics: Aza Compounds; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA Topoisomerase IV; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Ofloxacin; Polymerase Chain Reaction; Quinolines | 2004 |
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjunctivitis, Bacterial; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.
Topics: Acute Kidney Injury; Animals; Anti-Infective Agents; Antineoplastic Agents; Bile Ducts; Biological Availability; Blotting, Western; Caco-2 Cells; Ciprofloxacin; Cisplatin; Duodenum; Fluoroquinolones; Humans; Injections, Intravenous; Levofloxacin; Male; Ofloxacin; Piperazines; Rats; Rats, Wistar; Time Factors | 2004 |
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Failure | 2004 |
Atomic absorption spectroscopic, conductometric and colorimetric methods for determination of fluoroquinolone antibiotics using ammonium reineckate ion-pair complex formation.
Topics: Absorption; Acetone; Anti-Bacterial Agents; Ciprofloxacin; Colorimetry; Dose-Response Relationship, Drug; Electric Conductivity; Enrofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Ions; Linear Models; Norfloxacin; Ofloxacin; Quaternary Ammonium Compounds; Quinolones; Salts; Solvents; Spectrophotometry, Atomic; Thiocyanates | 2004 |
Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gonorrhea; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Ofloxacin | 2004 |
A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates.
Topics: Bacterial Outer Membrane Proteins; Ciprofloxacin; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2004 |
Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Endophthalmitis; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Viridans Streptococci | 2004 |
[Isolation-frequency and antibiotic susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa isolated in regional core hospitals in the Nagaoka district of Niigata Prefecture (changes for 3 years)].
Topics: Anti-Infective Agents; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Haemophilus influenzae; Hospitals, Urban; Humans; Japan; Levofloxacin; Ofloxacin; Penicillin G; Pseudomonas aeruginosa; Streptococcus pneumoniae; Time Factors | 2004 |
Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Cost Savings; Drug Costs; Fluoroquinolones; Formularies, Hospital as Topic; Hospital Costs; Hospitals, University; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Organizational Policy | 2004 |
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Cornea; Drug Resistance, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Staphylococcal Infections | 2004 |
High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Ferredoxin-NADP Reductase; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Ofloxacin; Penicillins; Repressor Proteins; Tetracycline | 2004 |
New 6-nitroquinolones: synthesis and antimicrobial activities.
Topics: Anti-Bacterial Agents; Cell Line; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Italy; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Mycobacterium tuberculosis; Nitroquinolines; Ofloxacin; Structure-Activity Relationship | 2004 |
[Study on the gene mutation of quinolone-resistant Mycobacterium tuberculosis isolated from Sichuan Province].
Topics: Antibiotics, Antitubercular; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Mutation; Mycobacterium tuberculosis; Ofloxacin; Polymorphism, Single-Stranded Conformational; Quinolones | 2004 |
[Study on the molecular mechanism of quinolone resistance in Shigellae spp].
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pipemidic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Quinolones; Shigella | 2004 |
Pharmacodynamics and bactericidal activity of gatifloxacin in experimental pneumonia caused by penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gatifloxacin; Levofloxacin; Lung; Mice; Mice, Inbred CBA; Ofloxacin; Penicillin Resistance; Pneumonia, Pneumococcal; Survival Rate | 2004 |
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Serratia Infections; Serratia marcescens | 2004 |
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Diabetes Complications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Ofloxacin; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
A cost threshold analysis of ciprofloxacin-dexamethasone versus ofloxacin for acute otitis media in pediatric patients with tympanostomy tubes.
Topics: Anti-Bacterial Agents; Canada; Child; Ciprofloxacin; Cost-Benefit Analysis; Costs and Cost Analysis; Dexamethasone; Drug Therapy, Combination; Humans; Middle Ear Ventilation; Ofloxacin; Otitis Media; Practice Patterns, Physicians'; Surveys and Questionnaires; United States | 2004 |
Oral quinolones in hospitalized patients: an evaluation of a computerized decision support intervention.
Topics: Administration, Oral; Ciprofloxacin; Costs and Cost Analysis; Decision Support Systems, Clinical; Fluoroquinolones; Hospital Units; Hospitalization; Humans; Injections, Intravenous; Ofloxacin; Prospective Studies; Quinolones | 2004 |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors | 2005 |
Spectrophotometric determination of some fluoroquinolone antibacterials by binary complex formation with xanthene dyes.
Topics: Anti-Infective Agents; Ciprofloxacin; Eosine Yellowish-(YS); Levofloxacin; Merbromin; Norfloxacin; Ofloxacin; Spectrophotometry, Ultraviolet; Tablets | 2004 |
Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Erythromycin; Humans; Legionella pneumophila; Microbial Sensitivity Tests; Ofloxacin; Thiamphenicol | 2004 |
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins | 2004 |
A retrospective study of endophtalmitis rates comparing quinolone antibiotics.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Databases, Factual; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Male; Middle Aged; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumococcal Infections; Population Surveillance; Serotyping; Streptococcus pneumoniae; Time Factors; United States | 2005 |
In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Models, Animal; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gemifloxacin; Levofloxacin; Mice; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Pneumococcal Infections; Point Mutation; Quinolines; Sepsis; Streptococcus pneumoniae; Treatment Outcome | 2005 |
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
[Simultaneous determination of quinolones in foods by LC/MS/MS].
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fishes; Fluoroquinolones; Food Analysis; Meat; Ofloxacin; Quinolones; Spectrometry, Mass, Electrospray Ionization | 2004 |
A comparison of effects of fluoroquinolones on fracture healing (an experimental study in rats).
Topics: Animals; Ciprofloxacin; Femoral Fractures; Fluoroquinolones; Fracture Healing; Norfloxacin; Ofloxacin; Pefloxacin; Rats; Rats, Wistar | 2005 |
Simultaneous determination of trace of loxacin, ciprofloxacin, and sparfloxacin by micelle TLC-fluorimetry.
Topics: Anti-Bacterial Agents; Calibration; Chromatography, Thin Layer; Ciprofloxacin; Fluorometry; Fluoroquinolones; Micelles; Ofloxacin | 2004 |
Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates--a retrospective study from a chest-disease institute in India.
Topics: Adult; Aged; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary | 2005 |
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line, Tumor; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcus aureus; Time Factors | 2005 |
Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
Topics: Amikacin; Aminosalicylic Acid; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethionamide; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Thailand | 2005 |
Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Forecasting; France; Hospitals, University; Humans; Ofloxacin; Regression Analysis; Time Factors; Urinary Tract Infections | 2005 |
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Taurine; Thiadiazines | 2005 |
Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Ciprofloxacin; Cystic Fibrosis; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia | 2005 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.
Topics: Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Computer Simulation; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Streptococcus pneumoniae; Time Factors | 2005 |
Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2005 |
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.
Topics: Anti-Infective Agents; Aza Compounds; Cell Line; Ciprofloxacin; Fluoroquinolones; Heat-Shock Response; Humans; Kinetics; Levofloxacin; Macrophages; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2005 |
In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Topics: Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Quinolones; Sampling Studies; Sensitivity and Specificity | 2005 |
The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.
Topics: Anti-Bacterial Agents; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Industry; Drug Stability; Fluoroquinolones; Hydrogen-Ion Concentration; Models, Chemical; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Reproducibility of Results; Tablets; Time Factors | 2005 |
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa | 2005 |
HPLC determination of enoxacin, ciprofloxacin, norfloxacin and ofloxacin with photoinduced fluorimetric (PIF) detection and multiemission scanning: application to urine and serum.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Sensitivity and Specificity; Spectrometry, Fluorescence | 2005 |
The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.
Topics: Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Levofloxacin; Moxifloxacin; Mutagenicity Tests; Naphthyridines; Ofloxacin; Quinolines; Selection, Genetic; Staphylococcus aureus; Streptococcus pneumoniae | 2005 |
Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
Topics: Amino Acid Substitution; Anti-Infective Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Molecular Epidemiology; Molecular Sequence Data; Ofloxacin; Spain; Streptococcal Infections; Streptococcus pyogenes | 2005 |
Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Transplantation; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rabbits | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Fetus; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Ofloxacin; Placenta; Pregnancy; Pregnancy Complications, Infectious | 2005 |
Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.
Topics: Anti-Bacterial Agents; Aza Compounds; Biopsy; Ciprofloxacin; Conjunctiva; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Tissue Distribution | 2005 |
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Point Mutation; Quinolines; Sequence Analysis, DNA | 2005 |
Ciprofloxacin, but not levofloxacin, affects cyclosporine blood levels in a patient with pure red blood cell aplasia.
Topics: Adult; Ciprofloxacin; Cyclosporine; Humans; Levofloxacin; Male; Ofloxacin; Red-Cell Aplasia, Pure | 2005 |
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Ceftriaxone; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Middle Aged; Ofloxacin; Product Surveillance, Postmarketing; Retrospective Studies | 2005 |
Glucose homeostasis abnormalities associated with use of gatifloxacin.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Glucose; Homeostasis; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines | 2005 |
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cystic Fibrosis; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Opportunistic Infections; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Quinolones | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
New, rapid fluorescence stain method for histologic sections using lanthanide complexes.
Topics: Ciprofloxacin; Fluorescent Dyes; Humans; Keratosis; Lanthanoid Series Elements; Microscopy, Fluorescence; Ofloxacin; Photons; Salivary Glands; Staining and Labeling | 2005 |
Typhoid and paratyphoid fever.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nepal; Ofloxacin; Salmonella enterica | 2005 |
Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Synergism; Fluoroquinolones; Fosfomycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones | 2005 |
Determinations of fluoroquinolones and nonsteroidal anti-inflammatory drugs in urine by extractive spectrophotometry and photoinduced spectrofluorimetry using multivariate calibration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry Techniques, Analytical; Ciprofloxacin; Diclofenac; Fluoroquinolones; Humans; Least-Squares Analysis; Mefenamic Acid; Ofloxacin; Photochemistry; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry; Spectrophotometry, Ultraviolet | 2005 |
Interactions between 4-quinolone antibacterials and multivalent metal ions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Bacteria; Metals; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones | 1989 |
Effect of fluorinated quinolones on heat-labile toxin production by Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Ciprofloxacin; Enterotoxins; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin | 1989 |
Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bronchitis; Cefixime; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Empyema, Pleural; Humans; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Safety; Treatment Outcome | 1989 |
Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Urinary Tract Infections | 2005 |
In vitro efficacy of the successive or staggered use of eardrops.
Topics: Acetic Acid; Adjuvants, Pharmaceutic; Administration, Topical; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dexamethasone; Drug Administration Schedule; Escherichia coli; Glucocorticoids; Humans; Microbial Sensitivity Tests; Ofloxacin; Otitis Media, Suppurative; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2006 |
Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP1A1; Dogs; Drug Interactions; Enrofloxacin; Fluoroquinolones; Male; Microsomes, Liver; Norfloxacin; Ofloxacin | 2005 |
Pharmacodynamic assessment of the activity of high-dose (750 mg) levofloxacin, ciprofloxacin, and gatifloxacin against clinical strains of Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Area Under Curve; Ciprofloxacin; DNA, Bacterial; Evaluation Studies as Topic; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2006 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits | 2006 |
Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa | 2006 |
Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Cell Line; Ciprofloxacin; Dogs; Female; Fluoroquinolones; Lactation; Male; Mice; Mice, Knockout; Milk; Neoplasm Proteins; Norfloxacin; Ofloxacin; Transfection | 2006 |
Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in mice.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Lung; Mice; Mice, Inbred BALB C; Ofloxacin; Orthomyxoviridae Infections; Pneumonia, Pneumococcal | 2006 |
Drug-induced QT prolongation.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Electrocardiography; Female; Humans; Long QT Syndrome; Ofloxacin; Risk Factors | 2006 |
Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Levofloxacin; Long QT Syndrome; Male; Ofloxacin; Prognosis; Prospective Studies; Prostatitis; Respiratory Tract Infections; Severity of Illness Index; Urinary Tract Infections | 2006 |
Comparative study of antimicrobial release kinetics from polymethylmethacrylate.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Cefazolin; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Polymethyl Methacrylate; Rifampin | 2006 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
Role of topical fluoroquinolones on the pathogenesis of diffuse lamellar keratitis in experimental in vivo studies.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Corneal Stroma; Disease Models, Animal; Endotoxins; Female; Keratitis; Keratomileusis, Laser In Situ; Ofloxacin; Pseudomonas aeruginosa; Rabbits; Surgical Flaps | 2006 |
Influence of sex on the pharmacokinetics of ciprofloxacin and ofloxacin.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Female; Glomerular Filtration Rate; Humans; Male; Ofloxacin; Sex Factors | 2006 |
Ultrastructural changes of the gemifloxacin on Achilles tendon in immature rats: comparison with those of ciproxacin and ofloxacin.
Topics: Achilles Tendon; Animals; Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Male; Microscopy, Electron, Transmission; Naphthyridines; Ofloxacin; Rats; Rats, Sprague-Dawley | 2006 |
Functional analysis of spoT, relA and dksA genes on quinolone tolerance in Pseudomonas aeruginosa under nongrowing condition.
Topics: Ciprofloxacin; Drug Resistance; Guanosine Tetraphosphate; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Quinolones | 2006 |
Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Humans; Levofloxacin; Male; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2006 |
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2006 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Escherichia coli; Fluoroquinolones; Formularies as Topic; Gatifloxacin; Gram-Negative Bacteria; Humans; Levofloxacin; Methicillin; Methicillin Resistance; Ofloxacin; Pseudomonas aeruginosa; Regression Analysis; Retrospective Studies; Staphylococcus aureus | 2006 |
Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Case-Control Studies; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Levofloxacin; Male; Middle Aged; Ofloxacin; Pseudomonas Infections; Quinolones; Regression Analysis; Retrospective Studies; Risk Factors | 2006 |
In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Enterococcus; Fluoroquinolones; Gatifloxacin; Gram-Positive Cocci; In Vitro Techniques; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pyrrolidines; Quinolines; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 2006 |
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body | 2007 |
Effectiveness of flouroquinolone therapy for gram-negative infections within the intensive care unit setting.
Topics: Acinetobacter; Alabama; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter cloacae; Escherichia coli; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Community; Humans; Intensive Care Units; Klebsiella oxytoca; Microbial Sensitivity Tests; Ofloxacin; Proteus mirabilis; Pseudomonas aeruginosa; Retrospective Studies | 2006 |
In vitro activity of fluoroquinolones against common respiratory pathogens.
Topics: Aza Compounds; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2006 |
Quinolones sensitize gram-negative bacteria to antimicrobial peptides.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 2006 |
Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.
Topics: Alleles; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance; Erythromycin; Genes, Bacterial; Genetic Variation; Hospitals; Humans; Levofloxacin; Medical Records; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Ofloxacin; Pneumococcal Infections; Retrospective Studies; Spain; Species Specificity; Streptococcus pyogenes; Superantigens; Tetracycline; Urban Population | 2006 |
Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Salmonella paratyphi A; Salmonella typhi | 2007 |
Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Joint Diseases; Male; Middle Aged; Ofloxacin; Retrospective Studies | 2006 |
[Otitis externa: which antibiotics are first choice?].
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Humans; Methicillin; Ofloxacin; Ointments; Otitis Externa; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
In vitro development of resistance to DX-619 and other quinolones in enterococci.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Polymerase Chain Reaction; Pyrrolidines; Quinolines; Quinolones; Sequence Analysis, DNA | 2006 |
Adsorption and oxidation of fluoroquinolone antibacterial agents and structurally related amines with goethite.
Topics: Absorption; Anti-Bacterial Agents; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Iron Compounds; Kinetics; Minerals; Molecular Structure; Norfloxacin; Ofloxacin; Oxidation-Reduction | 2007 |
Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aza Compounds; Bacterial Proteins; Canada; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genotype; Humans; Infant; Infant, Newborn; Levofloxacin; Middle Aged; Moxifloxacin; Naphthyridines; Ofloxacin; Pneumococcal Infections; Quinolines; Serotyping; Streptococcus pneumoniae | 2007 |
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Topics: Acute Disease; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Ciprofloxacin; Female; Humans; Itraconazole; Leukemia; Male; Middle Aged; Models, Theoretical; Ofloxacin; Practice Guidelines as Topic; Reproducibility of Results; Treatment Outcome | 2007 |
Determination of ofloxacin, norfloxacin, and ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography with fluorescence detection, and liquid chromatography--tandem mass spectrometry.
Topics: Chromatography, Liquid; Ciprofloxacin; Fluorescence; Molecular Structure; Norfloxacin; Ofloxacin; Reproducibility of Results; Sewage; Solid Phase Extraction; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2007 |
Evaluation of the penetration of fluoroquinolones in human conjunctival tissue.
Topics: Anti-Bacterial Agents; Aza Compounds; Biopsy; Ciprofloxacin; Conjunctiva; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Tissue Distribution | 2006 |
[Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration].
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutagenicity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines | 2006 |
Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Microbial Sensitivity Tests; Ofloxacin; Salmonella paratyphi A | 2006 |
In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Brazil; Ciprofloxacin; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2007 |
The first steps towards fluoroquinolone resistance in Hungarian pneumococci.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Hungary; Microbial Sensitivity Tests; Moxifloxacin; Mutation, Missense; Ofloxacin; Pneumococcal Infections; Quinolines; Streptococcus pneumoniae | 2006 |
Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
Topics: Administration, Inhalation; Aerosols; Animals; Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Ciprofloxacin; Disease Models, Animal; Mice; Mice, Inbred BALB C; Ofloxacin; Spores, Bacterial | 2007 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection | 2006 |
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
Topics: Anti-Infective Agents, Urinary; Bacterial Adhesion; Ciprofloxacin; Dioxolanes; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hemolysin Proteins; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Ultraviolet Rays; Urinary Tract Infections | 2007 |
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Topics: Action Potentials; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Fluoroquinolones; Heart Conduction System; In Vitro Techniques; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Rabbits; Torsades de Pointes | 2007 |
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus; Urinary Tract Infections | 2006 |
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical | 2007 |
Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Aza Compounds; Benzalkonium Compounds; Cells, Cultured; Ciprofloxacin; Drug Combinations; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Preservatives, Pharmaceutical; Quinolines; Staphylococcus aureus | 2007 |
Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Doxycycline; Female; Fluoroquinolones; Gatifloxacin; Injections, Intraperitoneal; Leptospira interrogans; Leptospirosis; Levofloxacin; Mesocricetus; Ofloxacin; Serotyping; Survival Analysis | 2007 |
Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.
Topics: Anti-Infective Agents; Antimutagenic Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Osmolar Concentration; Quinolines | 2007 |
Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones.
Topics: Antigens, Polyomavirus Transforming; Antiviral Agents; Cell Line, Tumor; Ciprofloxacin; Cytopathogenic Effect, Viral; DNA Helicases; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Reproducibility of Results; Simian virus 40; Time Factors; Viral Plaque Assay; Virus Replication | 2007 |
Development of a monoclonal antibody-based broad-specificity ELISA for fluoroquinolone antibiotics in foods and molecular modeling studies of cross-reactive compounds.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibody Specificity; Ciprofloxacin; Enrofloxacin; Enzyme-Linked Immunosorbent Assay; Fluoroquinolones; Food Contamination; Inhibitory Concentration 50; Norfloxacin; Ofloxacin; Quantitative Structure-Activity Relationship; Sensitivity and Specificity | 2007 |
Resolution of ofloxacin-ciprofloxacin and ofloxacin-norfloxacin binary mixtures by flow-injection chemiluminescence in combination with partial least squares multivariate calibration.
Topics: Anti-Infective Agents; Cerium; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Combinations; Flow Injection Analysis; Least-Squares Analysis; Luminescent Measurements; Multivariate Analysis; Norfloxacin; Ofloxacin; Organometallic Compounds; Sulfuric Acids | 2007 |
Multidrug-induced erythema multiforme.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Levofloxacin; Methenamine; Ofloxacin; Piroxicam; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteriological Techniques; Cell Count; Cell Survival; Cells, Cultured; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Epithelium, Corneal; Fluoroquinolones; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pseudomonas aeruginosa; Quinolines; Serratia marcescens; Staphylococcus aureus | 2007 |
[Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory infections].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Levofloxacin; Moraxella catarrhalis; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections; Streptococcus | 2007 |
Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
Topics: Anti-Bacterial Agents; Armenia; Ciprofloxacin; Doxycycline; Gonorrhea; Humans; Kanamycin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Penicillins | 2007 |
An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Italy; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Effect of ototopical medications on tympanostomy tube biofilms.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biofilms; Ciprofloxacin; Dexamethasone; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Equipment Contamination; Humans; Middle Ear Ventilation; Ofloxacin; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors | 2007 |
Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Monte Carlo Method; Ofloxacin; Pseudomonas aeruginosa | 2007 |
In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple; Ethidium; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Reserpine; Streptococcus pneumoniae | 2007 |
[Fluoroquinolone-induced tendon diseases].
Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Female; Humans; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Ofloxacin; Rupture; Tendinopathy; Ultrasonography | 2007 |
Uptake of ciprofloxacin and ofloxacin by 2 Brucella strains and their fluoroquinolone-resistant variants under different conditions. An in vitro study.
Topics: Anti-Infective Agents; Brucella abortus; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Uncoupling Agents | 2007 |
Effects of ciprofloxacin/dexamethasone and ofloxacin on tympanic membrane perforation healing.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Dexamethasone; Ofloxacin; Rats; Rats, Sprague-Dawley; Tympanic Membrane; Tympanic Membrane Perforation; Wound Healing | 2007 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo.
Topics: Biological Transport; Carnitine; Cell Line, Tumor; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Ofloxacin; Organic Cation Transport Proteins; Piperazines; Placenta; Sodium; Solute Carrier Family 22 Member 5 | 2008 |
Improving the penetration of ototopicals through tympanostomy tubes: role of surfactants.
Topics: Administration, Topical; Anti-Bacterial Agents; Biological Products; Ciprofloxacin; Dexamethasone; Dioctyl Sulfosuccinic Acid; Middle Ear Ventilation; Models, Biological; Ofloxacin; Surface-Active Agents | 2008 |
Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease.
Topics: Adult; Aged; Ciprofloxacin; Female; Fluoroquinolones; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Ofloxacin; Outpatients; Pharmacy; Risk Factors; Tennessee; Time Factors; Tuberculosis | 2007 |
Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells.
Topics: Anti-Bacterial Agents; Aza Compounds; Biological Assay; Ciprofloxacin; Cornea; Corneal Stroma; Endothelial Cells; Endothelium, Corneal; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines | 2008 |
Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Cytokines; Disease Models, Animal; Fluoroquinolones; Levofloxacin; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Moxifloxacin; Ofloxacin; Quinolines; Respiratory Distress Syndrome | 2008 |
Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Fluoroquinolones; Humans; India; Male; Microbial Sensitivity Tests; Ofloxacin; Population Surveillance; Salmonella typhi; Typhoid Fever | 2008 |
Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis | 2008 |
[Clostridium clostridiiforme vertebral osteomyelitis].
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clostridium; Clostridium Infections; Drug Therapy, Combination; Humans; Immunocompetence; Male; Metronidazole; Ofloxacin; Osteomyelitis; Spine; Treatment Outcome | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Occurrence of qnr-positive clinical isolates in Klebsiella pneumoniae producing ESBL or AmpC-type beta-lactamase from five pediatric hospitals in China.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Child; Child, Preschool; China; Ciprofloxacin; Conjugation, Genetic; Cross Infection; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Ofloxacin; Plasmids | 2008 |
Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Chryseobacterium; Ciprofloxacin; Female; Flavobacteriaceae Infections; Humans; Infant; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2008 |
Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Bacterial; Porins | 2008 |
In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Anti-Bacterial Agents; Brucella abortus; Ciprofloxacin; DNA Gyrase; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Ofloxacin; Selection, Genetic; Sequence Analysis, DNA | 2008 |
In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay.
Topics: Agar; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Reproducibility of Results; Species Specificity; Tetrazolium Salts; Time Factors | 2008 |
Comparison of solid-phase sorbents for the determination of fluoroquinolone antibiotics in wastewater.
Topics: Adsorption; Anti-Bacterial Agents; Cation Exchange Resins; Chromatography, High Pressure Liquid; Ciprofloxacin; Edetic Acid; Enrofloxacin; Fluoroquinolones; Hydrophobic and Hydrophilic Interactions; Norfloxacin; Ofloxacin; Polymers; Reproducibility of Results; Sensitivity and Specificity; Sewage; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2008 |
Study of fluorescence characteristics of the charge-transfer reaction of quinolone agents with bromanil.
Topics: Anti-Bacterial Agents; Benzoquinones; Catalysis; Ciprofloxacin; Electrons; Energy Transfer; Models, Biological; Norfloxacin; Ofloxacin; Osmolar Concentration; Quinolones; Solvents; Spectrometry, Fluorescence; Technology, Pharmaceutical; Temperature; Time Factors | 2009 |
Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clostridioides difficile; Colony Count, Microbial; Cytotoxins; DNA Gyrase; Feces; Fluoroquinolones; Gastrointestinal Tract; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Ribotyping | 2009 |
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Cross-Sectional Studies; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines; Retrospective Studies | 2008 |
Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells.
Topics: Anti-Infective Agents; Aza Compounds; Cell Line; Cell Survival; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Epithelial Cells; Epithelium, Corneal; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Tetrazolium Salts; Thiazoles | 2008 |
[Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Eye; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pyelonephritis; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2008 |
Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Norfloxacin; Ofloxacin | 2009 |
Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; United States | 2009 |
Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumococcal Infections; Streptococcus pneumoniae; United States | 2008 |
[Fluorquinolone associated tendon rupture].
Topics: Achilles Tendon; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Bacterial Agents; Athletic Injuries; Chlamydia Infections; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Risk Factors; Rupture, Spontaneous; Soccer; Switzerland; Tendon Injuries; Urethritis | 2008 |
Common antibiotics for the treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Humans; Nitrofurantoin; Nurse's Role; Ofloxacin; Patient Education as Topic; Patient Selection; Sulfamethoxazole; Urinary Tract Infections | 2008 |
Determination of quinolone antibiotics in urine by capillary electrophoresis with chemiluminescence detection.
Topics: Anti-Infective Agents; Ciprofloxacin; Electrophoresis, Capillary; Humans; Luminescent Measurements; Molecular Structure; Norfloxacin; Ofloxacin; Quinolones; Sensitivity and Specificity; Solvents | 2008 |
Disturbance of cellular glucose transport by two prevalently used fluoroquinolone antibiotics ciprofloxacin and levofloxacin involves glucose transporter type 1.
Topics: Anti-Bacterial Agents; Biological Transport; Cell Line, Tumor; Ciprofloxacin; Glucose; Glucose Transporter Type 1; Humans; Levofloxacin; Ofloxacin; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes.
Topics: Animals; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Aza Compounds; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Fluoroquinolones; Gatifloxacin; Humans; Isoenzymes; Levofloxacin; Microsomes, Liver; Molecular Structure; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results | 2008 |
Study of antibiotic resistance by efflux in clinical isolates of Pseudomonas aeruginosa.
Topics: Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2007 |
The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacteria, Aerobic; Ciprofloxacin; Conjunctiva; Eye; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2009 |
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Aza Compounds; Candida albicans; Ciprofloxacin; Drug Antagonism; Drug Synergism; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2009 |
[Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
Topics: Administration, Oral; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Cost Control; Critical Care; Drug Costs; Enteral Nutrition; Humans; Injections, Intravenous; Intensive Care Units; Ofloxacin; Retrospective Studies | 2009 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines | 2009 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines | 2009 |
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Retrospective Studies; Staphylococcus; Streptococcus | 2010 |
Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
Topics: Anti-Bacterial Agents; Aza Compounds; Brucella melitensis; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Norfloxacin; Ofloxacin; Quinolines; Sequence Analysis, DNA | 2009 |
Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma.
Topics: Aza Compounds; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines | 2009 |
Development and in vitro evaluation of an Escherichia coli probiotic able to inhibit the growth of pathogenic Escherichia coli K88.
Topics: Animals; Anti-Bacterial Agents; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Feces; Ofloxacin; Probiotics; Rumen; Soil Microbiology; Swine | 2009 |
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies?
Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis as Topic; Metronidazole; Ofloxacin; Pancreatitis; Randomized Controlled Trials as Topic | 2009 |
[Resistant mutant prevention concentration of fluoroquinolones in clinical isolates of extended spectrum beta-lactamase (ESBL) producing and non-producing strains of Escherichia coli].
Topics: Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin | 2009 |
[Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo].
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cornea; Corneal Stroma; Corneal Ulcer; Data Interpretation, Statistical; Disease Models, Animal; Female; Gentamicins; Ofloxacin; Prospective Studies; Pseudomonas Infections; Rabbits; Tobramycin; Treatment Outcome | 2009 |
Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Topics: Anti-Infective Agents; Argentina; Biofilms; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Stenotrophomonas maltophilia | 2009 |
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Mutational Analysis; DNA Transposable Elements; Fluoroquinolones; Gene Expression Profiling; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Ofloxacin; Penicillin-Binding Proteins; Selection, Genetic; SOS Response, Genetics; Staphylococcal Infections; Transcription Factors; Up-Regulation | 2009 |
Antibiotic prophylaxis and ventilation tubes.
Topics: Administration, Topical; Antibiotic Prophylaxis; Child; Ciprofloxacin; Drug Approval; Humans; Middle Ear Ventilation; Ofloxacin; Practice Guidelines as Topic; Scotland | 2009 |
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Dioxolanes; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Phenylacetates; Piperazines; Receptors, GABA-A; Seizures | 2009 |
Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Neisseria gonorrhoeae; Ofloxacin; Quinolines; Selection, Genetic | 2009 |
Oxidative stress-mediated myocardiotoxicity of ciprofloxacin and ofloxacin in juvenile rats.
Topics: Animals; Anti-Infective Agents; Biomarkers; Ciprofloxacin; Heart; Heart Diseases; Malondialdehyde; Myocardium; Nitric Oxide; Ofloxacin; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2009 |
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
[Multi-residue determination of 11 quinolones in chicken muscle by high performance liquid chromatography with fluorescence detection].
Topics: Animals; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Fluorescence; Norfloxacin; Ofloxacin; Poultry Products; Quinolones | 2009 |
Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.
Topics: Anti-Infective Agents; Aza Compounds; Cell Survival; Cells, Cultured; Ciprofloxacin; Electric Impedance; Epithelial Cells; Epithelium, Corneal; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Norfloxacin; Ofloxacin; Ophthalmic Solutions; Preservatives, Pharmaceutical; Quinolines | 2010 |
[Chronic prostatitis and biofilm].
Topics: Adult; Biofilms; Chronic Disease; Ciprofloxacin; Contraception Behavior; Diet; Disease Susceptibility; Drug Resistance, Microbial; Humans; Italy; Male; Middle Aged; Ofloxacin; Prospective Studies; Prostatitis; Risk Factors; Sexual Behavior; Sexual Partners; Sexually Transmitted Diseases, Bacterial; Sexually Transmitted Diseases, Viral; Urinary Tract Infections; Young Adult | 2009 |
Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.
Topics: Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Comorbidity; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Outpatients; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Rhinitis; Sinusitis; Surgical Wound Infection | 2009 |
In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.
Topics: Aerosols; Anti-Bacterial Agents; Bacteria; Biofilms; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Cystic Fibrosis; Humans; Levofloxacin; Lung Diseases; Microbial Sensitivity Tests; Ofloxacin; Sputum | 2010 |
Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection.
Topics: Anti-Bacterial Agents; Aza Compounds; Calibration; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluorescence; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Reproducibility of Results | 2009 |
[Spontaneous bacterial peritonitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Humans; Ofloxacin; Peritonitis; Primary Prevention; Renal Insufficiency; Secondary Prevention | 2009 |
[Simultaneous analysis of 7 fluoroquinolone residues in chicken muscle by ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry].
Topics: Animals; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Fluoroquinolones; Food Contamination; Meat; Norfloxacin; Ofloxacin; Poultry; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cephalosporins; Cetuximab; Ciprofloxacin; ErbB Receptors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Paronychia; Retrospective Studies; Skin | 2010 |
Fluoroquinolone-induced generalized fixed drug eruption.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Eruptions; Female; Fluoroquinolones; Humans; Middle Aged; Ofloxacin | 2009 |
Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan | 2010 |
A comparative analysis of chromosomal aberrations in cultured human lymphocytes due to fluoroquinolone drugs at different expression periods.
Topics: Anti-Infective Agents; Cell Cycle; Cells, Cultured; Chromosome Aberrations; Ciprofloxacin; DNA Replication; Dose-Response Relationship, Drug; Fluoroquinolones; Gatifloxacin; Humans; Lymphocytes; Ofloxacin | 2010 |
Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteriological Techniques; Ciprofloxacin; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2010 |
Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Mass Index; Cefazolin; Ciprofloxacin; Cohort Studies; Drainage; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Obesity, Morbid; Ofloxacin; Retrospective Studies; Subcutaneous Fat, Abdominal; Surgical Wound Infection | 2010 |
Development of an immunoassay for ciprofloxacin based on phage-displayed antibody fragments.
Topics: Amino Acid Sequence; Binding, Competitive; Carbodiimides; Ciprofloxacin; Cross Reactions; Enrofloxacin; Enzyme-Linked Immunosorbent Assay; Fluoroquinolones; Humans; Immunoglobulin Light Chains; Immunoglobulin Variable Region; Microspheres; Ofloxacin; Peptide Library; Single-Chain Antibodies | 2010 |
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dioxolanes; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Respiratory Tract Infections; Selection, Genetic; Urinary Tract Infections | 2010 |
Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Fluoroquinolones; Humans; Least-Squares Analysis; Levofloxacin; Ofloxacin; Oxazines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
Topics: Acinetobacter; Anti-Infective Agents; Burn Units; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Ofloxacin; Pseudomonas aeruginosa | 2010 |
A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06).
Topics: Anti-Bacterial Agents; Canada; Ciprofloxacin; Drug Utilization; Fluoroquinolones; Humans; Influenza, Human; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Factors; Socioeconomic Factors | 2010 |
Competitive sorption and desorption behavior for three fluoroquinolone antibiotics in a wastewater treatment wetland soil.
Topics: Absorption; Adsorption; Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Kinetics; Norfloxacin; Ofloxacin; Soil; Soil Pollutants; Waste Disposal, Fluid; Wetlands | 2010 |
Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma.
Topics: Anti-Infective Agents; Chromatography, Liquid; Ciprofloxacin; Drug Stability; Fluoroquinolones; Humans; Levofloxacin; Linear Models; Norfloxacin; Ofloxacin; Reproducibility of Results; Sensitivity and Specificity | 2011 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Ofloxacin; Randomized Controlled Trials as Topic; Recurrence; Salmonella paratyphi A; Salmonella typhi; Travel; Typhoid Fever | 2010 |
Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Salmonella typhi | 2010 |
Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Escherichia coli; Feces; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Nasal Cavity; Ofloxacin; Pharynx; Prospective Studies; Risk Factors; Staphylococcus; Streptococcus; Young Adult | 2010 |
Effects of pathological conditions on ocular pharmacokinetics of antimicrobial drugs.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Ciprofloxacin; Cornea; Diffusion; Eye; Ofloxacin; Rabbits; Retina; Sclera; Time Factors; Vitreous Body | 2010 |
First molecular characterization of fluoroquinolone resistance in Aerococcus spp.
Topics: Aerococcus; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Molecular Sequence Data; Mutation; Ofloxacin; Polymerase Chain Reaction | 2011 |
Enhanced bacterial uptake and bactericidal properties of ofloxacin loaded on bioadhesive hydrogels against Pseudomonas aeruginosa.
Topics: Acrylic Resins; Adhesiveness; Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Hydrogels; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rheology; Viscosity | 2010 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Stability; Lactic Acid; Levofloxacin; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Surface-Active Agents; Vitamin E; Water | 2011 |
Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Cricetinae; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Male; Mesocricetus; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Prohibitins; Quinolines | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
Chemiluminescence determination of fluoroquinolones using Fenton system in the presence of terbium(iii) ions.
Topics: Ciprofloxacin; Fluoroquinolones; Hydrogen Peroxide; Ions; Iron; Luminescent Measurements; Norfloxacin; Ofloxacin; Pharmaceutical Preparations; Spectrometry, Fluorescence; Terbium | 2011 |
JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcus aureus | 2011 |
[Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Lethal Dose 50; Levofloxacin; Mice; Models, Animal; Nalidixic Acid; Ofloxacin; Plague; Virulence; Yersinia pestis | 2010 |
Fluoroquinolones influence the intracellular calcium handling in individuals susceptible to malignant hyperthermia.
Topics: Animals; Calcium; Ciprofloxacin; Disease Susceptibility; Fluoroquinolones; Levofloxacin; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Nucleic Acid Synthesis Inhibitors; Ofloxacin; Swine | 2011 |
Comparison of the chromatographic behavior of levofloxacin, ciprofloxacin and moxifloxacin on various HPLC phases.
Topics: Anti-Bacterial Agents; Aza Compounds; Calixarenes; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Indicators and Reagents; Ions; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Reference Standards; Solutions | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroparesis; Gastroscopy; Humans; Imipenem; Klebsiella oxytoca; Male; Ofloxacin; Pneumonia; Tomography, X-Ray Computed | 2011 |
Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.
Topics: Anti-Bacterial Agents; Aza Compounds; Binding Sites; Canada; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pneumococcal Infections; Quinolines; Streptococcus pneumoniae | 2011 |
Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats.
Topics: Achilles Tendon; Administration, Oral; Animals; Anti-Bacterial Agents; Ciprofloxacin; Elastic Modulus; Elasticity; Fluoroquinolones; Male; Norfloxacin; Ofloxacin; Pefloxacin; Rats; Rats, Wistar; Tensile Strength | 2011 |
In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Hydrogen-Ion Concentration; Klebsiella pneumoniae; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 2011 |
Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Prostatitis; Young Adult | 2011 |
Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.
Topics: Antitubercular Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Spain; Tuberculosis | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Prevalence of plasmid-mediated quinolone resistance determinants in Citrobacter freundii isolates from Anhui province, PR China.
Topics: China; Ciprofloxacin; Citrobacter freundii; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Sequence Data; Ofloxacin; Plasmids | 2011 |
Genotyping of two Neisseria gonorrhoeae fluroquinolone-resistant strains in the Brazilian Amazon Region.
Topics: Adult; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Phenotype | 2011 |
Two fluoroalcohols as components of basic buffers for liquid chromatography electrospray ionization mass spectrometric determination of antibiotic residues.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Lactuca; Mass Spectrometry; Norfloxacin; Ofloxacin; Propanols; Spectrometry, Mass, Electrospray Ionization; Sulfadimethoxine; Sulfamethoxazole | 2011 |
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Piperazine; Piperazines; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Italy; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pneumococcal Infections; Streptococcus pneumoniae | 2011 |
Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacte
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Line, Tumor; Ciprofloxacin; Dimerization; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Ofloxacin | 2011 |
In vivo sequential selection of Escherichia coli with topoisomerase- and efflux-mediated misleading quinolone resistance phenotypes.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type I; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Phenotype; Quinolones; Selection, Genetic; Sequence Analysis, DNA | 2012 |
Epididymo-orchitis: an unusual manifestation of salmonellosis.
Topics: Abscess; Administration, Intravenous; Administration, Oral; Ceftriaxone; Ciprofloxacin; Developing Countries; Epididymitis; Humans; India; Male; Middle Aged; Ofloxacin; Orchitis; Salmonella Infections; Salmonella paratyphi A; Treatment Outcome | 2012 |
Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Transcriptome; Young Adult | 2012 |
Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Delivery Systems; Implants, Experimental; Levofloxacin; Linear Models; Ofloxacin; Rabbits; Tandem Mass Spectrometry; Vitreous Body | 2012 |
Grafting of norfloxacin imprinted polymeric membranes on silica surface for the selective solid-phase extraction of fluoroquinolones in fish samples.
Topics: Adsorption; Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Fishes; Limit of Detection; Membranes, Artificial; Methacrylates; Molecular Imprinting; Norfloxacin; Ofloxacin; Polymers; Porosity; Silanes; Silica Gel; Solid Phase Extraction; Solvents; Vinyl Compounds | 2012 |
Critical appraisal of air pouch infection model in rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Exudates and Transudates; Female; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin | 2012 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
Application of ionic surfactant as a carrier and emulsifier agent for the microextraction of fluoroquinolones.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Ciprofloxacin; Emulsifying Agents; Environmental Monitoring; Limit of Detection; Liquid Phase Microextraction; Ofloxacin; Solvents; Surface-Active Agents; Water Pollutants, Chemical | 2012 |
[Prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr among ESBL producing enterobacteria isolates from Chilean hospitals].
Topics: Acetylation; Anti-Bacterial Agents; Bacterial Proteins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Ofloxacin; Polymorphism, Restriction Fragment Length; R Factors; Sequence Analysis, DNA; Substrate Specificity | 2012 |
Induction of mycobacterial resistance to quinolone class antimicrobials.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines | 2012 |
Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Respiratory Tract Infections; Thailand; Urinary Tract Infections | 2012 |
Plasmid-mediated quinolone resistance in extended-spectrum-β-lactamase- and AmpC β-lactamase-producing Serratia marcescens in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Quinolones; Serratia Infections; Serratia marcescens | 2012 |
Aluminium sensitized spectrofluorimetric determination of fluoroquinolones in milk samples coupled with salting-out assisted liquid-liquid ultrasonic extraction.
Topics: Acetonitriles; Aluminum; Ammonium Sulfate; Animals; Cattle; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Limit of Detection; Liquid-Liquid Extraction; Milk; Norfloxacin; Ofloxacin; Solutions; Spectrometry, Fluorescence; Temperature; Ultrasonics; Water | 2012 |
In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Topics: Bacterial Typing Techniques; Biofilms; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Levofloxacin; Lung Diseases; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gallbladder Diseases; Hospitalization; Humans; Levofloxacin; Liver Diseases; Microbial Sensitivity Tests; Ofloxacin; Population Surveillance; Practice Guidelines as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Taiwan; Time Factors | 2012 |
Susceptibility of Streptococcus pneumoniae clinical isolates to quinolones.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Piperazines; Streptococcus pneumoniae | 2012 |
Photodegradation of fluoroquinolones in surface water and antimicrobial activity of the photoproducts.
Topics: Anti-Infective Agents; Aza Compounds; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Moxifloxacin; Ofloxacin; Photolysis; Quinolines; Tandem Mass Spectrometry | 2012 |
Evidence of in vivo prophage induction during Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA, Viral; Feces; Fluoroquinolones; Genetic Variation; Genome, Viral; Humans; Levofloxacin; Lysogeny; Microbial Sensitivity Tests; Mitomycin; Molecular Sequence Data; Moxifloxacin; Myoviridae; Ofloxacin; Prophages; Quinolines; Sequence Analysis, DNA; Virus Activation | 2012 |
Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Gene Expression; Genes, MDR; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Stenotrophomonas maltophilia; Tetracycline | 2013 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
[The improvement of complex treatment of odontogenous periostitis in elderly patients].
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Jaw Diseases; Male; Middle Aged; Ofloxacin; Periostitis; Suppuration; Treatment Outcome | 2012 |
Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin | 2013 |
Interactions between new quinolone antibacterials and diagnostic drug containing manganese.
Topics: Algorithms; Anti-Bacterial Agents; Chelating Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Interactions; Levofloxacin; Manganese Compounds; Ofloxacin; Quinolones | 2013 |
Synthesis, in vitro antimycobacterial and antibacterial evaluation of IMB-070593 derivatives containing a substituted benzyloxime moiety.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Bacteria; Levofloxacin; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oximes; Piperidines; Staphylococcus aureus | 2013 |
The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Middle Aged; Mycoplasma hominis; Ofloxacin; Reproductive Tract Infections; Ureaplasma urealyticum; Young Adult | 2014 |
Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Norfloxacin; Ofloxacin; Streptococcal Infections; Streptococcus pyogenes; Virulence | 2013 |
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis | 2013 |
Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Case-Control Studies; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Tuberculosis | 2013 |
Ciprofloxacin is an inhibitor of the Mcm2-7 replicative helicase.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Ciprofloxacin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Minichromosome Maintenance Proteins; Ofloxacin; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2013 |
Biodegradation of ofloxacin, norfloxacin, and ciprofloxacin as single and mixed substrates by Labrys portucalensis F11.
Topics: Alphaproteobacteria; Anti-Bacterial Agents; Biotransformation; Carbon; Chromatography, Liquid; Ciprofloxacin; Culture Media; Environmental Pollutants; Fluorides; Humans; Mass Spectrometry; Metabolic Networks and Pathways; Norfloxacin; Ofloxacin | 2014 |
Performance of aerobic granular sludge in a sequencing batch bioreactor exposed to ofloxacin, norfloxacin and ciprofloxacin.
Topics: Aerobiosis; Bacteria; Batch Cell Culture Techniques; Biological Oxygen Demand Analysis; Bioreactors; Ciprofloxacin; Cluster Analysis; Denaturing Gradient Gel Electrophoresis; Nitrogen; Norfloxacin; Ofloxacin; Phosphates; Phylogeny; RNA, Ribosomal, 16S; Sewage | 2014 |
The Successive Projections Algorithm for interval selection in trilinear partial least-squares with residual bilinearization.
Topics: Algorithms; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Hydroquinones; Least-Squares Analysis; Levodopa; Ofloxacin; Phenylalanine; Software; Spectrophotometry, Ultraviolet; Tryptophan; Water | 2014 |
Degradation of fluoroquinolone antibiotics and identification of metabolites/transformation products by liquid chromatography-tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Aza Compounds; Biotransformation; Chromatography, Liquid; Ciprofloxacin; Fluoroquinolones; Moxifloxacin; Norfloxacin; Ofloxacin; Photolysis; Quinolines; Tandem Mass Spectrometry | 2014 |
Inhibitory effect of ciprofloxacin on β-glucuronidase-mediated deconjugation of mycophenolic acid glucuronide.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Enterohepatic Circulation; Glucuronidase; Glucuronides; Immunosuppressive Agents; In Vitro Techniques; Inhibitory Concentration 50; Levofloxacin; Mycophenolic Acid; Ofloxacin; Phenolphthaleins; Time Factors | 2014 |
[Simultaneous determination of clopidol, sulfonamide and quinolone residues in chickens by ultra performance liquid chromatography-tandem mass spectrometry].
Topics: Animals; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Clopidol; Drug Residues; Enrofloxacin; Fluoroquinolones; Food Contamination; Hexanes; Meat; Norfloxacin; Ofloxacin; Quinolones; Sulfanilamide; Sulfanilamides; Sulfonamides; Tandem Mass Spectrometry | 2013 |
Design optimality for models defined by a system of ordinary differential equations.
Topics: Ciprofloxacin; Computer Simulation; Models, Chemical; Models, Statistical; Ofloxacin; Research Design | 2014 |
The effect of some fluoroquinolone family members on biospeciation of copper(II), nickel(II) and zinc(II) ions in human plasma.
Topics: Ciprofloxacin; Coordination Complexes; Copper; Fluoroquinolones; Humans; Ions; Levofloxacin; Moxifloxacin; Nickel; Ofloxacin; Zinc | 2014 |
Utilization of theoretical studies of the imprinting ratio to guide experimental research into the molecular imprinted polymers formed using enrofloxacin and methacrylic acid.
Topics: Adsorption; Ciprofloxacin; Computer Simulation; Energy Transfer; Enrofloxacin; Fluoroquinolones; Hydrogen Bonding; Kinetics; Microscopy, Electron, Scanning; Models, Chemical; Models, Molecular; Molecular Imprinting; Molecular Structure; Ofloxacin; Polymethacrylic Acids; Spectrophotometry, Infrared; Structure-Activity Relationship; Surface Properties | 2014 |
Prevalence and detection of antibiotic-resistant determinant in Salmonella isolated from food-producing animals.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalothin; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Food Microbiology; Foodborne Diseases; Goats; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Polymerase Chain Reaction; Salmonella; Salmonella Infections; South Africa; Tetracycline | 2015 |
DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line; Ciprofloxacin; DNA Repair; Fluoroquinolones; HeLa Cells; Humans; Indoles; Ofloxacin; Photosensitizing Agents; Proliferating Cell Nuclear Antigen; Protein Carbonylation; Sulfonamides; Thioguanine; Ultraviolet Rays; Vemurafenib | 2014 |
[Contamination characteristics of fluoroquinolones in different kinds of soil profiles in Southeast suburb of Beijing].
Topics: Anti-Bacterial Agents; China; Chromatography, High Pressure Liquid; Ciprofloxacin; Cities; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Soil; Soil Pollutants | 2014 |
Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2015 |
Parameters influencing ciprofloxacin, ofloxacin, amoxicillin and sulfamethoxazole retention by natural and converted calcium phosphates.
Topics: Adsorption; Amoxicillin; Anti-Bacterial Agents; Calcium Phosphates; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Durapatite; Hydrogen-Ion Concentration; Kinetics; Ofloxacin; Powders; Sulfamethoxazole | 2015 |
Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Linear Models; Longitudinal Studies; Male; Middle Aged; Moxifloxacin; Multivariate Analysis; Mycobacterium tuberculosis; Ofloxacin; Pneumonia, Bacterial; Taiwan; Tuberculosis, Pulmonary; Young Adult | 2015 |
[Determination of 25 quinolones in cosmetics by liquid chromatography-tandem mass spectrometry].
Topics: Chromatography, Liquid; Ciprofloxacin; Cosmetics; Drug Residues; Enrofloxacin; Fluoroquinolones; Hexanes; Norfloxacin; Ofloxacin; Quinolones; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
In-tube magnetic solid phase microextraction of some fluoroquinolones based on the use of sodium dodecyl sulfate coated Fe3O4 nanoparticles packed tube.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Humans; Limit of Detection; Magnetics; Magnetite Nanoparticles; Ofloxacin; Sodium Dodecyl Sulfate; Solid Phase Microextraction | 2015 |
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacteremia; Base Sequence; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Nalidixic Acid; Ofloxacin; Pefloxacin; Salmonella enterica; Salmonella Infections; Sequence Analysis, DNA | 2015 |
Simultaneous determination of fluoroquinolones in environmental water by liquid chromatography-tandem mass spectrometry with direct injection: A green approach.
Topics: Anti-Bacterial Agents; Brazil; Chromatography, Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Fresh Water; Gemifloxacin; Green Chemistry Technology; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2015 |
Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Humans; Imipenem; Keratoplasty, Penetrating; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Visual Acuity | 2016 |
The occurrence and removal of selected fluoroquinolones in urban drinking water treatment plants.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; China; Ciprofloxacin; Drinking Water; Enrofloxacin; Environmental Monitoring; Fluoroquinolones; Norfloxacin; Ofloxacin; Water Pollutants, Chemical; Water Purification | 2015 |
Impacts of urbanization on the prevalence of antibiotic-resistant Escherichia coli in the Chaophraya River and its tributaries.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Rivers; Tetracycline; Thailand; Urbanization; Water Microbiology | 2016 |
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gatifloxacin; Gene Expression; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Thailand; Tuberculosis, Pulmonary | 2016 |
Electrochemical oxidation of fluoroquinolone antibiotics: Mechanism, residual antibacterial activity and toxicity change.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin | 2016 |
National Utilization and Forecasting of Ototopical Antibiotics: Medicaid Data Versus "Dr. Google".
Topics: Anti-Bacterial Agents; Ciprofloxacin; Databases, Factual; Dexamethasone; Drug Combinations; Forecasting; Humans; Hydrocortisone; Internet; Male; Medicaid; Neomycin; Ofloxacin; Otitis Externa; Polymyxin B; Practice Patterns, Physicians'; Seasons; United States | 2016 |
[Development of Determination Method of Fluoroquinolone Antibiotics in Sludge Based on Solid Phase Extraction and HPLC-Fluorescence Detection Analysis].
Topics: Adsorption; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluorescence; Fluoroquinolones; Norfloxacin; Ofloxacin; Sewage; Solid Phase Extraction; Wastewater; Water Pollutants, Chemical | 2016 |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella | 2016 |
Surface plasmon resonance sensor for antibiotics detection based on photo-initiated polymerization molecularly imprinted array.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cross-Linking Reagents; Methacrylates; Molecular Imprinting; Ofloxacin; Penicillins; Polymerization; Succinates; Surface Plasmon Resonance; Ultraviolet Rays | 2016 |
[Donovanosis (granuloma inguinale)].
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Erythromycin; Granuloma Inguinale; Humans; Ofloxacin | 2016 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2016 |
Preparation of polysulfone materials on nickel foam for solid-phase microextraction of floxacin in water and biological samples.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Eggs; Enrofloxacin; Fluoroquinolones; Food Analysis; Milk; Molecular Imprinting; Nickel; Ofloxacin; Polymers; Solid Phase Microextraction; Sulfones; Water; Water Pollutants, Chemical | 2017 |
Penetration of 0.3% ciprofloxacin, 0.3% ofloxacin, and 0.5% moxifloxacin into the cornea and aqueous humor of enucleated human eyes.
Topics: Aqueous Humor; Bayes Theorem; Cadaver; Ciprofloxacin; Cornea; Eye Enucleation; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin | 2017 |
Prevalence and characterisation of quinolone resistance genes in Aeromonas spp. isolated from pet turtles in South Korea.
Topics: Aeromonas; Amino Acid Substitution; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Plasmids; Polymerase Chain Reaction; Quinolones; Republic of Korea; Turtles | 2017 |
The SIGN 104 guideline (2014) for topical antibiotic prophylaxis during grommet insertion: Misguided?
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clinical Protocols; Humans; Middle Ear Ventilation; Ofloxacin; Otitis Media with Effusion; Practice Guidelines as Topic; Sodium Chloride; Therapeutic Irrigation | 2018 |
Oil shale powders and their interactions with ciprofloxacin, ofloxacin, and oxytetracycline antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Ciprofloxacin; Environmental Restoration and Remediation; Hydrophobic and Hydrophilic Interactions; Minerals; Morocco; Ofloxacin; Oxytetracycline; Powders; Soil Pollutants | 2017 |
Biochanin A partially restores the activity of ofloxacin and ciprofloxacin against topoisomerase IV mutation-associated fluoroquinolone-resistant Ureaplasma species.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Genistein; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Phytoalexins; Sesquiterpenes; Ureaplasma | 2017 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Cytotoxicity of Ciprofloxacin and Steroids in Mouse Tympanic Membrane Fibroblasts.
Topics: Animals; Cells, Cultured; Ciprofloxacin; Dexamethasone; Ear Diseases; Fibroblasts; Fluocinolone Acetonide; In Vitro Techniques; Mice; Ofloxacin; Prospective Studies; Tympanic Membrane | 2018 |
Effects of Common Ear Drops on Tympanic Membrane Healing in Rats.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dexamethasone; Glucocorticoids; Instillation, Drug; Male; Neomycin; Ofloxacin; Rats; Rats, Sprague-Dawley; Time Factors; Tympanic Membrane Perforation; Wound Healing | 2018 |
When antibiotics turn toxic.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antioxidants; Ciprofloxacin; Female; Fluoroquinolones; Genetic Testing; Humans; Inactivation, Metabolic; Levofloxacin; Male; Mice; Mitochondria; Naphthyridines; Ofloxacin; Oxidative Stress; Syndrome; Topoisomerase II Inhibitors; United States; United States Food and Drug Administration | 2018 |
Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicity and evaluation against drug-resistant tuberculosis.
Topics: Cell Line, Tumor; Cell Survival; Ciprofloxacin; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Fluoroquinolones; Humans; MCF-7 Cells; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Multidrug-Resistant | 2018 |
Variable-valence metals catalyzed solid NaBiO
Topics: Bismuth; Catalysis; Ciprofloxacin; Metals; Nanostructures; Norfloxacin; Ofloxacin; Oxidation-Reduction; Oxidative Stress; Oxygen; Sodium; X-Ray Diffraction | 2018 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
An automated on-line turbulent flow liquid-chromatography technology coupled to a high resolution mass spectrometer LTQ-Orbitrap for suspect screening of antibiotic transformation products during microalgae wastewater treatment.
Topics: Anti-Bacterial Agents; Biotransformation; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Macrolides; Microalgae; Ofloxacin; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical; Water Purification | 2018 |
Lipid metabolism disorder induced by up-regulation of miR-125b and miR-144 following β-diketone antibiotic exposure to F0-zebrafish (Danio rerio).
Topics: Animals; Anti-Bacterial Agents; Atherosclerosis; Chlortetracycline; Cholesterol; Ciprofloxacin; Computational Biology; Disease Models, Animal; Doxycycline; Enrofloxacin; Female; Hyperlipidemias; Larva; Lipid Metabolism; Male; MicroRNAs; Ofloxacin; Oxytetracycline; Peroxisome Proliferator-Activated Receptors; Triglycerides; Up-Regulation; Zebrafish; Zebrafish Proteins | 2018 |
[Effect of Fluoroquinolones on Performance and Microbial Community of a Vertical Flow Constructed Wetland].
Topics: Ammonia; Ciprofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Proteobacteria; Water Pollutants, Chemical; Wetlands | 2018 |
Anaphylactic shock secondary to oral ofloxacin administration with cross-reactivity to levofloxacin and ciprofloxacin.
Topics: Administration, Oral; Adolescent; Anaphylaxis; Ciprofloxacin; Cross Reactions; Drug Hypersensitivity; Escherichia coli Infections; Female; Humans; Levofloxacin; Ofloxacin; Skin Tests; Urinary Tract Infections | 2018 |
Degradation kinetics of cold plasma-treated antibiotics and their antimicrobial activity.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Escherichia coli; Free Radical Scavengers; Kinetics; Nitrates; Ofloxacin; Oxalic Acid; Plasma Gases; Pseudomonas aeruginosa; Wastewater; Water Purification | 2019 |
Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Female; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Moxifloxacin; Norfloxacin; Ofloxacin; Peripheral Nervous System Diseases; Risk Factors; Sex Factors; United Kingdom | 2019 |
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Moxifloxacin; Ofloxacin; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Molecular Modification of Fluoroquinolone-Biodegrading Enzymes Based on Molecular Docking and Homology Modelling.
Topics: Amino Acids; Anti-Bacterial Agents; Binding Sites; Biodegradation, Environmental; Ciprofloxacin; Models, Molecular; Norfloxacin; Ofloxacin | 2019 |
Commercial Quinolone Ear Drops Cause Perforations in Intact Rat Tympanic Membranes.
Topics: Animals; Ciprofloxacin; Dexamethasone; Female; Hydrocortisone; Male; Methylprednisolone Hemisuccinate; Middle Ear Ventilation; Neomycin; Ofloxacin; Prostheses and Implants; Quinolones; Random Allocation; Rats; Rats, Sprague-Dawley; Tympanic Membrane; Tympanic Membrane Perforation | 2019 |
Development of quinolone resistance and prevalence of different virulence genes among Shigella flexneri and Shigella dysenteriae in environmental water samples.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Membrane Transport Proteins; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Plasmids; Prevalence; Quinolones; Shigella dysenteriae; Shigella flexneri; Virulence | 2020 |
Examination of Aggregate Formation upon Simultaneous Dissolution of Methacrylic Acid Copolymer LD Enteric Coating Agent, Pharmaceutical Additives, and Zwitterionic Ingredients.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Liberation; Ofloxacin; Polymethacrylic Acids; Static Electricity; Sulfur Compounds; Tablets, Enteric-Coated; Tegafur | 2020 |
Occurrence, sources and risk assessment of fluoroquinolones in dumpsite soil and sewage sludge from Chennai, India.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Cities; Environmental Monitoring; India; Norfloxacin; Ofloxacin; Risk Assessment; Sewage; Soil Pollutants; Waste Disposal Facilities; Water Pollutants, Chemical | 2020 |
Price Differences Between Otic and Ophthalmic Drops.
Topics: Administration, Topical; Anti-Bacterial Agents; Ciprofloxacin; Dexamethasone; Humans; Ofloxacin | 2021 |
Selective adsorption of ofloxacin and ciprofloxacin from a binary system using lignin-based adsorbents: Quantitative analysis, adsorption mechanisms, and structure-activity relationship.
Topics: Adsorption; Ciprofloxacin; Kinetics; Lignin; Ofloxacin; Structure-Activity Relationship; Water Pollutants, Chemical | 2021 |
Effects of natural colloidal particles derived from a shallow lake on the photodegradation of ofloxacin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Lakes; Ofloxacin; Photolysis; Water Pollutants, Chemical | 2021 |
A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Arthralgia; Ciprofloxacin; Connective Tissue Diseases; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Musculoskeletal Diseases; Myalgia; Norfloxacin; Ofloxacin; Pain; Risk Factors; Tendinopathy; Tendons; Young Adult | 2021 |
Cost-effectiveness of Inpatient Tympanostomy Prophylaxis.
Topics: Administration, Topical; Child; Ciprofloxacin; Cost-Benefit Analysis; Humans; Inpatients; Middle Ear Ventilation; Ofloxacin | 2021 |
Chronic ecotoxicology and statistical investigation of ciprofloxacin and ofloxacin to Daphnia magna under extendedly long-term exposure.
Topics: Animals; Ciprofloxacin; Daphnia; Ecosystem; Ecotoxicology; Ofloxacin; Reproduction; Water Pollutants, Chemical | 2021 |
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
Green preparation of porous hierarchical TiO
Topics: Anti-Bacterial Agents; Catalysis; Chloramphenicol; Ciprofloxacin; Ofloxacin; Particle Size; Photochemical Processes; Porosity; Surface Properties; Titanium | 2021 |
Simultaneous Determination of Ciprofloxacin and Ofloxacin in Animal Tissues with the Use of Capillary Electrophoresis with Transient Pseudo-Isotachophoresis.
Topics: Animals; Ciprofloxacin; Electrophoresis, Capillary; Isotachophoresis; Liquid-Liquid Extraction; Ofloxacin | 2021 |
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Laos; Ofloxacin; Prevalence; Sulfamethoxazole; Trimethoprim | 2022 |
Occurrence of plasmid-mediated quinolone resistance genes in Pseudomonas aeruginosa strains isolated from clinical specimens in southwest Iran: a multicentral study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Quinolones | 2022 |
A molecularly imprinted polymer nanoparticle-based surface plasmon resonance sensor platform for antibiotic detection in river water and milk.
Topics: Allergens; Animals; Anti-Bacterial Agents; Ciprofloxacin; Milk; Molecular Imprinting; Molecularly Imprinted Polymers; Moxifloxacin; Nanoparticles; Ofloxacin; Rivers; Surface Plasmon Resonance; Water | 2022 |
Simple, fast and reliable CE method for simultaneous determination of ciprofloxacin and ofloxacin in human urine.
Topics: Borates; Ciprofloxacin; Electrophoresis, Capillary; Humans; Liquid-Liquid Extraction; Ofloxacin; Reproducibility of Results | 2022 |
Efficient with low-cost removal and adsorption mechanisms of norfloxacin, ciprofloxacin and ofloxacin on modified thermal kaolin: experimental and theoretical studies.
Topics: Adsorption; Ciprofloxacin; Humans; Kaolin; Kinetics; Models, Theoretical; Norfloxacin; Ofloxacin; Water Pollutants, Chemical | 2022 |
Association between fluoroquinolone exposure and children's growth and development: A multisite biomonitoring-based study in northern China.
Topics: Animals; Anti-Bacterial Agents; Biological Monitoring; Child; China; Ciprofloxacin; Enrofloxacin; Fleroxacin; Fluoroquinolones; Humans; Obesity; Ofloxacin; Overweight | 2022 |
Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Urinary Tract; Urinary Tract Infections | 2022 |
Antibiotics in sewage treatment plants, receiving water bodies and groundwater of Chennai city and the suburb, South India: Occurrence, removal efficiencies, and risk assessment.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Environmental Monitoring; Erythromycin; Fluoroquinolones; Groundwater; India; Macrolides; Ofloxacin; Risk Assessment; Sewage; Sulfamethazine; Tetracyclines; Water; Water Pollutants, Chemical | 2022 |
Antibiotics and antimycotics in waste water treatment plants: Concentrations, removal efficiency, spatial and temporal variations, prediction, and ecological risk assessment.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clotrimazole; Environmental Monitoring; Moxifloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Purification | 2022 |
EEM-PARAFAC as a convenient methodology to study fluorescent emerging pollutants degradation: (fluoro)quinolones oxidation in different water matrices.
Topics: Anti-Bacterial Agents; Chlorides; Ciprofloxacin; Coloring Agents; Enrofloxacin; Environmental Pollutants; Ferric Compounds; Humic Substances; Hydrogen Peroxide; Iron; Ofloxacin; Oxolinic Acid; Quinolones; Thiabendazole; Wastewater; Water; Water Pollutants, Chemical | 2022 |
Quantitative assessment of interactions of hydrophilic organic contaminants with microplastics in natural water environment.
Topics: Adsorption; Aged; Ciprofloxacin; Humans; Microplastics; Ofloxacin; Plastics; Polystyrenes; Water; Water Pollutants, Chemical | 2022 |
Introduction of maltodextrin nanosponges as green extraction phases: Magnetic solid phase extraction of fluoroquinolones.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Magnetic Phenomena; Moxifloxacin; Ofloxacin; Polysaccharides; Solid Phase Extraction; Wastewater; Water | 2022 |
Bioremediation of copper in sediments from a constructed wetland ex situ with the novel bacterium Cupriavidus basilensis SRS.
Topics: Anti-Bacterial Agents; Biodegradation, Environmental; Ciprofloxacin; Copper; Cupriavidus; Mercury; Metals, Heavy; Nickel; Ofloxacin; Tetracyclines; Tritium; Uranium; Water; Wetlands; Zinc | 2022 |
Insight into different adsorption behaviors of two fluoroquinolone antibiotics by sediment aggregation fractions.
Topics: Adsorption; Anti-Bacterial Agents; China; Ciprofloxacin; Extracellular Polymeric Substance Matrix; Geologic Sediments; Humic Substances; Ofloxacin; Water Pollutants, Chemical | 2023 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifloxacin; Humans; Longitudinal Studies; Moxifloxacin; Ofloxacin; Retrospective Studies | 2022 |
Mechanism of downward migration of quinolone antibiotics in antibiotics polluted natural soil replenishment water and its effect on soil microorganisms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Ofloxacin; Soil; Soil Pollutants; Water; Water Pollutants, Chemical; Water Pollution | 2023 |
Fluorescent strip sensor for rapid and ultrasensitive determination of fluoroquinolones in fish and milk.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Milk; Norfloxacin; Ofloxacin; Pefloxacin | 2023 |
Use of Fluorescence Spectroscopy and Chemometrics to Visualise Fluoroquinolones Photodegradation Major Trends: A Confirmation Study with Mass Spectrometry.
Topics: Chemometrics; Ciprofloxacin; Enrofloxacin; Factor Analysis, Statistical; Fluoroquinolones; Humic Substances; Mass Spectrometry; Ofloxacin; Oxolinic Acid; Photolysis; Spectrometry, Fluorescence; Water Pollutants, Chemical | 2023 |
Hybrid process of adsorption and electrochemically based green regeneration of bentonite clay for ofloxacin and ciprofloxacin removal.
Topics: Adsorption; Anti-Bacterial Agents; Bentonite; Ciprofloxacin; Clay; Kinetics; Ofloxacin; Water; Water Pollutants, Chemical | 2023 |
Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Drug Screening Assays, Antitumor; Fluoroquinolones; Humans; Molecular Structure; Moxifloxacin; Ofloxacin; Structure-Activity Relationship | 2023 |
In-Class Cross-Reactivity among Hospitalized Patients with Hypersensitivity Reactions to Fluoroquinolones.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Hypersensitivity; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines | 2023 |
Field measures of strengthen plant-microbial remediation of PAHs-FQs compound pollution.
Topics: Ciprofloxacin; Enrofloxacin; Fluorenes; Molecular Docking Simulation; Norfloxacin; Ofloxacin; Peroxidases; Polycyclic Aromatic Hydrocarbons | 2023 |
A luminous strategy for the recognition of toxic antibiotics in water via efficient energy transfer.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Energy Transfer; Fluoroquinolones; India; Metal-Organic Frameworks; Norfloxacin; Ofloxacin; Water | 2023 |
Adsorption kinetics of ciprofloxacin and ofloxacin by green-modified carbon nanotubes.
Topics: Adsorption; Ciprofloxacin; Kinetics; Nanotubes, Carbon; Ofloxacin; Spectroscopy, Fourier Transform Infrared; Water Pollutants, Chemical | 2023 |
The Use of Extraction on C18-Silica-Modified Magnetic Nanoparticles for the Determination of Ciprofloxacin and Ofloxacin in Meat Tissues.
Topics: Ciprofloxacin; Magnetite Nanoparticles; Meat; Ofloxacin; Silicon Dioxide | 2023 |
An optimized electro-fenton pretreatment for the degradation and mineralization of a mixture of ofloxacin, norfloxacin, and ciprofloxacin.
Topics: Carboxylic Acids; Ciprofloxacin; Electrodes; Fluoroquinolones; Hydrogen Peroxide; Norfloxacin; Ofloxacin; Oxidation-Reduction; Water Pollutants, Chemical | 2023 |
Biogenic synthesis of ZnO and Al2O3 nanoparticles using Camellia sinensis and Origanum vulgare L. leaves extract for spectroscopic estimation of ofloxacin and ciprofloxacin in commercial formulations.
Topics: Aluminum Oxide; Camellia sinensis; Ciprofloxacin; Metal Nanoparticles; Nanoparticles; Ofloxacin; Origanum; Oxides; Zinc Oxide | 2023 |